syndrome	score	normalized_score
EARLY-ONSET SCHIZOPHRENIA	8.079415689999998	100.0
SMITH-MAGENIS SYNDROME; SMS	5.127454474	63.463184353124944
PANDAS	2.62987681	32.550334218538026
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	2.21471485	27.41181955449059
KLEINE-LEVIN HIBERNATION SYNDROME	2.0192308	24.992287530139453
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	24.754265366930273
NARCOLEPSY 1; NRCLP1	1.8373013	22.740521969602984
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	1.4245958399999998	17.632411731992466
TRICHOTHIODYSTROPHY	1.2279428840000002	15.19841200298484
BRAIN-LUNG-THYROID SYNDROME	1.221783774	15.122179881302781
16P12.1P12.3 TRIPLICATION SYNDROME	1.2215289	15.119025271987216
CITRULLINEMIA TYPE II	1.188060604	14.704783731705731
MOWAT-WILSON SYNDROME; MOWS	1.1169643	13.824815343793759
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	1.1105442	13.745352914252646
SCHIZOPHRENIA	1.0894928	13.484796943279944
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	1.0666667	13.202275274933903
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	1.04261392	12.904570825467705
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	1.00740741	12.468815179875962
CHAR SYNDROME	1.000545554	12.383885077709131
PLUMMER-VINSON SYNDROME	1.0	12.377132683465137
KIFAFA SEIZURE DISORDER	1.0	12.377132683465137
RETINITIS PIGMENTOSA 75; RP75	1.0	12.377132683465137
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.0	12.377132683465137
EHLERS-DANLOS SYNDROME, TYPE I	1.0	12.377132683465137
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	12.377132683465137
TARDIVE DYSKINESIA	1.0	12.377132683465137
7Q11.23 MICRODUPLICATION SYNDROME	0.8758435399999999	10.840431704535805
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.8490228000000001	10.508467846887084
NARCOLEPSY 3; NRCLP3	0.8373013	10.363389286137847
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.78320745	9.693862527328386
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.78174704	9.675786838986127
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.74627125	9.236698279105383
CRI-DU-CHAT SYNDROME	0.71661628	8.869654780691203
FRONTOTEMPORAL DEMENTIA; FTD	0.70380691	8.711111508609605
POSTENCEPHALITIC PARKINSONISM	0.7008730400000001	8.674798610343569
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.6642505	8.221516573558059
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.66145674	8.186937835352301
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.6593625099999999	8.161017272772607
48,XXXY SYNDROME	0.626612904	7.755671053979403
INHERITED CREUTZFELDT-JAKOB DISEASE	0.61823916	7.652028113434032
XQ12-Q13.3 DUPLICATION SYNDROME	0.57218761	7.082041968804803
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.5641516299999999	6.982579578103129
OBSESSIVE-COMPULSIVE DISORDER 1	0.55883255	6.916744619189165
15Q OVERGROWTH SYNDROME	0.55616517	6.883730103011944
MOMO SYNDROME	0.5495250500000001	6.801544456737814
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.5492597	6.798260184580256
COG5-CDG	0.54119421	6.698432544693095
BRACHYDACTYLY TYPE A2	0.537037	6.6469782049300665
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.5365890639999998	6.641434041624364
MANGANESE POISONING	0.53548949	6.627824468331078
NON-DISTAL MONOSOMY 20Q	0.5256812500000001	6.506426580459809
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.52487445	6.496440709810787
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.52487445	6.496440709810787
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.52487445	6.496440709810787
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.5172414	6.401965437181263
CHROMOSOME 1P36 DELETION SYNDROME	0.517214754	6.401635636103781
ZUNICH NEUROECTODERMAL SYNDROME	0.51640336	6.391592904907213
RING CHROMOSOME 13 SYNDROME	0.51073229	6.321401319059994
WILLIAMS-BEUREN SYNDROME; WBS	0.51001775	6.312557362672353
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.506101114	6.264080639227515
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.502714754	6.222167212193535
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.5021692	6.215414817949541
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.5021692	6.215414817949541
SPONDYLOPERIPHERAL DYSPLASIA	0.50204918	6.213929314484871
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.500545554	6.195318735976564
W SYNDROME	0.500545554	6.195318735976564
BRACHYDACTYLY, TYPE D	0.5	6.188566341732568
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	6.188566341732568
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	0.5	6.188566341732568
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.5	6.188566341732568
613241 PSEUDOPILI ANNULATI	0.5	6.188566341732568
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.5	6.188566341732568
BRACHYDACTYLY TYPE C	0.5	6.188566341732568
SEMANTIC DEMENTIA	0.5	6.188566341732568
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.5	6.188566341732568
MADELUNG DEFORMITY	0.5	6.188566341732568
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	6.188566341732568
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.5	6.188566341732568
YOUNG-ONSET PARKINSON DISEASE	0.48612374999999997	6.0168181543336345
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.476074244	5.8924340851683565
16P13.2 MICRODELETION SYNDROME	0.462467824	5.724025619481403
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.461298714	5.709555389889837
MUCOPOLYSACCHARIDOSIS TYPE 2	0.45852682400000006	5.675247339575868
CONGENITAL MYASTHENIC SYNDROME	0.45476170000000005	5.628645900258168
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.45476170000000005	5.628645900258168
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.44987445	5.568155758550902
AUTISM	0.44987445	5.568155758550902
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.44987445	5.568155758550902
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.44987445	5.568155758550902
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.44987445	5.568155758550902
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.44987445	5.568155758550902
WILLIAMS SYNDROME	0.44665295	5.52828282561112
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.44283220000000006	5.480992895910771
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.433169264	5.361393454926938
PRADER-WILLI SYNDROME	0.43041703	5.327328689532994
CHILDHOOD ABSENCE EPILEPSY	0.42509113	5.261409318574127
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	0.40920604	5.064797451955342
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.40644752399999995	5.03065493341388
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.4047616	5.009788028371642
CHILDHOOD DISINTEGRATIVE DISORDER	0.39708261	4.91474415026664
11Q22.2Q22.3 MICRODELETION SYNDROME	0.39644612399999996	4.906866278593472
X-LINKED ADRENOLEUKODYSTROPHY	0.39616841999999997	4.903429099338743
MONOSOMY 22Q13.3	0.393769224	4.873733932113105
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.3888886	4.813325801287
PLACENTAL INSUFFICIENCY	0.38385355	4.751006319369119
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.37821724999999995	4.681245086425304
CHRISTIANSON SYNDROME	0.36596514	4.529599095302895
CHROMOSOME 17Q12 DELETION SYNDROME	0.36537525000000004	4.522297948504246
NORMAL PRESSURE HYDROCEPHALUS	0.3585671	4.438032572625312
49,XXXXY SYNDROME	0.35426289400000005	4.384758843866346
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.352702394	4.365444328313798
ADNP SYNDROME	0.35143280999999993	4.349730518692993
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.34956927	4.326665236852048
TRICHOTILLOMANIA; TTM	0.349462	4.325337541829093
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.34453515	4.264357265667564
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.343644214	4.253330032583088
POSTERIOR CORTICAL ATROPHY	0.34280516	4.242944949896495
POLAND SYNDROME	0.34226157	4.236216864341091
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.34226157	4.236216864341091
ANGELMAN SYNDROME	0.340308434	4.212042640920238
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.33777744	4.180716192361184
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	0.33777744	4.180716192361184
MAJOR AFFECTIVE DISORDER 1	0.33777744	4.180716192361184
SPINOCEREBELLAR ATAXIA TYPE 42	0.33777744	4.180716192361184
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.337568594	4.178131277708774
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33702304	4.1713788834647785
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.333333	4.125706768777484
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	4.125706768777484
ISOLATED CLEFT LIP	0.333333	4.125706768777484
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.333333	4.125706768777484
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	4.125706768777484
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.333333	4.125706768777484
MAST SYNDROME	0.333333	4.125706768777484
BRACHYDACTYLY, TYPE A6	0.333333	4.125706768777484
BETA-KETOTHIOLASE DEFICIENCY	0.3287949	4.069538102946652
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.32573161	4.03162335616872
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.31839112399999997	3.9407691869856007
DUPLICATION/INVERSION 15Q11	0.31697817	3.9232808678519686
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.31154531	3.8560376387812783
GITELMAN SYNDROME	0.3104085	3.841967190575388
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.304561894	3.769602972365445
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.30326199	3.753513888081677
OROMANDIBULAR DYSTONIA	0.29989924	3.7118926851503553
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.296450364	3.669205489289537
2Q23.1 MICRODELETION SYNDROME	0.29409525000000003	3.6400559308268505
MYOCLONUS-DYSTONIA SYNDROME	0.29335654999999994	3.630912942913574
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.29239448000000007	3.6190052748727943
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.29190447	3.612940356086569
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.291667	3.6100011583882265
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.291667	3.6100011583882265
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.287607014	3.5597501729732155
21Q22.11Q22.12 MICRODELETION SYNDROME	0.28695860000000006	3.551724666861399
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.28283142	3.500642012392855
1P21.3 MICRODELETION SYNDROME	0.282549214	3.4971491112867854
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.27767455999999996	3.4368148719428007
HYPERTRYPTOPHANEMIA; HYPTRP	0.277273234	3.4318476067914765
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.27397014	3.390964774087519
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.27339140999999995	3.3838017560896168
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.262981554	3.2549575871618517
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.25921145	3.208294509723389
WILSON DISEASE	0.25918378	3.2079520344620374
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25892857	3.204793266429891
ESOPHAGEAL ATRESIA	0.25773862000000003	3.190065097393201
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25704225	3.1814460335064165
CHOANAL ATRESIA	0.25613719999999995	3.1702441095712457
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25369004	3.1399552855535777
PRADER-WILLI-LIKE SYNDROME	0.253023834	3.1317095654970575
PALLISTER-HALL SYNDROME	0.252594734	3.126398537862582
LYSINURIC PROTEIN INTOLERANCE	0.2521692	3.121131647083257
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	3.1010355651102794
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.250545554	3.1010355651102794
SEVERE HEMOPHILIA A	0.25	3.094283170866284
DYSTONIA 6, TORSION	0.25	3.094283170866284
GLOMUVENOUS MALFORMATION	0.25	3.094283170866284
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	3.094283170866284
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	3.094283170866284
HYPERPARATHYROIDISM 2	0.25	3.094283170866284
HEMOPHILIA B	0.25	3.094283170866284
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.25	3.094283170866284
CONGENITAL FACTOR II DEFICIENCY	0.25	3.094283170866284
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.25	3.094283170866284
UVEAL MELANOMA	0.25	3.094283170866284
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	3.094283170866284
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.24268294	3.003718948393409
8Q24.3 MICRODELETION SYNDROME	0.242305954	2.9990529426515997
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.23843362	2.9511245509389066
SPASTIC PARAPLEGIA 16, X-LINKED	0.23803410000000003	2.946179638889209
ADENYLOSUCCINASE DEFICIENCY	0.23648485400000002	2.9270044155878816
SAY-BARBER-MILLER SYNDROME	0.23548559400000002	2.914636441982602
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.23225810000000002	2.8746893205095145
PITT-HOPKINS SYNDROME	0.22731774400000002	2.813541878793961
PITT-HOPKINS-LIKE SYNDROME	0.22695584000000002	2.8090625449672846
NARCOLEPSY 7; NRCLP7	0.2261903	2.7995873548127848
PHELAN-MCDERMID SYNDROME	0.22590730399999998	2.796084675771894
DYSTONIA 11, MYOCLONIC	0.22549955000000002	2.791037850411681
POPOV-CHANG SYNDROME; POPCHAS	0.22520261400000002	2.787362634141184
TUBEROUS SCLEROSIS COMPLEX	0.22452100000000003	2.778926207224276
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.22247001000000002	2.753540831861816
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.220953754	2.734773930167716
CLEFT VELUM	0.2208333	2.733283055027462
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2204082	2.7280215359237205
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.21947030400000003	2.7164130726884297
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.219279264	2.7140485452605803
ALCOHOL DEPENDENCE	0.2172414	2.6888256321417234
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.21607024400000002	2.6743300789366873
CHROMOSOME 16P13.3 DELETION SYNDROME	0.215530554	2.667650264198748
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.21472004	2.6576184248789416
SCHIZOPHRENIA 10	0.2144928	2.6548058452479513
PAROXYSMAL HEMICRANIA	0.20990245	2.5979904742344067
STIFF-PERSON SYNDROME; SPS	0.20937055000000002	2.591407077360072
NARCOLEPSY TYPE 1	0.2089371	2.5860422091984234
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.20877193000000002	2.583997878193096
KEPPEN-LUBINSKY SYNDROME	0.20740741000000001	2.567109033103854
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.20648184	2.5556531304060193
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.20570885	2.5460857306130276
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.20570885	2.5460857306130276
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.20479756999999998	2.534806697141239
VELOCARDIOFACIAL SYNDROME	0.2047392	2.534084243906505
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.20444444	2.5304359602767272
BROOKE-SPIEGLER SYNDROME	0.203704	2.521271436152582
APNEA, OBSTRUCTIVE SLEEP	0.20368649999999996	2.521054836330621
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.2034824	2.5185286635499264
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.20271475400000002	2.5090274071539955
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20216920000000002	2.50227501291
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20216920000000002	2.50227501291
CARPENTER SYNDROME	0.20204918000000002	2.500789509445331
HSD10 DISEASE	0.20170466400000003	2.4965253892017545
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.20054555400000001	2.482178930937023
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.20054555400000001	2.482178930937023
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	2.4754265366930275
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.2	2.4754265366930275
PORPHYRIA CUTANEA TARDA, TYPE I	0.2	2.4754265366930275
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.2	2.4754265366930275
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.2	2.4754265366930275
ACUTE PROMYELOCYTIC LEUKEMIA	0.2	2.4754265366930275
LINEAR VERRUCOUS NEVUS SYNDROME	0.2	2.4754265366930275
CRANIOSYNOSTOSIS 4; CRS4	0.2	2.4754265366930275
ROMANO-WARD SYNDROME	0.2	2.4754265366930275
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.2	2.4754265366930275
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.2	2.4754265366930275
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	2.4754265366930275
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.199729394	2.4720772103260855
PEDIATRIC-ONSET GRAVES DISEASE	0.19800696399999998	2.4507584656781045
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.197928414	2.4497862419058185
PROGRESSIVE NON-FLUENT APHASIA	0.19787205000000002	2.449088617199248
HEREDITARY COPROPORPHYRIA	0.19663756000000002	2.433809170672837
TURNER SYNDROME	0.19660313999999998	2.433383149765872
MONOSOMY X	0.19660313999999998	2.433383149765872
MOSAIC MONOSOMY X	0.19660313999999998	2.433383149765872
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.19660313999999998	2.433383149765872
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.19535468000000003	2.4179307946958732
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.19457093000000003	2.4082302169552077
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.1938224	2.3989655618276533
8Q22.1 MICRODELETION SYNDROME	0.193053694	2.3894511856710774
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.19216655000000002	2.3784708866737376
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.18998064000000003	2.3514155885696244
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.187620754	2.322206966429772
GITELMAN SYNDROME	0.1870752	2.315454572185777
KOOLEN-DE VRIES SYNDROME; KDVS	0.186832944	2.3124561375304116
GM2 GANGLIOSIDOSIS, AB VARIANT	0.18674431000000002	2.311359102752146
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.18645467	2.307774190041706
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.1852756	2.2931806842086138
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.18500004	2.2897700415263578
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.18500004	2.2897700415263578
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.184875444	2.2882279003025285
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.184564554	2.284379973522566
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.18445289	2.2829978933786
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.18381190000000003	2.275064275099826
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.182857	2.2632453511003843
WITTEVEEN-KOLK SYNDROME	0.18199276399999997	2.252548587458557
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.18180294400000002	2.250199160132582
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.1813081	2.244074410286965
KOOLEN-DE VRIES SYNDROME	0.180350264	2.232219147025966
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.18021894	2.2305937324534426
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.18021894	2.2305937324534426
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.17700351	2.190795928709048
PFAPA SYNDROME	0.17543893000000002	2.1714309144551525
INSULINOMA	0.17526791	2.169314177223626
2Q32Q33 MICRODELETION SYNDROME	0.174990314	2.1658783346992267
AURICULOCONDYLAR SYNDROME	0.174143154	2.1553929229751025
MULTIPLE SYSTEM ATROPHY	0.173611	2.1488063823090657
TRIGEMINAL NEURALGIA	0.17328064	2.1447174727557567
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.17286090999999998	2.139522418854525
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.17275575999999998	2.138220963352859
XIA-GIBBS SYNDROME	0.17197395399999998	2.12854444675813
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.17195189400000002	2.128271407211133
PEMPHIGUS VULGARIS	0.17071558	2.1129693847947073
WAARDENBURG SYNDROME	0.17035704000000002	2.108531687642378
268650 RUDIGER SYNDROME	0.17020057000000002	2.106595037691396
ROIFMAN SYNDROME; RFMN	0.16926173400000002	2.0949749399513826
CHROMOSOME 16P13.2 DELETION SYNDROME	0.169095444	2.092916746557449
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.16871618000000002	2.0882225457073873
BRACHYDACTYLY, TYPE E	0.16871618000000002	2.0882225457073873
17Q24.2 MICRODELETION SYNDROME	0.16868845	2.0878793278180745
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.16836796399999998	2.083912630072881
MCLEOD SYNDROME; MCLDS	0.16835655	2.0837713574804324
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.167857	2.0775883608484076
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.16673976399999998	2.0637601826376635
BRACHYDACTYLY, TYPE B1	0.166667	2.062859572955084
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.166667	2.062859572955084
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.166667	2.062859572955084
247150 LIP PRINTS	0.166667	2.062859572955084
BRACHYDACTYLY TYPE B	0.166667	2.062859572955084
PARAGANGLIOMAS 4	0.166667	2.062859572955084
ACUTE ADRENAL INSUFFICIENCY	0.166667	2.062859572955084
XANTHOMA DISSEMINATUM	0.166667	2.062859572955084
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	2.062859572955084
SOLAR URTICARIA	0.166667	2.062859572955084
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.166667	2.062859572955084
PARAGANGLIOMAS 3	0.166667	2.062859572955084
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.166667	2.062859572955084
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.166667	2.062859572955084
PHLEBECTASIA OF LIPS	0.166667	2.062859572955084
BRACHYDACTYLY TYPE E	0.166667	2.062859572955084
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.166667	2.062859572955084
GRANULOMATOSIS WITH POLYANGIITIS	0.166667	2.062859572955084
PARAGANGLIOMAS 1	0.166667	2.062859572955084
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.166667	2.062859572955084
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.166667	2.062859572955084
BRACHYDACTYLY TYPE B2	0.166667	2.062859572955084
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	2.062859572955084
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	2.062859572955084
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.166667	2.062859572955084
HOLT-ORAM SYNDROME	0.166667	2.062859572955084
SCALP-EAR-NIPPLE SYNDROME	0.166667	2.062859572955084
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.166667	2.062859572955084
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	2.062859572955084
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.166667	2.062859572955084
ADDISON DISEASE	0.166667	2.062859572955084
PITYRIASIS RUBRA PILARIS	0.166667	2.062859572955084
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.16542486000000003	2.0474854413636447
MELAS	0.16541866	2.047408703141007
PERRY SYNDROME	0.16532722	2.0462769381284307
CARIBBEAN PARKINSONISM	0.16459617999999998	2.0372287590515104
MYOTONIC DYSTROPHY 1	0.16430498000000002	2.033624538014086
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.16300838	2.017576347776705
SPINOCEREBELLAR ATAXIA TYPE 7	0.162165404	2.007142721975728
LEPTIN DEFICIENCY OR DYSFUNCTION	0.16208779999999998	2.0061822069709603
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.16009839999999997	1.9815591392104746
AUTOIMMUNE HYPOPARATHYROIDISM	0.15893896	1.9672085964919581
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.15893896	1.9672085964919581
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.1571427	1.9449760481379568
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.156618924	1.9384932030895423
CHRONIC HICCUP	0.15454781999999997	1.9128588740802865
LENNOX-GASTAUT SYNDROME	0.15430775	1.9098874958369674
DRAVET SYNDROME	0.15188942000000002	1.8799555045545635
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15032022	1.8605333079476698
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.14745177399999998	1.8250301712103147
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.14730143999999998	1.8231694673454784
49,XYYYY SYNDROME	0.14485067000000001	1.792835961878823
KUFOR-RAKEB SYNDROME	0.14423214	1.7851803340001193
DE BARSY SYNDROME	0.143402554	1.774912438005774
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.143402554	1.774912438005774
WRINKLY SKIN SYNDROME	0.143402554	1.774912438005774
3Q27.3 MICRODELETION SYNDROME	0.1432077	1.7725007041938703
EHLERS-DANLOS SYNDROME, TYPE VI	0.14285699999999998	1.7681600437617788
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.14285699999999998	1.7681600437617788
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	1.7681600437617788
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.14285699999999998	1.7681600437617788
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.14285699999999998	1.7681600437617788
ACROOTOOCULAR SYNDROME	0.14285699999999998	1.7681600437617788
JUVENILE PRIMARY LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617788
PRIMARY PROGRESSIVE FREEZING GAIT	0.14285699999999998	1.7681600437617788
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	1.7681600437617788
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	1.7681600437617788
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.14285699999999998	1.7681600437617788
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	1.7681600437617788
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.14285699999999998	1.7681600437617788
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	1.7681600437617788
RESTRICTIVE DERMOPATHY, LETHAL	0.14285699999999998	1.7681600437617788
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.14285699999999998	1.7681600437617788
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14285699999999998	1.7681600437617788
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	1.7681600437617788
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617788
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.141939794	1.7568076634017087
HUNTINGTON DISEASE-LIKE 1	0.14042569000000002	1.7380673972971434
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.13892525000000003	1.7194962523335653
ADRENOCORTICAL CARCINOMA	0.13663752	1.6911807145796214
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.13647167000000002	1.6891279671240687
USHER SYNDROME	0.13582966000000002	1.6811817241699574
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.13498865	1.6707724318118358
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.13293111999999999	1.645306110001626
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.1326971	1.6424096134110417
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.13138522000000002	1.6261723005862576
SYDENHAM CHOREA	0.13129341	1.6250359560345884
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.13115090000000001	1.6232720908558678
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.130438554	1.6144552898973323
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.12992611	1.6081127025164867
CREUTZFELDT-JAKOB DISEASE; CJD	0.12961786	1.6042974513668085
SMITH-MAGENIS SYNDROME	0.129273884	1.6000400147748808
49,XXXYY SYNDROME	0.12899125	1.5965418162560225
TONNE-KALSCHEUER SYNDROME; TOKAS	0.12819491400000002	1.5866854599234026
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.12790654	1.5831162166629411
LUSCAN-LUMISH SYNDROME; LLS	0.127062314	1.5726671194461102
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.12591117000000002	1.5584192574203353
BRUNNER SYNDROME; BRNRS	0.12551649	1.5535342506928251
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.12522982	1.549986098066456
LYSINURIC PROTEIN INTOLERANCE; LPI	0.125	1.547141585433142
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.125	1.547141585433142
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.125	1.547141585433142
NON-FUNCTIONING PARAGANGLIOMA	0.125	1.547141585433142
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.125	1.547141585433142
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.12481703400000001	1.5448769909745794
SMITH-FINEMAN-MYERS SYNDROME	0.12407411	1.5356817220528487
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.123930064	1.5338988455983262
CHILDHOOD APRAXIA OF SPEECH	0.12316631	1.524445761002799
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.12295130000000001	1.5217845537045271
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.12295130000000001	1.5217845537045271
DIASTEMA, DENTAL MEDIAL	0.1222223	1.512761623978281
FG SYNDROME TYPE 1	0.121751194	1.5069306825083044
NON-24-HOUR SLEEP-WAKE SYNDROME	0.12003584	1.4856995184511919
MOHR-TRANEBJAERG SYNDROME	0.11965903000000001	1.4810356910847355
NOONAN SYNDROME 7; NS7	0.11913691000000001	1.4745733425680445
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.11890293399999999	1.4716773905712979
ROLANDIC EPILEPSY	0.11662072999999998	1.443430248852563
MACULAR CORNEAL DYSTROPHY	0.11565645	1.4314952273485513
48,XYYY SYNDROME	0.115104494	1.4246635947011168
WIEDEMANN-STEINER SYNDROME	0.11507355000000001	1.4242805967073597
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.11482948400000001	1.421259759441837
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.114782834	1.4206823662021533
MUCOLIPIDOSIS III ALPHA/BETA	0.11464456999999999	1.4189710543288065
ADULT-ONSET DYSTONIA-PARKINSONISM	0.11463909400000001	1.4189032771502323
DISTAL MONOSOMY 12Q	0.11433558400000002	1.4151466936094739
GM2-GANGLIOSIDOSIS, AB VARIANT	0.114181954	1.4132451947153128
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.11347775	1.404529168371086
SOMATOMAMMOTROPINOMA	0.11316602000000002	1.4006708447996696
ACROMEGALY	0.11316602000000002	1.4006708447996696
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.11316017999999999	1.4005985623447978
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.113045554	1.399179821133823
KBG SYNDROME	0.112859754	1.3968801498812353
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.11232785	1.3902967034983695
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.11215972400000002	1.3882157856888293
RING CHROMOSOME 22 SYNDROME	0.11212498400000001	1.3877858040994058
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.11210831000000002	1.3875794277890416
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.112059924	1.3869805478470192
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.11189495	1.3849386427596972
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.11189495	1.3849386427596972
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.11189495	1.3849386427596972
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.11165655399999999	1.38198798383649
15Q13.3 MICRODELETION SYNDROME	0.111284584	1.3773840617922215
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.11111099999999999	1.3752355895924946
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.11111099999999999	1.3752355895924946
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.11111099999999999	1.3752355895924946
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.110422544	1.3667144783337672
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.10973714	1.3582311420839894
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.10840336	1.3417227700534373
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.106010034	1.3121002565966504
TETRASOMY 9P	0.10589082400000001	1.3106247786094547
DEMENTIA, LEWY BODY; DLB	0.1055556	1.3064756666827726
BECKWITH-WIEDEMANN SYNDROME	0.10533855	1.3037892100338266
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.105284894	1.3031251026025625
EARLY-ONSET LAFORA BODY DISEASE	0.1046099	1.2947706123040197
KUFOR-RAKEB SYNDROME	0.10459870000000002	1.2946319884179651
HUNTINGTON DISEASE-LIKE 1	0.10444444	1.2927226919302135
IDIOPATHIC HYPERSOMNIA	0.1036867	1.2833440434106447
NIEMANN-PICK DISEASE, TYPE C2	0.103502854	1.2810685570753204
HUNTINGTON DISEASE-LIKE 2	0.10330205999999999	1.2785833030952765
RAMOS-ARROYO SYNDROME	0.10325498000000001	1.2780005876885392
MYASTHENIA GRAVIS	0.1029573	1.274316162831325
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.10256544000000001	1.2694660596179825
22Q11.2 DELETION SYNDROME	0.10248147399999999	1.2684268012950826
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.102474964	1.2683462261613134
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.10244824400000001	1.2680155091760112
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.100682934	1.2461660330785633
SPINOCEREBELLAR ATAXIA TYPE 29	0.10054555400000001	1.244465662590509
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.10054555400000001	1.244465662590509
PSEUDOAMINOPTERIN SYNDROME	0.10035113400000001	1.2420593004541898
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.10033526400000001	1.241862875358503
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.09920405399999999	1.2278617390956401
POSTORGASMIC ILLNESS SYNDROME	0.09903460000000001	1.2257643844538968
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0981997	1.2154307163764713
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.09782610000000001	1.2108066196059288
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.09775640000000001	1.2099439334578914
TRISOMY 8P	0.09690986	1.1994661955560306
ERMINE PHENOTYPE	0.09688776000000002	1.1991926609237262
CHIARI MALFORMATION TYPE I	0.09545455000000001	1.1814536305904573
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.09537729400000002	1.1804974228278635
RAYNAUD-CLAES SYNDROME; MRXSRC	0.09525585399999999	1.1789943438347832
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.09507361400000001	1.1767387351745489
AMISH INFANTILE EPILEPSY SYNDROME	0.09445241000000001	1.1690500108430495
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.09424558	1.1664900484901282
ABLEPHARON-MACROSTOMIA SYNDROME	0.0940171	1.1636621212146103
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0938597	1.1617139605302327
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.09290991000000001	1.1499582836788045
HYPERTRICHOSIS CUBITI	0.09219245400000001	1.1410782355722562
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.09175435400000001	1.1356558137436303
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.09166453999999999	1.1345441739487971
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.09145210000000001	1.131914775881522
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.0912088	1.128903419499635
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0909091	1.1251939928344006
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0909091	1.1251939928344006
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09074071000000002	1.123109807461832
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.09057968000000001	1.1211167177858135
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.090013394	1.1141077208270245
SCHIZOPHRENIA 1; SCZD1	0.08949280000000001	1.107664259814809
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.08925809400000001	1.1047592725112034
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.08856062	1.0961265442699364
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08825228999999998	1.0923103029496433
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.08807264000000001	1.090086751063059
GABRIELE-DE VRIES SYNDROME	0.08806046	1.0899359975869742
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08786423	1.087507232840498
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.087859244	1.0874455204569382
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.08768959000000001	1.0853456903886578
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.087528834	1.0833559920469944
KBG SYNDROME	0.087251924	1.079928640235616
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.08713383400000001	1.0784670246370258
47,XYY SYNDROME	0.08701528	1.0769996660488703
NARCOLEPSY TYPE 2	0.08675089999999999	1.0737273997100156
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.08674443000000001	1.0736473196615537
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.08604805400000001	1.065028181511973
PRADER-WILLI SYNDROME; PWS	0.085997884	1.0644072207652435
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.085961674	1.0639590447907754
NASU-HAKOLA DISEASE	0.08565881	1.0602104568777302
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08538248000000001	1.0567902838033085
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08538079	1.0567693664490734
LAFORA DISEASE	0.08479032	1.0494610409134677
3Q29 MICRODELETION SYNDROME	0.08466487399999999	1.0479083791268575
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.08442411	1.0449284111534558
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.08439329000000001	1.0445469479241516
GLYCINE ENCEPHALOPATHY; GCE	0.08417805	1.0418828938853624
1P36 DELETION SYNDROME	0.08403786399999999	1.040147793162998
RETT SYNDROME, CONGENITAL VARIANT	0.08399551000000001	1.0396235720853229
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.08387885400000002	1.0381797052950008
PRIMROSE SYNDROME; PRIMS	0.08386609	1.0380217235734286
CONGENITAL ENTEROVIRUS INFECTION	0.08363451000000001	1.035155427186592
POTOCKI-LUPSKI SYNDROME	0.083346884	1.0315954420213773
SCLEROSTEOSIS	0.08333330000000001	1.0314273110510055
MUCKLE-WELLS SYNDROME	0.08333330000000001	1.0314273110510055
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	1.0314273110510055
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	1.0314273110510055
ALKAPTONURIA	0.08333330000000001	1.0314273110510055
DIPROSOPUS	0.08333330000000001	1.0314273110510055
9P13 MICRODELETION SYNDROME	0.08317707999999999	1.0294937553831942
FRAXE INTELLECTUAL DISABILITY	0.08251991	1.0213598750976016
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08250585	1.021185852612072
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.08239476400000001	1.0198109264507969
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.08228929	1.0185054607581407
GLASS SYNDROME	0.08226905400000001	1.0182549971011583
PHENYLKETONURIA	0.08224077999999999	1.0179050460516659
MEND SYNDROME	0.082207994	1.0174992493795059
METACHROMATIC LEUKODYSTROPHY	0.0820367	1.0153791208136245
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.08155609000000001	1.0094305470746243
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.08136754	1.0070968387071568
JACOBSEN SYNDROME	0.080513114	0.9965214947369544
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.079782904	0.9874835886801615
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.079676354	0.9861648051927383
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.079094394	0.9789618090562687
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0790923	0.9789358913404297
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.078506794	0.9716890058914648
MUCOPOLYSACCHARIDOSIS TYPE 1	0.07820027	0.9678951176727982
ATKIN-FLAITZ SYNDROME	0.07820026999999999	0.9678951176727981
CLARK-BARAITSER SYNDROME	0.07820026999999999	0.9678951176727981
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.07778558	0.9627624445202919
ATHYREOSIS	0.07767692400000001	0.9614175947914376
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07692310000000001	0.9520874151234572
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	0.9520874151234572
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	0.9520874151234572
DDOST-CDG	0.07692310000000001	0.9520874151234572
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	0.9520874151234572
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	0.9520874151234572
DIGEORGE SYNDROME; DGS	0.076464534	0.9464116828973311
CONGENITAL ANALBUMINEMIA	0.07573640000000001	0.9373994717679891
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.07550772400000001	0.934569118574465
THYROID HEMIAGENESIS	0.07550772400000001	0.934569118574465
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.07550772400000001	0.934569118574465
THYROID ECTOPIA	0.07550772400000001	0.934569118574465
FAMILIAL THYROID DYSHORMONOGENESIS	0.07550772400000001	0.934569118574465
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.07550772400000001	0.934569118574465
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.075212254	0.9309120471804816
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.07414335400000001	0.9176821300551258
CUSHING DISEASE	0.07411962999999999	0.917388494959343
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.073923664	0.9149629977758952
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.07392259999999998	0.9149498285067196
SCHINZEL-GIEDION SYNDROME	0.07373067	0.9125742854307826
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.07373067	0.9125742854307826
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.073654754	0.9116346630259845
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.073621454	0.9112225045076252
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.07320315399999999	0.9060451499061315
CRANIOPHARYNGIOMA	0.07286775399999999	0.9018938596040974
17P11.2 MICRODUPLICATION SYNDROME	0.07214499399999999	0.8929481631857962
NORRIE DISEASE	0.07201613	0.8913531963596741
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.071978754	0.890890588648497
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.07168092400000001	0.8872043072213806
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.07142860000000001	0.884081259594158
ALZHEIMER DISEASE 4	0.07142860000000001	0.884081259594158
POSTPOLIOMYELITIS SYNDROME	0.07142860000000001	0.884081259594158
AREGENERATIVE ANEMIA	0.07111113999999999	0.8801520150524649
SCHAAF-YANG SYNDROME; SHFYNG	0.07108890400000001	0.8798767971301157
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.070695334	0.875005529019884
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.070657664	0.8745392824316979
MICROPHTHALMIA, SYNDROMIC 1	0.07047855	0.8723223646882319
DARIER-WHITE DISEASE; DAR	0.0704545	0.8720246946471946
16Q24.3 MICRODELETION SYNDROME	0.07010212	0.867663240632195
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.06978679400000001	0.8637604088916488
RABIES	0.06932783	0.8580797505667146
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.069264	0.8572897181875294
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.069206404	0.8565768448534924
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.06899329	0.8539391045987884
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.06875619999999999	0.8510046102108655
FRONTONASAL DYSPLASIA 1; FND1	0.06871588	0.8505055642210683
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.06861319	0.8492345564658034
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.06818805400000001	0.8439725917852858
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.0679538	0.8410731989456531
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067641964	0.8372135633981722
MYOCLONIC EPILEPSY OF LAFORA	0.0676038	0.8367412025064405
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.06704545	0.8298304304726276
EPISODIC ATAXIA TYPE 6	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.06704545	0.8298304304726276
ARNOLD-CHIARI MALFORMATION TYPE I	0.06704545	0.8298304304726276
EPISODIC ATAXIA, TYPE 6	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.06704545	0.8298304304726276
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.06704545	0.8298304304726276
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.06704545	0.8298304304726276
COFS SYNDROME	0.06701159000000001	0.8294113407599656
DESANTO-SHINAWI SYNDROME	0.066998704	0.8292518490282066
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.06694444	0.8285802163002707
9Q33.3Q34.11 MICRODELETION SYNDROME	0.06681480000000001	0.8269756448191865
HEPATOCELLULAR CARCINOMA	0.0666667	0.8251425914687651
GLIOBLASTOMA	0.0666667	0.8251425914687651
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.0666667	0.8251425914687651
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.066656754	0.8250194885070955
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.066411304	0.8219815212899391
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.06584025399999999	0.8149135596710461
SMITH-LEMLI-OPITZ SYNDROME	0.065492644	0.8106111445789469
ALG11-CDG	0.065228294	0.807339249554073
OROFACIODIGITAL SYNDROME TYPE 14	0.065107254	0.8058411214140663
PORPHYRIA VARIEGATA	0.06492615	0.8035995731765601
CORNELIA DE LANGE SYNDROME	0.06489647	0.8032322198785148
MEIER-GORLIN SYNDROME 1; MGORS1	0.06468018	0.8005551698504081
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0644928	0.7982359427281803
EMANUEL SYNDROME	0.064355364	0.7965348791206956
NEUROLEPTIC MALIGNANT SYNDROME	0.06429791	0.7958237633394998
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.06428798	0.795700858411953
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.06398344	0.7919315264245306
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.063873624	0.7905723192217632
ACUTE INTERMITTENT PORPHYRIA	0.06386335	0.7904451565605732
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.06373695400000001	0.7888807364979142
MUCOLIPIDOSIS TYPE IV	0.06363462	0.7876141350018844
6Q16 MICRODELETION SYNDROME	0.063624164	0.787484719702546
MICROHYDRANENCEPHALY; MHAC	0.06349210000000001	0.7858501460518369
KLEEFSTRA SYNDROME	0.06346701999999999	0.7855397275641354
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.06313021	0.7813709855050177
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.063045554	0.7803231869605662
PARKINSONIAN-PYRAMIDAL SYNDROME	0.06280198000000001	0.777308439244324
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.06270057	0.7760532742188936
NANCE-HORAN SYNDROME	0.06259785000000001	0.7747818951496482
HADDAD SYNDROME	0.0625	0.773570792716571
DYSTONIA 12; DYT12	0.06247675	0.7732830243816805
RAPID-ONSET DYSTONIA-PARKINSONISM	0.06247675	0.7732830243816805
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.06215023	0.7692416430178755
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.062048200000000005	0.7679788041701816
CENTRAL DIABETES INSIPIDUS	0.06203685	0.7678383237142241
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.061947140000000005	0.7667279711411906
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0618502	0.7655281318988554
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.061840374	0.7654065141931076
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.06172844	0.7640210922233167
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.061656714	0.7631333300044625
COSTELLO SYNDROME; CSTLO	0.061483824	0.7609934475348181
SUSAC SYNDROME	0.0610913	0.7561351259053738
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.061088	0.7560942813675183
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.061014694	0.7551869632790242
PERRY SYNDROME	0.060733920000000004	0.751711786226957
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	0.7515357834001981
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.060377259999999995	0.7472973580840722
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.060338294	0.7468150707319283
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.060331524	0.7467312775436613
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.060294940000000005	0.7462784725215695
VAN BOGAERT-HOZAY SYNDROME	0.06025901	0.7458337621442526
1Q21.1 MICRODELETION SYNDROME	0.060224774	0.7454100186297015
COFFIN-LOWRY SYNDROME	0.05995654	0.7420900508214848
TURNPENNY-FRY SYNDROME; TPFS	0.059627124000000004	0.7380128252814285
SPINOCEREBELLAR ATAXIA 12	0.05937055	0.7348371748403011
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	0.7338996070395286
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.05905466	0.7309273623969212
RETT SYNDROME; RTT	0.05833875	0.7220664493375017
TRISOMY 9P	0.058150334000000005	0.719734399505814
16P13.11 MICRODELETION SYNDROME	0.057928254	0.71698568587947
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.057910834	0.716770076228124
USHER SYNDROME TYPE 3	0.05787236	0.7162938784252605
AREDYLD SYNDROME	0.05760478	0.7129820052618189
DYSOSTOSIS, STANESCU TYPE	0.05760478	0.7129820052618189
TETRALOGY OF FALLOT	0.05760478	0.7129820052618189
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.05760478	0.7129820052618189
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	0.7095735904634463
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.057325443999999996	0.7095246265265504
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.05707604	0.7064377201267634
ALEXANDER DISEASE	0.05690614	0.7043348452838428
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.056905250000000004	0.7043238296357546
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.056711410000000004	0.7019246462363916
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.056680180000000004	0.701538108382687
13Q12.3 MICRODELETION SYNDROME	0.0563492	0.6974415250071136
DOORS SYNDROME	0.056290494	0.6967149130557982
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.056217640000000006	0.6958131894312771
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.056101154	0.6943714267535108
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.0559079	0.6919794963539005
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.055861654	0.6914071034758209
2Q23.1 MICRODUPLICATION SYNDROME	0.055750844	0.6900355934031662
XP22.13P22.2 DUPLICATION SYNDROME	0.05574732999999999	0.6899921001589164
FAMILIAL MEDIAN CLEFT OF THE UPPER AND LOWER LIPS	0.055555600000000004	0.6876190325095158
POSTERIOR URETHRAL VALVE	0.055555600000000004	0.6876190325095158
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.055555600000000004	0.6876190325095158
RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARYDIASTEMA	0.055555600000000004	0.6876190325095158
DEAFNESS-OLIGODONTIA SYNDROME	0.055555600000000004	0.6876190325095158
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.055555600000000004	0.6876190325095158
BENIGN OCCIPITAL EPILEPSY	0.055555600000000004	0.6876190325095158
CLASSICAL EHLERS-DANLOS SYNDROME	0.055555600000000004	0.6876190325095158
NAGER SYNDROME	0.055555600000000004	0.6876190325095158
ANOPHTHALMIA PLUS SYNDROME	0.055555600000000004	0.6876190325095158
CLEFT LIP AND ALVEOLUS	0.055555600000000004	0.6876190325095158
3MC SYNDROME	0.055555600000000004	0.6876190325095158
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.055555600000000004	0.6876190325095158
NIEMANN-PICK DISEASE TYPE B	0.05536342	0.6852403951504075
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.05526076	0.6839697587091229
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.055155454	0.6826663723747579
FILIPPI SYNDROME	0.055155454	0.6826663723747579
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.055155454	0.6826663723747579
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.055155454	0.6826663723747579
MIETENS SYNDROME	0.055155454	0.6826663723747579
COFFIN-SIRIS SYNDROME 8; CSS8	0.054903520000000004	0.6795481518292819
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.0548395	0.6787557677948863
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.05482505	0.6785769182276102
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.05482505	0.6785769182276102
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0548008	0.6782767727600362
KNIEST-LIKE DYSPLASIA, LETHAL	0.05468078	0.6767912692953668
LETHAL KNIEST-LIKE DYSPLASIA	0.05468078	0.6767912692953668
N-ACETYLASPARTATE DEFICIENCY; NACED	0.054639154	0.6762760587702848
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0546099	0.6759139781307628
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.0546099	0.6759139781307628
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.0546099	0.6759139781307628
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0546099	0.6759139781307628
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.05441928	0.6735546490986406
15Q24 MICRODELETION SYNDROME	0.054010034	0.6684893570564633
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.053757679999999995	0.6653659381152601
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.05346055	0.6616883206810221
CHAR SYNDROME	0.053232294	0.6588631658832251
AICARDI SYNDROME	0.05312268999999999	0.6575065826325865
CEREBROFACIOARTICULAR SYNDROME	0.052802894	0.6535484251089453
COFFIN-SIRIS SYNDROME 1; CSS1	0.052716464000000005	0.6524786695311133
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	0.6514282965430637
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	0.6514282965430637
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	0.6514282965430637
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0526316	0.6514282965430637
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	0.6514282965430637
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	0.6514282965430637
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	0.6514282965430637
1Q21.1 MICRODUPLICATION SYNDROME	0.052545084	0.6503574765318211
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.05253729	0.6502610091596861
PARKINSON DISEASE, LATE-ONSET; PD	0.052499420000000005	0.6497922871449634
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.05242669	0.6488920982848948
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.05242669	0.6488920982848948
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.051859294	0.6418693627088276
MONOSOMY 18P	0.051545234	0.6379822004182584
GANGLIOCYTOMA	0.0514889	0.6372849470256681
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.051377123999999996	0.635901480642841
RENPENNING SYNDROME 1; RENS1	0.05131497	0.635132192338033
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.05114946	0.6330836531075926
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.050846470000000005	0.6293335056758297
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.050828894	0.6291159651917849
AMYOTROPHIC LATERAL SCLEROSIS	0.05072395	0.6278170593794514
HAMAMY SYNDROME; HMMS	0.05059527	0.6262243699457432
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.05059527	0.6262243699457432
KLEEFSTRA SYNDROME	0.050554054	0.6257142340450614
HISTIDINEMIA	0.05043863	0.6242856158822052
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.05019384	0.6212558175726197
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.050100484	0.6201003379738221
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.05	0.6188566341732569
MENINGIOMA	0.049802	0.6164059619019308
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.049673024	0.6148096088369481
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.049576060000000005	0.6136094725434287
USHER SYNDROME TYPE 1	0.049408904000000003	0.6115405605525914
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04939145999999999	0.6113246538500609
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.049339454000000005	0.6106809686877247
OCULOCEREBRORENAL SYNDROME OF LOWE	0.04909711	0.607681444844683
MICROTRIPLICATION 11Q24.1	0.04898807	0.606331842296878
USHER SYNDROME TYPE 2	0.04886335	0.6047881663085962
MARSHALL SYNDROME	0.04865564	0.6022173120789136
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.04860162	0.6015486993713528
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.048378109999999995	0.5987822864452715
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.04817627000000001	0.596284085984441
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.04806555	0.5949136898537276
YELLOW FEVER	0.048023750000000004	0.594396325707559
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.048022553999999995	0.5943815226568694
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.047619	0.5893866812539263
RING CHROMOSOME 1 SYNDROME	0.04752688000000001	0.5882464997911256
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.047414074	0.5868502849616345
PGM3-CDG	0.04740591999999999	0.5867493618217334
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.047222259999999995	0.5844761776330883
LISSENCEPHALY, X-LINKED, 2	0.047170290000000004	0.5838329380475288
PACHYDERMOPERIOSTOSIS	0.047011870000000004	0.5818721526878142
48,XXYY SYNDROME	0.046519614	0.5757794348615823
WOLFRAM SYNDROME	0.04619596	0.5717735263600482
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.046073034000000006	0.5702520549478005
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.04601637	0.5695507171014246
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.046000054	0.5693487718045612
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.046000054	0.5693487718045612
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.04590219399999999	0.5681375456001572
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.045867254	0.567705088584197
MAJOR AFFECTIVE DISORDER 2	0.0454545	0.562596377560566
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.0454545	0.562596377560566
LITHIUM TRANSPORT	0.0454545	0.562596377560566
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.045261194000000005	0.5602038035500562
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.045197554	0.5594161228260804
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.044757594	0.553970679530663
CONGENITAL HYPOTHYROIDISM	0.044744634	0.5538102718910854
OGDEN SYNDROME; OGDNS	0.044734764	0.5536881095914996
SLC39A8-CDG	0.04472331	0.5535463419137432
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.044594134	0.5519475134222238
LYME DISEASE	0.04454545	0.551344945094662
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.044494604	0.5507156174062386
YUNIS-VARON SYNDROME	0.044444410000000004	0.5500943596083249
ALLAN-HERNDON-DUDLEY SYNDROME	0.044444410000000004	0.5500943596083249
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.04422715	0.5474053037615151
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.04418211	0.5468478377054519
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.04414605	0.5464015183008861
DISTAL TRISOMY 18Q	0.044023854	0.5448890821954975
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.044023854	0.5448890821954975
ABLEPHARON MACROSTOMIA SYNDROME	0.044023854	0.5448890821954975
TARP SYNDROME	0.044023854	0.5448890821954975
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.044017060000000004	0.544804991956046
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.044011804	0.5447399377466616
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.04385976	0.5428580689849368
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0438359	0.5425627505991093
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.043623973999999996	0.5399397143780333
LASSA FEVER	0.043478300000000004	0.5381366879515023
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	0.5381366879515023
HYDATIDIFORM MOLE	0.043478300000000004	0.5381366879515023
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	0.5381366879515023
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.043478300000000004	0.5381366879515023
VIRAL HEMORRHAGIC FEVER	0.043478300000000004	0.5381366879515023
KEUTEL SYNDROME; KTLS	0.043478300000000004	0.5381366879515023
FRASER SYNDROME	0.043478300000000004	0.5381366879515023
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.043478300000000004	0.5381366879515023
RINGED HAIR DISEASE	0.043478300000000004	0.5381366879515023
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	0.5381366879515023
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	0.5381366879515023
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	0.5381366879515023
OCULOTRICHOANAL SYNDROME	0.043478300000000004	0.5381366879515023
WERNER SYNDROME	0.043478300000000004	0.5381366879515023
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	0.5381366879515023
ASHERMAN SYNDROME	0.043478300000000004	0.5381366879515023
FAMILIAL THROMBOCYTOSIS	0.043478300000000004	0.5381366879515023
BRADDOCK SYNDROME	0.043478300000000004	0.5381366879515023
C SYNDROME	0.043478300000000004	0.5381366879515023
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	0.5381366879515023
JOHANSON-BLIZZARD SYNDROME	0.043478300000000004	0.5381366879515023
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	0.5381366879515023
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.043411370000000005	0.537308286460998
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.04320984	0.5348139229112991
JUVENILE MYOCLONIC EPILEPSY	0.043200840000000004	0.5347025287171481
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	0.5337231262079055
OGDEN SYNDROME	0.043048633999999995	0.5328186548599284
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.043028354	0.5325676466091078
16P13.11 MICRODUPLICATION SYNDROME	0.04279162399999999	0.5296376079889511
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.042697094000000005	0.5284675976363833
8P INVERTED DUPLICATION/DELETION SYNDROME	0.04264144	0.5277787606940176
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0424828	0.5258152523651127
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.042435764	0.5252330815522133
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.042324794	0.5238595911383291
JAWAD SYNDROME	0.042321894	0.5238236974535471
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0422414	0.5228274125353243
SHPRINTZEN OMPHALOCELE SYNDROME	0.04215154	0.521715203392388
HARTNUP DISEASE	0.042053814	0.5205056357237637
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.041956474	0.5193008456283552
4Q21 MICRODELETION SYNDROME	0.04195338	0.5192625507798326
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.04189021	0.5184806873082181
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.041666699999999994	0.5157142743821367
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	0.5157142743821367
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	0.5157142743821367
BARATELA-SCOTT SYNDROME	0.041365613999999995	0.511987693011003
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.041279504	0.5109218981156299
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.04108196	0.5084768698168074
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.04107527400000001	0.5083941163076859
INFANTILE MYOFIBROMATOSIS	0.0408333	0.505399172003737
611426 TENTED EYEBROWS	0.0408333	0.505399172003737
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0408086	0.5050934568264553
CORNELIA DE LANGE SYNDROME 1	0.040794010000000006	0.5049128744606037
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.040769613999999996	0.5046109219316578
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04072704	0.504083977884792
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.04065564	0.5032002506111926
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040630700000000006	0.502891564922067
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.0406015	0.5025301526477097
WILSON DISEASE	0.0406015	0.5025301526477097
CHROMOSOME 10Q26 DELETION SYNDROME	0.040529264	0.501636078091187
ACROCEPHALOPOLYDACTYLY	0.04051068	0.5014060614573975
MAL DE MELEDA	0.04051068	0.5014060614573975
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.040308434000000004	0.4989028358806974
MUCOPOLYSACCHARIDOSIS, TYPE II	0.040104970000000004	0.4963845349563889
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.04006544	0.4958952669014114
DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD	0.04	0.4950853073386055
BUERGER DISEASE	0.04	0.4950853073386055
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.04	0.4950853073386055
TYPHOID	0.04	0.4950853073386055
MERCURY POISONING	0.04	0.4950853073386055
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.039973369999999994	0.49475570429524474
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.039969264	0.49470488378844646
NOVELTY SEEKING PERSONALITY TRAIT	0.039968699999999996	0.494697903085613
ZELLWEGER SYNDROME	0.03976288000000001	0.49215044163670235
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.03974961	0.49198619708599267
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	0.4913870200927861
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.039638999999999994	0.49061716243987447
MEHMO SYNDROME	0.03962027	0.49038533874471324
MILD CANAVAN DISEASE	0.039504479999999995	0.48895219055129474
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.039325453999999996	0.4867363619955048
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0391926	0.48509201040997574
SPINOCEREBELLAR ATAXIA TYPE 10	0.03915746	0.4846570779674787
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.03908618	0.4837748359498013
CLEIDOCRANIAL DYSPLASIA; CCD	0.03908618	0.4837748359498013
GORLIN SYNDROME	0.03908618	0.4837748359498013
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.03902825	0.4830578286534482
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.03896951	0.48233079587962147
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.03896951	0.48233079587962147
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.03895456	0.48214575774600366
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.038909554	0.4815887125124516
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.038842864	0.48076328153379133
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.038718394	0.4792226998286805
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.038718394	0.4792226998286805
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.038587064000000004	0.47759721099336105
2Q37 MICRODELETION SYNDROME	0.038476843999999996	0.47623300342898944
CYCLIC NEUTROPENIA	0.0384615	0.4760430887050944
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	0.4760430887050944
LIP, HAMARTOMATOUS	0.0384615	0.4760430887050944
LIP, MEDIAN NODULE OF UPPER	0.0384615	0.4760430887050944
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	0.4760430887050944
JUVENILE ABSENCE EPILEPSY	0.0384615	0.4760430887050944
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	0.4760430887050944
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	0.4760430887050944
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	0.4760430887050944
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	0.4760430887050944
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	0.4760430887050944
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	0.4760430887050944
BAZEX SYNDROME; BZX	0.0384615	0.4760430887050944
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.038429054000000004	0.4756415002580467
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.038402783999999995	0.47531635298245195
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.03811734	0.47178337472075293
248100 MACROSOMIA ADIPOSA CONGENITA	0.0380987	0.47155266496753323
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.4712556137831301
TETRASOMY 12P	0.03801637	0.47053365563370353
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.037994933999999994	0.4702683394175007
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.037948784	0.4696971347441588
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0378835	0.46888910601405154
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0378835	0.46888910601405154
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.0378835	0.46888910601405154
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03776348	0.467403602549382
BAKER-GORDON SYNDROME; BAGOS	0.037632554	0.46578311407566664
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.03759781	0.4653530829777124
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.037582554	0.4651642574414934
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.037582554	0.4651642574414934
SILVER-RUSSELL SYNDROME; SRS	0.037582554	0.4651642574414934
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.037170654	0.46006611648917406
HELSMOORTEL-VAN DER AA SYNDROME	0.037088734	0.4590521817797446
SMITH-MAGENIS SYNDROME	0.03707336	0.45886189574186903
BRACHYDACTYLY, TYPE A1, D	0.037037	0.45841186319749827
DIABETIC EMBRYOPATHY	0.037037	0.45841186319749827
KAPOSIFORM LYMPHANGIOMATOSIS	0.037037	0.45841186319749827
CERVICAL VERTEBRAE, AGENESIS OF	0.037037	0.45841186319749827
FIBROSCLEROSIS, MULTIFOCAL	0.037037	0.45841186319749827
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.037037	0.45841186319749827
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.037037	0.45841186319749827
PROTEUS SYNDROME	0.037037	0.45841186319749827
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.037037	0.45841186319749827
SYNPOLYDACTYLY 1	0.037037	0.45841186319749827
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.037037	0.45841186319749827
PAROTIDOMEGALY, HEREDITARY BILATERAL	0.037037	0.45841186319749827
MALAKOPLAKIA	0.037037	0.45841186319749827
KIKUCHI-FUJIMOTO DISEASE	0.037037	0.45841186319749827
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.037037	0.45841186319749827
BRACHYDACTYLY TYPE A4	0.037037	0.45841186319749827
OCULODENTODIGITAL DYSPLASIA; ODDD	0.037037	0.45841186319749827
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.037037	0.45841186319749827
CLEIDORHIZOMELIC SYNDROME	0.037037	0.45841186319749827
CARCINOMA OF ESOPHAGUS	0.037037	0.45841186319749827
BRACHYDACTYLY, TYPE A2; BDA2	0.037037	0.45841186319749827
BRACHYDACTYLY, TYPE A4	0.037037	0.45841186319749827
CLEIDORHIZOMELIC SYNDROME	0.037037	0.45841186319749827
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.037037	0.45841186319749827
BRANCHIAL CLEFT ANOMALIESBRANCHIAL CYSTS, INCLUDED	0.037037	0.45841186319749827
HYPOPARATHYROIDISM, X-LINKED	0.037037	0.45841186319749827
BRACHYDACTYLY, TYPE A3	0.037037	0.45841186319749827
HYPERPROLINEMIA, TYPE I	0.036996304	0.457908163405812
HURLER-SCHEIE SYNDROME	0.03697476	0.4576415104592794
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.036841399999999996	0.4559908960446124
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.03680556	0.4555472996092371
PITUITARY APOPLEXY	0.03680355	0.4555224215725433
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0367747	0.4551653412946254
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.036724234	0.4545407169166216
WHITE-SUTTON SYNDROME; WHSUS	0.036629374000000006	0.4533666221102682
KEIPERT SYNDROME; KPTS	0.03653198	0.4521611636496947
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.03649369399999999	0.4516872927477755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.036340774	0.44979458161782004
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	0.44879302404107413
YOU-HOOVER-FONG SYNDROME; YHFS	0.036259854	0.44879302404107413
TRANSKETOLASE DEFICIENCY	0.036223533999999995	0.44834348658201056
DISTAL MONOSOMY 10Q	0.036149254	0.44742411316628283
THUMBS, CONGENITAL CLASPED	0.0361093	0.4469295972070476
LYNCH SYNDROME	0.03603924	0.4460624552912441
FAMILIAL COLORECTAL CANCER TYPE X	0.03603924	0.4460624552912441
COG1-CDG	0.035948139999999996	0.4449348985037804
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.035945753999999996	0.44490536666519764
OCULOFACIOCARDIODENTAL SYNDROME	0.035844134	0.443647602441904
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03579167	0.44299824855279857
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.035714300000000004	0.442040629797079
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.035714300000000004	0.442040629797079
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.03567798	0.44159109233801547
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.035664554	0.4414249169546073
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.03561658	0.44083113639125077
RABSON-MENDENHALL SYNDROME	0.035598424	0.44060641717024973
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.03549958	0.43938301186728534
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.035459484	0.4388867383552091
CUSHING SYNDROME	0.035376540000000005	0.43786012946191183
17Q21.31 MICRODUPLICATION SYNDROME	0.035354123999999994	0.4375826836556791
MARTSOLF SYNDROME	0.03529858	0.43689520819790884
XQ28 (MECP2) DUPLICATION	0.035292634	0.436821613766973
CHARGE SYNDROME	0.035279043999999996	0.4366534085338046
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.035242384	0.4361996628496288
MAN1B1-CDG	0.035221964	0.4359469218002325
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.03519641	0.43563063655163914
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.035034764	0.43362992256188776
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.035028354	0.4335505851413867
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.035028354	0.4335505851413867
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.035028354	0.4335505851413867
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.035028354	0.4335505851413867
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.035028354	0.4335505851413867
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.035028354	0.4335505851413867
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.035007144	0.4332880661571704
RODRIGUES BLINDNESS	0.03494004	0.43245751104557917
MYOCLONIC-ASTASTIC EPILEPSY	0.034723604	0.42977865395610076
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.034672514	0.42914630624730254
TYSHCHENKO SYNDROME	0.034659154	0.4289809477546514
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.0344828	0.4267981908973917
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	0.4267981908973917
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0344828	0.4267981908973917
NASODIGITOACOUSTIC SYNDROME	0.0344828	0.4267981908973917
LATHOSTEROLOSIS	0.0344828	0.4267981908973917
DIAMOND-BLACKFAN ANEMIA 8	0.0344828	0.4267981908973917
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0344828	0.4267981908973917
ISOTRETINOIN-LIKE SYNDROME	0.034427299999999994	0.4261112600334592
MEIER-GORLIN SYNDROME 5; MGORS5	0.034427299999999994	0.4261112600334592
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03437055	0.42540885775367265
OCULODENTODIGITAL DYSPLASIA	0.034307279999999996	0.42462575656878976
22Q11.2 MICRODUPLICATION SYNDROME	0.034107394	0.42215174102522274
SAETHRE-CHOTZEN SYNDROME	0.033993579999999995	0.4207430500459868
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.03398416	0.42062645745610855
CHOREOACANTHOCYTOSIS	0.03389067	0.41946931932153136
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.033440584	0.41389854518056135
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.03335805	0.41287701091166423
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.03329918	0.41214836911058855
WEILL-MARCHESANI SYNDROME 1; WMS1	0.03329918	0.41214836911058855
WEILL-MARCHESANI SYNDROME 2; WMS2	0.03329918	0.41214836911058855
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.0332735	0.4118305243432772
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.033165534	0.41049421483597426
JOUBERT SYNDROME 1	0.033062694000000004	0.4092213505108067
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.033062694	0.40922135051080666
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.03301584	0.40864143233605554
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	0.4060151780604818
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.032803653999999995	0.4060151780604818
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.03274593	0.4053007204534615
ALSTRM SYNDROME	0.032706694	0.4048150912754931
CHERUBISM	0.03261998	0.4037418205919791
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.032547964	0.40285046900464666
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.032540483999999995	0.4027578880521743
ALLAN-HERNDON-DUDLEY SYNDROME	0.032453100000000006	0.4016763246897625
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.032431094	0.40140395350793007
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.03242833	0.40136974311319296
COSTELLO SYNDROME	0.03236687	0.40060904453846724
SCHWARTZ-JAMPEL SYNDROME	0.03226168	0.3993070939514935
SECKEL SYNDROME	0.0322581	0.39926278381648667
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	0.39926278381648667
PRIMARY BILIARY CHOLANGITIS	0.0322581	0.39926278381648667
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	0.39926278381648667
FLUSHING OF EARS AND SOMNOLENCE	0.0322581	0.39926278381648667
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	0.39926278381648667
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	0.39926278381648667
OBESITY-HYPOVENTILATION SYNDROME	0.0322581	0.39926278381648667
DENT DISEASE	0.0322581	0.39926278381648667
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0322581	0.39926278381648667
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0322581	0.39926278381648667
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	0.39926278381648667
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0322581	0.39926278381648667
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.0322581	0.39926278381648667
FETAL AKINESIA DEFORMATION SEQUENCE	0.0322581	0.39926278381648667
DEND SYNDROME	0.0322581	0.39926278381648667
DYSTONIA, JUVENILE-ONSET	0.0322581	0.39926278381648667
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0322581	0.39926278381648667
SECKEL SYNDROME 2; SCKL2	0.0322581	0.39926278381648667
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0322581	0.39926278381648667
HYPER-BETA-ALANINEMIA	0.0322581	0.39926278381648667
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.032173954	0.3982212976097038
WHIPPLE DISEASE	0.03209902	0.39729382954920106
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0319766	0.39577862096609134
OBESITY DUE TO SIM1 DEFICIENCY	0.031952244	0.39547716352245277
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.031795554	0.39353779060228067
CHROMOSOME 18P DELETION SYNDROME	0.031795554	0.39353779060228067
RETT SYNDROME	0.03174403	0.39290007121789783
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.031601434	0.39113514160576635
CLASSIC PHENYLKETONURIA	0.031581224	0.3908849997542336
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.03157324	0.3907861807268888
FRAGILE X SYNDROME	0.03151734	0.39009429900988307
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.031383629999999996	0.38843935259877693
NEPHRONOPHTHISIS 11; NPHP11	0.03126305399999999	0.38694696744833534
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.03125	0.3867853963582855
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.03125	0.3867853963582855
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.03125	0.3867853963582855
MELNICK-NEEDLES SYNDROME	0.03125	0.3867853963582855
TOOTH MALFORMATION	0.03125	0.3867853963582855
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.03125	0.3867853963582855
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.03125	0.3867853963582855
GIGANTIFORM CEMENTOMA, FAMILIAL	0.03125	0.3867853963582855
MELNICK-NEEDLES SYNDROME	0.03125	0.3867853963582855
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.03122452	0.3864700270175108
MONILETHRIX	0.03117284	0.38583037680042936
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.03116819	0.38577282313345124
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.03116819	0.38577282313345124
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.031110724	0.38506155882666326
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.03105588	0.3843827473617713
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.030974964	0.383381239293556
HUNTINGTON DISEASE; HD	0.03076024	0.38072357185523165
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03076024	0.38072357185523165
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.03076024	0.38072357185523165
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.030567954	0.3783436225200589
SHUKLA-VERNON SYNDROME; SHUVER	0.030540714000000004	0.3780064694257613
TEMPLE-BARAITSER SYNDROME	0.03045544	0.37695102181331147
20Q11.2 MICRODUPLICATION SYNDROME	0.030394924	0.3762020072518389
SIALURIA	0.030376904	0.3759789713208828
DUBOWITZ SYNDROME	0.03036438	0.3758239601111551
HARTNUP DISORDER	0.030137654000000003	0.37301774232636387
INTELLECTUAL DISABILITY, WOLFF TYPE	0.02989154	0.3699715566931055
MENTAL RETARDATION, X-LINKED 21	0.02976955	0.3684616702770495
19P13.3 MICRODUPLICATION SYNDROME	0.029744824	0.3681556332943182
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.02967996	0.3673528029599379
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.029643810000000003	0.36690536961343073
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.029580774	0.36612516467759576
ATYPICAL TERATOID RHABDOID TUMOR	0.02943871	0.36436681970005197
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.02943871	0.36436681970005197
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.029365060000000002	0.3634552438779148
MONOSOMY 18Q	0.029305614	0.3627194728484135
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.029281164000000002	0.3624168519543028
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.029194190000000002	0.3613403632162911
15Q11Q13 MICRODUPLICATION SYNDROME	0.029181284	0.3611806239418783
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.029116954	0.360384402996351
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.029105564	0.3602434274550863
16P11.2P12.2 MICRODELETION SYNDROME	0.029103614	0.36021929204635356
HYPERCALCEMIA, INFANTILE, 1	0.0288333	0.35687357980215534
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.028799494000000002	0.35645515845465814
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.028737334	0.3556857958870539
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.028737334	0.3556857958870539
ADIPOSIS DOLOROSA	0.028665130000000004	0.35479211739877703
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.028587844	0.35383553832220277
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	0.35363200875235584
DYSOSTEOSCLEROSIS	0.0285714	0.35363200875235584
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.35363200875235584
ACHONDROPLASIA	0.0285714	0.35363200875235584
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	0.35363200875235584
SCHEIE SYNDROME	0.0285714	0.35363200875235584
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0285714	0.35363200875235584
HALLERMANN-STREIFF SYNDROME; HSS	0.0285714	0.35363200875235584
MARSHALL-SMITH SYNDROME; MRSHSS	0.0285714	0.35363200875235584
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.028403360000000002	0.35155215537622636
LEIGH SYNDROME; LS	0.028398754	0.35149514630308626
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	0.35056191049875307
DUPLICATION OF THE PITUITARY GLAND	0.028323354000000002	0.35056191049875307
WOLFRAM-LIKE SYNDROME	0.028130160000000005	0.3481707227271037
FRAGILE X MENTAL RETARDATION SYNDROME	0.02811972	0.3480415054618883
1Q41Q42 MICRODELETION SYNDROME	0.02811627	0.34799880435413033
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.02810493	0.34785844766949986
XQ25 MICRODUPLICATION SYNDROME	0.027832814000000004	0.34449043183220607
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.3438095162547579
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.3438095162547579
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.3438095162547579
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.3438095162547579
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	0.3438095162547579
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.3438095162547579
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.3438095162547579
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.3438095162547579
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.3438095162547579
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	0.3438095162547579
OROFACIAL CLEFT 3	0.027777800000000002	0.3438095162547579
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.3438095162547579
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.3438095162547579
CLEFT CHIN	0.027777800000000002	0.3438095162547579
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.3438095162547579
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.3438095162547579
MENKES DISEASE	0.027777800000000002	0.3438095162547579
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.3438095162547579
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.3438095162547579
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	0.3438095162547579
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.027777800000000002	0.3438095162547579
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.3438095162547579
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.3438095162547579
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.3438095162547579
DIMPLES, FACIAL	0.027777800000000002	0.3438095162547579
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.3438095162547579
DWARFISM, LEVI TYPE	0.027777800000000002	0.3438095162547579
NASAL BONES, ABSENCE OF	0.027777800000000002	0.3438095162547579
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.3438095162547579
ADAMS-OLIVER SYNDROME 2; AOS2	0.027521513999999997	0.3406374304278433
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.02746664	0.33995824764897087
COFFIN-SIRIS SYNDROME 2; CSS2	0.027408604	0.33923992837655326
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.02727275	0.3375584453929738
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.027269684000000002	0.3375204971041663
PROGRESSIVE SUPRANUCLEAR PALSY	0.02717174	0.336308231220617
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.02717174	0.336308231220617
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.02711961	0.335663011293828
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.027098464	0.3354012844461034
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.027081624	0.33519285353171385
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.027051323999999998	0.33481782641140484
OSTEOGENESIS IMPERFECTA, TYPE V	0.027006139999999998	0.33425857804823517
SALT-AND-PEPPER SYNDROME	0.026970064000000002	0.3338120606095465
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.026914450000000003	0.33312371875248825
HOLMES-GANG SYNDROME	0.026863334	0.33249104923824024
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.026861354	0.332466542515527
BAND HETEROTOPIA; BH	0.026659834	0.3299723027371551
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.026583474	0.3290271848854457
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.02658292	0.32902032795393904
PETTIGREW SYNDROME	0.026566984000000002	0.3288230859674954
RICHARDS-RUNDLE SYNDROME; RRNS	0.026561493999999998	0.3287551355090631
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.3285014785518482
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.3285014785518482
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.026524254	0.3282942110879309
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.026424510000000002	0.32705966636555134
HURLER SYNDROME	0.026342504000000003	0.32604466722271114
ALZHEIMER DISEASE 10	0.0263158	0.32571414827153183
HUNTINGTON DISEASE-LIKE 2	0.0263158	0.32571414827153183
NIPAH VIRUS DISEASE	0.0263158	0.32571414827153183
7Q11.23 DUPLICATION SYNDROME	0.0263158	0.32571414827153183
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0263158	0.32571414827153183
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0263158	0.32571414827153183
WILLIAMS-BEUREN SYNDROME (WBS)	0.0263158	0.32571414827153183
ALZHEIMER DISEASE 3; AD	0.0263158	0.32571414827153183
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0263158	0.32571414827153183
HYPERLYSINEMIA, TYPE I	0.0263158	0.32571414827153183
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.02618362	0.32407813887343145
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02617284	0.32394471338310366
HEART AND BRAIN MALFORMATION SYNDROME	0.026089454	0.3229126337971603
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02594221	0.3210901752723161
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.025899619999999998	0.3205630331913273
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.02572202	0.31836485442674395
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.025597233999999996	0.316820361547705
LETTERER-SIWE DISEASE	0.02557931	0.3165985138214866
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.025545554	0.3161807113306236
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.025512194	0.31576781018430317
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02546448	0.31517724767544436
COFFIN-SIRIS SYNDROME 5	0.025359424	0.31387695562425016
SARCOSINEMIA	0.025335834	0.31358497906424726
AGEL AMYLOIDOSIS	0.02527774	0.31286594191813405
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.025140554	0.3111679725938202
PRIMARY HYPEROXALURIA TYPE 1	0.02504074	0.30993256147215276
KLEEFSTRA SYNDROME 2; KLEFS2	0.025031504	0.3098182462746883
SCHIZOPHRENIA 19; SCZD19	0.025	0.30942831708662843
ACATALASEMIA	0.025	0.30942831708662843
MYOPATHY AND DIABETES MELLITUS	0.025	0.30942831708662843
SCHIZOPHRENIA 4	0.025	0.30942831708662843
SCHIZOPHRENIA 15; SCZD15	0.025	0.30942831708662843
MADRAS MOTOR NEURON DISEASE	0.025	0.30942831708662843
HYPERPROLINEMIA TYPE 1	0.025	0.30942831708662843
CYSTINOSIS, NEPHROPATHIC; CTNS	0.024953649999999997	0.3088546369867498
CYSTINOSIS	0.024953649999999997	0.3088546369867498
NEPHROPATHIC INFANTILE CYSTINOSIS	0.024953649999999997	0.3088546369867498
TOXIC EPIDERMAL NECROLYSIS	0.024953649999999997	0.3088546369867498
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.02488188	0.3079663301740575
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.02488188	0.3079663301740575
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.024800864000000002	0.30696358439257393
TRISOMY 18P	0.02469528	0.3056567572153229
ALG13-CDG	0.02458615	0.30430604072557643
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02454545	0.30380229142535936
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02454545	0.30380229142535936
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.024456779999999997	0.30270481107031644
COFFIN-SIRIS SYNDROME 7; CSS7	0.024426503999999998	0.30233008100119185
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.024355704	0.3014537800072025
SULFOCYSTEINURIA	0.024355054	0.3014457348709583
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.024355054	0.3014457348709583
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.024355054	0.3014457348709583
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.024355054	0.3014457348709583
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.024255310000000002	0.3002111901485788
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.024255310000000002	0.3002111901485788
OCULOSKELETODENTAL SYNDROME; OCSKD	0.024118794	0.2985215135031628
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.024107484000000002	0.2983815281325129
RECOMBINANT 8 SYNDROME	0.024050323999999998	0.29767405122832596
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.02397014	0.296681603221235
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.023862309999999998	0.29534697700397694
ENCEPHALITIS LETHARGICA	0.02384003	0.2950712144877894
DISTAL 16P11.2 MICRODELETION SYNDROME	0.023832544	0.294978559272521
HYPOTONIA-CYSTINURIA SYNDROME	0.023824934	0.29488436929279976
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0238095	0.2946933406269632
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.0238095	0.2946933406269632
CLUSTER HEADACHE, FAMILIAL	0.0238095	0.2946933406269632
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0238095	0.2946933406269632
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0238095	0.2946933406269632
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.02377625	0.2942818009652379
6Q TERMINAL DELETION SYNDROME	0.023750054	0.2939575695974619
RUBINSTEIN-TAYBI SYNDROME	0.023745314000000003	0.2938989019885423
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.023712344	0.2934908279239684
RECOMBINANT CHROMOSOME 8 SYNDROME	0.023646964	0.2926816109891235
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.023553934000000002	0.29153016633558076
COFFIN-LOWRY SYNDROME; CLS	0.02353357	0.2912781184056146
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.023476593999999996	0.2905729188938415
MENTAL RETARDATION, X-LINKED 91; MRX91	0.023473464	0.29053417846854224
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.023452163999999998	0.2902705455423844
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0234458	0.29019177746998687
OCCIPITAL HORN SYNDROME	0.023428034	0.2899718853307324
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.02341424	0.2898011551624967
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.02333679	0.2888425462361624
CORNELIA DE LANGE SYNDROME 3	0.023309974	0.28851064104612256
TEMPLE SYNDROME	0.02327938	0.2881319750488046
NEPHROGENIC DIABETES INSIPIDUS	0.023122953999999998	0.2861958696916609
NOONAN SYNDROME	0.02302633	0.28499994162325376
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0230025	0.2847049945514068
CHROMOSOME 2Q37 DELETION SYNDROME	0.022902963999999998	0.28347302427262544
CLEIDOCRANIAL DYSPLASIA	0.02288248	0.28321949108673733
HYPOCHONDROPLASIA	0.02288248	0.28321949108673733
MENTAL RETARDATION, X-LINKED 104; MRX104	0.022828794	0.28255501234149283
2Q31.1 MICRODELETION SYNDROME	0.022794964	0.2821362939428112
TAY-SACHS DISEASE; TSD	0.0227273	0.2812988076369172
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0227273	0.2812988076369172
CAUDAL REGRESSION SEQUENCE	0.0227273	0.2812988076369172
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0227273	0.2812988076369172
GAUCHER DISEASE, PERINATAL LETHAL	0.0227273	0.2812988076369172
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.0227273	0.2812988076369172
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.022676694	0.2806724504603378
MEGAEPIPHYSEAL DWARFISM	0.02255794	0.27920261644564554
NEPHROSIALIDOSIS	0.02255794	0.27920261644564554
DISTAL MONOSOMY 15Q	0.022427854	0.2775925247633843
COFFIN-SIRIS SYNDROME	0.022300544000000002	0.27601679200145235
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.02224623	0.2753445404168826
FONTAINE PROGEROID SYNDROME; FPS	0.02220887	0.27488213073982837
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.022138034	0.27400538416906245
HENNEKAM-BEEMER SYNDROME	0.02211882	0.2737675699416824
ACRODERMATITIS ENTEROPATHICA	0.02208935	0.2734028158415006
TRISOMY 20P	0.02208885	0.27339662727515884
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.021988340000000002	0.27215260166914385
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.021988340000000002	0.27215260166914385
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.021988340000000002	0.27215260166914385
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.021965954	0.27187552717689173
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.021850403999999997	0.27044534949531734
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.021833164000000002	0.27023196772785446
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.021822154	0.27009569549700946
RIDDLE SYNDROME	0.021779494	0.26956768701673284
WILSON-TURNER SYNDROME	0.021779494	0.26956768701673284
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.021779494	0.26956768701673284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.021779494	0.26956768701673284
PORPHYRIA	0.02173918	0.26906871528973164
QAZI-MARKOUIZOS SYNDROME	0.02169311	0.2684985007870044
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.02159248	0.2672529899250673
INFANT BOTULISM	0.021532080000000002	0.266505411110986
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.021418750000000004	0.26510271066396895
TRISOMY 17P	0.021411054	0.26500745625083694
VASCULAR EHLERS-DANLOS SYNDROME	0.021378854	0.26460891257842933
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.021378854	0.26460891257842933
CHROMOSOME 16Q22 DELETION SYNDROME	0.021378854	0.26460891257842933
KAGAMI-OGATA SYNDROME	0.021378854	0.26460891257842933
EARLY MYOCLONIC ENCEPHALOPATHY	0.021378854	0.26460891257842933
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.021378854	0.26460891257842933
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.021378854	0.26460891257842933
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.021378854	0.26460891257842933
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.021378854	0.26460891257842933
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.021341464	0.26414613158739464
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0212766	0.2633433012530143
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.0212766	0.2633433012530143
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.0212766	0.2633433012530143
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0212766	0.2633433012530143
HUNTINGTON DISEASE-LIKE 3	0.0212766	0.2633433012530143
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.021243074	0.26292834550266847
XQ25 DUPLICATION SYNDROME	0.021121404000000003	0.2614224197690713
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.021118994	0.2613925908793041
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.020953753999999998	0.25934739347468827
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.020953753999999998	0.25934739347468827
ENDOCARDIAL FIBROELASTOSIS	0.02093144	0.2590712101359895
FABRY DISEASE	0.02090412	0.2587330668710773
CRANDALL SYNDROME	0.0208333	0.25785651833443424
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.25785651833443424
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.25785651833443424
DERMOIDS OF CORNEA	0.0208333	0.25785651833443424
PUPIL, EGG-SHAPED	0.0208333	0.25785651833443424
POLYARTERITIS NODOSA	0.0208333	0.25785651833443424
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.25785651833443424
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.25785651833443424
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.25785651833443424
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.25785651833443424
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.25785651833443424
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0208333	0.25785651833443424
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.25785651833443424
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.25785651833443424
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.25785651833443424
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.0208333	0.25785651833443424
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0208333	0.25785651833443424
STICKLER SYNDROME, TYPE III	0.0208333	0.25785651833443424
IMINOGLYCINURIA	0.0208333	0.25785651833443424
UNIQUE GREEN PHENOMENON	0.0208333	0.25785651833443424
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.25785651833443424
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.25785651833443424
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.25785651833443424
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.25785651833443424
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0208333	0.25785651833443424
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.25785651833443424
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.25785651833443424
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0208333	0.25785651833443424
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.0208333	0.25785651833443424
RIBOFLAVIN DEFICIENCY	0.0208333	0.25785651833443424
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.25785651833443424
GAUCHER DISEASE, TYPE I	0.0208333	0.25785651833443424
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0208333	0.25785651833443424
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.25785651833443424
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.25785651833443424
GLAUCOMA - SLEEP APNEA	0.0208333	0.25785651833443424
TRANSALDOLASE DEFICIENCY	0.0208333	0.25785651833443424
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.25785651833443424
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.25785651833443424
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.0208333	0.25785651833443424
APNEA, CENTRAL SLEEP	0.0208333	0.25785651833443424
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.25785651833443424
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.25785651833443424
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.25785651833443424
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0208333	0.25785651833443424
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.25785651833443424
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.25785651833443424
CROUZON SYNDROME	0.0208333	0.25785651833443424
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.0208333	0.25785651833443424
OSTEOPETROSIS AND RELATED DISORDERS	0.0208333	0.25785651833443424
CLEFT LIP/PALATE	0.0208333	0.25785651833443424
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.0208333	0.25785651833443424
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0208333	0.25785651833443424
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0208333	0.25785651833443424
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.25785651833443424
GLYCINE ENCEPHALOPATHY	0.0208333	0.25785651833443424
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.25785651833443424
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.0208333	0.25785651833443424
DISTAL MONOSOMY 6P	0.020802894	0.2574801792380608
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.02077497	0.25713456018500774
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.020545554	0.2542950479132979
NEPHRONOPHTHISIS 1	0.020408199999999998	0.2525949992306932
APPARENT MINERALOCORTICOID EXCESS	0.020408199999999998	0.2525949992306932
NEPHRONOPHTHISIS 4	0.020408199999999998	0.2525949992306932
SENIOR-LOKEN SYNDROME 3	0.020408199999999998	0.2525949992306932
SENIOR-LOKEN SYNDROME 4; SLSN4	0.020408199999999998	0.2525949992306932
OCHOA SYNDROME	0.020408199999999998	0.2525949992306932
SENIOR-LOKEN SYNDROME 1	0.020408199999999998	0.2525949992306932
HELIX SYNDROME; HELIX	0.020408199999999998	0.2525949992306932
ERDHEIM-CHESTER DISEASE	0.020408199999999998	0.2525949992306932
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.020408199999999998	0.2525949992306932
TERATOMA, PINEAL	0.020408199999999998	0.2525949992306932
FAMILIAL COLD URTICARIA	0.020408199999999998	0.2525949992306932
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.020408199999999998	0.2525949992306932
FAMILIAL HYPERALDOSTERONISM TYPE III	0.020408199999999998	0.2525949992306932
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.020408199999999998	0.2525949992306932
PANHYPOPHYSITIS	0.020408199999999998	0.2525949992306932
PRIMARY PARATHYROID HYPERPLASIA	0.020408199999999998	0.2525949992306932
PARATHYROID CARCINOMA	0.020408199999999998	0.2525949992306932
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.020408199999999998	0.2525949992306932
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.020408199999999998	0.2525949992306932
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.020258654	0.25074404854641175
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.020258654	0.25074404854641175
MENTAL RETARDATION, X-LINKED 98; MRX98	0.020258654	0.25074404854641175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.020258654	0.25074404854641175
ISOLATED COMPLEX I DEFICIENCY	0.020258654	0.25074404854641175
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.020258654	0.25074404854641175
COFFIN-SIRIS SYNDROME 6; CSS6	0.020208934	0.25012865750938984
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.020198494000000004	0.2499994402441745
GORLIN-CHAUDHRY-MOSS SYNDROME	0.02012011	0.24902927107591372
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.020060014	0.2482854549101682
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.020039670000000002	0.2480336545228558
SCARF SYNDROME	0.020039670000000002	0.2480336545228558
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.24754265366930275
DARIER DISEASE	0.02	0.24754265366930275
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02	0.24754265366930275
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.24754265366930275
WERNER SYNDROME; WRN	0.02	0.24754265366930275
GYRATE ATROPHY OF CHOROID AND RETINA	0.02	0.24754265366930275
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02	0.24754265366930275
CATATRICHY	0.02	0.24754265366930275
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02	0.24754265366930275
HAIR WHORL	0.02	0.24754265366930275
MIDPHALANGEAL HAIR	0.02	0.24754265366930275
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02	0.24754265366930275
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02	0.24754265366930275
HAIRY NOSE TIP	0.02	0.24754265366930275
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02	0.24754265366930275
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.24754265366930275
JUVENILE HYALINE FIBROMATOSIS	0.02	0.24754265366930275
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	0.24754265366930275
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.24754265366930275
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	0.24754265366930275
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.24754265366930275
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.24754265366930275
NEVUS COMEDONICUS SYNDROME	0.02	0.24754265366930275
FAMILIAL MELANOMA	0.02	0.24754265366930275
TRICHODENTOOSSEOUS SYNDROME	0.02	0.24754265366930275
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	0.24754265366930275
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02	0.24754265366930275
KNOBLOCH SYNDROME	0.02	0.24754265366930275
DISSECTING CELLULITIS OF THE SCALP	0.02	0.24754265366930275
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02	0.24754265366930275
RINGED HAIR	0.02	0.24754265366930275
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	0.24754265366930275
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.24754265366930275
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.24754265366930275
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01997806	0.24727109937822753
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.019799544	0.24506158316010604
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.019735464	0.24426845649774964
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.019656654000000003	0.24329301467096573
HADZISELIMOVIC SYNDROME	0.019656654000000003	0.24329301467096573
MEHMO SYNDROME; MEHMO	0.019570594	0.24222783863222672
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.019524734000000002	0.24166022332736303
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.01951446	0.24153306066617306
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019413454	0.240282896002347
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	0.240282896002347
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.01931055	0.23900923954068767
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	0.23876206820099893
CK SYNDROME	0.019242684	0.23816925305399167
SAGLIKER SYNDROME	0.01923343	0.23805471506813886
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.01923214	0.2380387485669772
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0192308	0.23802216320918135
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.0192308	0.23802216320918135
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0192308	0.23802216320918135
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0192308	0.23802216320918135
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0192308	0.23802216320918135
HYPOTONIA-CYSTINURIA SYNDROME	0.0192308	0.23802216320918135
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.0192308	0.23802216320918135
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.0192308	0.23802216320918135
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.0192308	0.23802216320918135
SECONDARY SHORT BOWEL SYNDROME	0.0192308	0.23802216320918135
ASPARTYLGLUCOSAMINURIA	0.019183310000000002	0.23743437317804364
MUENKE SYNDROME	0.019170314	0.23727351996168927
RIFT VALLEY FEVER	0.01903825	0.23563894631098015
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.01897775	0.23489012978363052
CEREBROTENDINOUS XANTHOMATOSIS	0.01893724	0.23438873213862335
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.23353050175835185
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.23353050175835185
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.23353050175835185
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.23353050175835185
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.23353050175835185
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.23353050175835185
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.23353050175835185
MONOPHALANGY OF GREAT TOE	0.0188679	0.23353050175835185
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.23353050175835185
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	0.23353050175835185
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.23353050175835185
RAYNAUD DISEASE	0.0188679	0.23353050175835185
PUBIC BONE DYSPLASIA	0.0188679	0.23353050175835185
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.23353050175835185
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.23353050175835185
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.23353050175835185
CARPAL DISPLACEMENT	0.0188679	0.23353050175835185
HHHH SYNDROME	0.0188679	0.23353050175835185
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.23353050175835185
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.23353050175835185
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.23353050175835185
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.23353050175835185
TRACHEOBRONCHOMEGALY	0.0188679	0.23353050175835185
VAN DEN BOSCH SYNDROME	0.0188679	0.23353050175835185
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.23353050175835185
THROMBOCYTOPENIA 3	0.0188679	0.23353050175835185
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.23353050175835185
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.23353050175835185
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.23353050175835185
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.23353050175835185
VESICOURETERAL REFLUX 1	0.0188679	0.23353050175835185
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.23353050175835185
TOE, MISSHAPEN	0.0188679	0.23353050175835185
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.23353050175835185
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.23353050175835185
KNUCKLE PADS	0.0188679	0.23353050175835185
SPINAL ARACHNOIDITIS	0.0188679	0.23353050175835185
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.23353050175835185
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.23353050175835185
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.018840454	0.23319079897472145
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.018804809999999998	0.23274962845735203
GAPO SYNDROME; GAPOS	0.01871829	0.23167875893757864
DUBOWITZ SYNDROME	0.01862476	0.23052112571769415
ALPHA-MANNOSIDOSIS	0.018571924	0.22986716753523057
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.018563084	0.22975775368230875
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.018551924	0.2296196248815613
MAPLE SYRUP URINE DISEASE; MSUD	0.01854138	0.2294891203945468
RING CHROMOSOME 7 SYNDROME	0.018518510000000002	0.229206055370076
WARBURG MICRO SYNDROME 2; WARBM2	0.018518510000000002	0.229206055370076
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.018515294	0.22916625051136597
MYHRE SYNDROME	0.018408914	0.22784957113649892
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.01840145	0.22775718821814953
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.018368064	0.22734396526637937
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.01817417	0.2249441135018516
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.018089454	0.22389557232943919
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.018089454	0.22389557232943919
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.018089454	0.22389557232943919
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.018089454	0.22389557232943919
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.018089454	0.22389557232943919
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.018089454	0.22389557232943919
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.018089454	0.22389557232943919
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.018089454	0.22389557232943919
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.018089454	0.22389557232943919
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.018089454	0.22389557232943919
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.018089454	0.22389557232943919
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.018042314	0.2233121142947406
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.018038044000000003	0.22325926393818224
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.017957924	0.222267608067583
MALAN OVERGROWTH SYNDROME	0.01790326	0.22159102448657408
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.017877484	0.22127199151452506
HALL-RIGGS SYNDROME	0.01785995	0.22105497087005316
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.01777454	0.2199978399675584
LISSENCEPHALY 5; LIS5	0.017716709999999997	0.2192820703844736
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.017716709999999997	0.2192820703844736
BETA-THALASSEMIA MAJOR	0.01771259	0.21923107659781774
CRANIOFRONTONASAL SYNDROME; CFNS	0.017696144	0.21902752227370548
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.017566263999999998	0.21741998028077697
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.017566263999999998	0.21741998028077697
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.017566263999999998	0.21741998028077697
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.0175439	0.21714317808544403
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0175439	0.21714317808544403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0175439	0.21714317808544403
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0175439	0.21714317808544403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0175439	0.21714317808544403
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.0175439	0.21714317808544403
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0175439	0.21714317808544403
ADRENOLEUKODYSTROPHY	0.017512680000000003	0.21675676400306626
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.01749249	0.21650686969418706
MYOCLONIC EPILEPSY OF INFANCY	0.017460784	0.21611444032532515
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.017460784	0.21611444032532515
CENTRAL CONGENITAL HYPOTHYROIDISM	0.01739359	0.21528277127179238
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.017370550000000002	0.21499760213476538
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.017333094000000004	0.21453400425297353
PITT-HOPKINS SYNDROME	0.01728192	0.21390061686502979
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.017279324	0.21386848582858353
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.21339909544869584
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.21339909544869584
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.21339909544869584
CARDIAC ARRHYTHMIA	0.0172414	0.21339909544869584
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.21339909544869584
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.21339909544869584
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.21339909544869584
CERVICAL RIB	0.0172414	0.21339909544869584
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.21339909544869584
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.21339909544869584
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.21339909544869584
MYOPATHY, CONGENITAL	0.0172414	0.21339909544869584
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.21339909544869584
MOTION SICKNESS	0.0172414	0.21339909544869584
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.21339909544869584
PALMOMENTAL REFLEX	0.0172414	0.21339909544869584
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.21339909544869584
SICKLE CELL ANEMIA	0.0172414	0.21339909544869584
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.21339909544869584
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.21339909544869584
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.21339909544869584
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.21339909544869584
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.21339909544869584
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.21339909544869584
RHEUMATOID ARTHRITIS	0.0172414	0.21339909544869584
JUMPING FRENCHMAN OF MAINE	0.0172414	0.21339909544869584
269800 SENILE PLAQUE FORMATION	0.0172414	0.21339909544869584
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.21339909544869584
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.21339909544869584
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.21339909544869584
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.21339909544869584
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.21339909544869584
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.21339909544869584
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.21339909544869584
TRANSSEXUALITY	0.0172414	0.21339909544869584
ERYTHERMALGIA, PRIMARY	0.0172414	0.21339909544869584
MOSAIC TRISOMY 15	0.0172414	0.21339909544869584
DIASTEMATOMYELIA	0.0172414	0.21339909544869584
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.21339909544869584
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.21339909544869584
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.21339909544869584
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.21339909544869584
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.017207554	0.21298017901589125
CRANIOFRONTONASAL DYSPLASIA	0.01715059	0.21227512802971035
HEART-HAND SYNDROME TYPE 2	0.01715059	0.21227512802971035
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.017102	0.21167372315262076
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.01708913	0.21151442945498455
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.01708913	0.21151442945498455
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.017078864000000003	0.21138736581085615
CARDIOFACIOCUTANEOUS SYNDROME	0.017056274	0.21110776638353662
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.017056104000000002	0.2111056622709805
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01703874	0.21089074573906477
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.017027694	0.2107540279314432
WIEACKER-WOLFF SYNDROME	0.017000453999999998	0.2104168748371456
BILATERAL POLYMICROGYRIA	0.017000453999999998	0.2104168748371456
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.016974310000000003	0.21009328708026914
HYPOPHOSPHATASIA	0.01693283	0.20957988361655897
SOTOS SYNDROME	0.016899634	0.20916901231999865
GABRIELE-DE VRIES SYNDROME; GADEVS	0.016887594	0.20901999164248974
CHROMOSOME 19P13.13 DELETION SYNDROME	0.016799254	0.20792659574123243
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.016714094	0.20687255912190855
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0167077	0.20679341973553045
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.01669385	0.20662199644786447
ACROOSTEOLYSIS DOMINANT TYPE	0.01669385	0.20662199644786447
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.01666666	0.20628546221020103
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.016642334	0.20598437608054312
ADIPOSIS DOLOROSA	0.016616930000000002	0.20566994740185235
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.016585854	0.20528531562658098
NIJMEGEN BREAKAGE SYNDROME	0.01657558	0.20515815296539103
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.016553654	0.2048867719541734
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.016510550000000002	0.20435326802698534
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.016492640000000003	0.20413159358062447
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0164549	0.20366448059315048
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0164549	0.20366448059315048
GENITOPATELLAR SYNDROME; GTPTS	0.016437603999999998	0.20345040570625725
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.016410413999999998	0.2031138714685938
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.016376670000000003	0.20269621750332303
AMISH LETHAL MICROCEPHALY	0.01628802	0.20159898469093385
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0162537	0.20117420149723728
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.016128999999999998	0.19963077305160917
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01612699	0.19960589501491544
SILVER-RUSSELL SYNDROME	0.01612699	0.19960589501491544
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.01612699	0.19960589501491544
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.01609678	0.19923198183654797
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01585044	0.19618299897130315
LEPRECHAUNISM	0.015738620000000002	0.1947989879946381
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.015727404	0.19466016607446035
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.01572366	0.19461382608969344
COHEN SYNDROME	0.015705234000000002	0.19438576504286792
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.015686343999999998	0.19415196100647722
MONOSOMY 9P	0.015646964	0.19366454952140238
45,X/46,XY MIXED GONADAL DYSGENESIS	0.01563998	0.1935781076267411
ACROMICRIC DYSPLASIA	0.01560474	0.19314193747097577
MENTAL RETARDATION, X-LINKED 9	0.015587804	0.1929323183518486
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.01554339	0.19238260038084518
FRIED SYNDROME	0.015529873999999999	0.19221531105549544
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.01551929	0.19208431148317365
CHIME SYNDROME	0.01544561	0.19117236434705595
TRISOMY X	0.015380584	0.19036752891718095
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.015346694000000001	0.18994806789053834
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.015299293999999998	0.18936139180134204
TENORIO SYNDROME; TNORS	0.015235409999999998	0.18857069105699154
2P15P16.1 MICRODELETION SYNDROME	0.015221484	0.18839832710724166
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.015190224	0.18801141793955653
X SMALL RINGS	0.015176894	0.18784643076088592
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.015159680000000002	0.1876333707988728
DYSTONIA 28, CHILDHOOD-ONSET	0.015110123999999999	0.18702000961161094
BRANCHIOOCULOFACIAL SYNDROME	0.01510141	0.18691215527740723
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014903434	0.18446178005726557
PROPIONIC ACIDEMIA	0.014903434	0.18446178005726557
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.014903434	0.18446178005726557
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.014903434	0.18446178005726557
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.014903434	0.18446178005726557
NIEMANN-PICK DISEASE, TYPE A	0.014903434	0.18446178005726557
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.014890644000000001	0.18430347653024404
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.014831254	0.18356839862017305
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.014831254	0.18356839862017305
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.014831254	0.18356839862017305
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.18356839862017305
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.014831254	0.18356839862017305
PROLIDASE DEFICIENCY	0.01480114	0.18319567364654318
LANDAU-KLEFFNER SYNDROME	0.014781964000000002	0.18295832975020507
19P13.12 MICRODELETION SYNDROME	0.014630054	0.18107811952425987
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.014630054	0.18107811952425987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.014630054	0.18107811952425987
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.014564569999999999	0.18026761536761582
GLYCEROL KINASE DEFICIENCY; GKD	0.014544894	0.18002408290493596
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.014544894	0.18002408290493596
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.014544894	0.18002408290493596
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01451115	0.1796064289396651
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.014504474	0.17952379920187028
GOLDBERG-SHPRINTZEN SYNDROME	0.014504474	0.17952379920187028
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014504474	0.17952379920187028
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014503344000000001	0.179509813041938
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0144928	0.17937930855492354
LEGIONELLOSIS	0.0144928	0.17937930855492354
KETAMINE-INDUCED BILIARY DILATATION	0.0144928	0.17937930855492354
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0144928	0.17937930855492354
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0144928	0.17937930855492354
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.014484130000000001	0.1792719988145579
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.014484130000000001	0.1792719988145579
KAPUR-TORIELLO SYNDROME	0.014484130000000001	0.1792719988145579
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.014484130000000001	0.1792719988145579
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.014450029999999999	0.17884993859005174
LEGIUS SYNDROME	0.014393050000000001	0.1781446895697479
AUTISM, SUSCEPTIBILITY TO, 18	0.01428863	0.17685226937494045
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.17681600437617792
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0142857	0.17681600437617792
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0142857	0.17681600437617792
SUPRABULBAR PARESIS, CONGENITAL	0.0142857	0.17681600437617792
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.0142857	0.17681600437617792
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0142857	0.17681600437617792
TEMTAMY SYNDROME	0.014128304	0.17486789320033122
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.01411882	0.17475050847396126
2Q24 MICRODELETION SYNDROME	0.01411882	0.17475050847396126
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.01409776	0.17448984605964749
MICROPHTHALMIA, LENZ TYPE	0.0140845	0.17432572528026472
KERATODERMA HEREDITARIUM MUTILANS	0.0140845	0.17432572528026472
HARLEQUIN ICHTHYOSIS	0.0140845	0.17432572528026472
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.0140845	0.17432572528026472
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0140845	0.17432572528026472
17Q12 MICRODUPLICATION SYNDROME	0.0140845	0.17432572528026472
LESCH-NYHAN SYNDROME; LNS	0.0140845	0.17432572528026472
FRANK-TER HAAR SYNDROME	0.01398611	0.17310793919553857
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01398611	0.17310793919553857
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.01395892	0.17277140495787516
SOTOS SYNDROME 2	0.013935119999999999	0.17247682920000867
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.013916000000000001	0.17224017842310085
ALAZAMI SYNDROME; ALAZS	0.013875024	0.17173301303426317
BOHRING-OPITZ SYNDROME	0.013825854	0.1711244294202172
BOHRING-OPITZ SYNDROME	0.013825854	0.1711244294202172
15Q14 MICRODELETION SYNDROME	0.013760643999999999	0.17031731659792843
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.013705834	0.16963892595554772
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.013688254	0.1694213359629724
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.013603144000000001	0.16836791820028268
MACS SYNDROME	0.013582750000000001	0.1681154989563361
CARPENTER-WAZIRI SYNDROME	0.013582750000000001	0.1681154989563361
FOUNTAIN SYNDROME	0.013582750000000001	0.1681154989563361
TRISOMY 13	0.013580249999999999	0.16808455612462742
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.013555560000000001	0.16777896471867268
ACROMICRIC DYSPLASIA	0.013555560000000001	0.16777896471867268
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.01355446	0.16776534987272088
HERMANSKY-PUDLAK SYNDROME	0.01355446	0.16776534987272088
X-LINKED RECESSIVE OCULAR ALBINISM	0.01355446	0.16776534987272088
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.01355446	0.16776534987272088
RETINAL CONE DYSTROPHY 3B	0.01355446	0.16776534987272088
OCULOCUTANEOUS ALBINISM	0.01355446	0.16776534987272088
OCULAR ALBINISM	0.01355446	0.16776534987272088
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01355446	0.16776534987272088
CONE-ROD DYSTROPHY, X-LINKED, 3	0.01355446	0.16776534987272088
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.013508524000000001	0.16719679390577322
PERIPHERAL HYPOTHYROIDISM	0.013494704	0.16702574193208772
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.013494704	0.16702574193208772
PRIMARY CONGENITAL HYPOTHYROIDISM	0.013494704	0.16702574193208772
PERMANENT CONGENITAL HYPOTHYROIDISM	0.013494704	0.16702574193208772
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.013494704	0.16702574193208772
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.013429804	0.16622246602093083
EPIDERMAL NEVUS SYNDROME	0.013244604	0.16393022104795307
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.013244604	0.16393022104795307
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.013215089999999999	0.16356492235393327
CONO-SPONDYLAR DYSPLASIA	0.01314663	0.16271758385042326
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.013143364000000001	0.1626771601350791
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.013143364000000001	0.1626771601350791
MOEBIUS SYNDROME	0.01314001	0.16263564723205873
STICKLER SYNDROME	0.01305759	0.16161552395628753
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.013052284	0.16154985089026908
10Q22.3Q23.3 MICRODELETION SYNDROME	0.013052284	0.16154985089026908
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.013052284	0.16154985089026908
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.013024053999999998	0.16120044443461481
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.013024053999999998	0.16120044443461481
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.013024053999999998	0.16120044443461481
GAUCHER DISEASE, TYPE II	0.013024053999999998	0.16120044443461481
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.013024053999999998	0.16120044443461481
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.013024053999999998	0.16120044443461481
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.013024053999999998	0.16120044443461481
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.013007694	0.16099795454391336
JOUBERT SYNDROME 10	0.012997494000000002	0.16087170779054202
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.012990159999999999	0.16078093389944148
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.01294915	0.16027334768809257
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.012904033999999998	0.15971494096994535
HYPOPHOSPHATASIA, INFANTILE	0.01288425	0.15947007177693567
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.01282051	0.15868115333969163
CAFFEY DISEASE	0.01282051	0.15868115333969163
MENKES DISEASE	0.01282051	0.15868115333969163
SCLERODERMA	0.01282051	0.15868115333969163
FAMILIAL DYSAUTONOMIA	0.01282051	0.15868115333969163
2Q33.1 DELETION SYNDROME	0.01282051	0.15868115333969163
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.012812524	0.15858230955808147
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.012812524	0.15858230955808147
CORNEODERMATOOSSEOUS SYNDROME	0.01276747	0.15802467022216063
MARFAN SYNDROME	0.012710860000000001	0.15732400074094968
NOONAN SYNDROME 5; NS5	0.012638954	0.1564340106382124
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.012638954	0.1564340106382124
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.012593754000000002	0.15587456424091983
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.012593754000000002	0.15587456424091983
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.012593754000000002	0.15587456424091983
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.012570650000000001	0.155588602967401
SIFRIM-HITZ-WEISS SYNDROME	0.01254258	0.15524117685297614
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.012531274	0.1551012409908569
RECESSIVE X-LINKED ICHTHYOSIS	0.01250673	0.15479745664627395
CYCLIC VOMITING SYNDROME	0.01250673	0.15479745664627395
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01250673	0.15479745664627395
TUBEROUS SCLEROSIS 2; TSC2	0.01250673	0.15479745664627395
TUBEROUS SCLEROSIS-1	0.01250673	0.15479745664627395
HURLER SYNDROME	0.012482484	0.15449736068723063
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.012482484	0.15449736068723063
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.012482484	0.15449736068723063
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.012478499999999998	0.1544480501906197
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.01246214	0.1542455602999182
SCARF SYNDROME	0.01246214	0.1542455602999182
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.01246214	0.1542455602999182
MILROY DISEASE	0.012461970000000001	0.15424345618736204
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.012451940000000002	0.1541193135465469
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.012451940000000002	0.1541193135465469
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.012380203999999999	0.15323142755636582
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.01229416	0.15216644955174974
MOEBIUS SYNDROME; MBS	0.0122706	0.1518748443057273
20Q13.33 MICRODELETION SYNDROME	0.01226697	0.15182991531408632
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.012235593999999999	0.1514415703990099
FLOATING-HARBOR SYNDROME	0.012198874000000002	0.15098708208687311
3P25.3 MICRODELETION SYNDROME	0.01217589	0.15070260606927632
STURGE-WEBER SYNDROME	0.01217589	0.15070260606927632
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.01214675	0.15034193642288013
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0120934	0.1496816163942173
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0120934	0.1496816163942173
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0120934	0.1496816163942173
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.012079124	0.14950492044802816
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01204918	0.14913429958695446
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.012048200000000002	0.14912216999692468
MIXED CONNECTIVE TISSUE DISEASE	0.012048200000000002	0.14912216999692468
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.012048200000000002	0.14912216999692468
PORPHYRIA VARIEGATA	0.012048200000000002	0.14912216999692468
SHEEHAN SYNDROME	0.012048200000000002	0.14912216999692468
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.012048200000000002	0.14912216999692468
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.012048200000000002	0.14912216999692468
CLASSIC HOMOCYSTINURIA	0.012048200000000002	0.14912216999692468
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.012048200000000002	0.14912216999692468
WERNICKE-KORSAKOFF SYNDROME	0.012048200000000002	0.14912216999692468
DEMENTIA, FAMILIAL DANISH	0.012048200000000002	0.14912216999692468
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.011960354000000001	0.148034888399213
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.011960354000000001	0.148034888399213
KID SYNDROME	0.01195286	0.1479421341668831
ATKIN-FLAITZ SYNDROME	0.01193693	0.14774496644323548
SCHEIE SYNDROME	0.01193693	0.14774496644323548
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.01193693	0.14774496644323548
VICI SYNDROME	0.011840514	0.14655161281842652
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.011840514	0.14655161281842652
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.011840514	0.14655161281842652
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.01178159	0.14582230265218601
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.01178159	0.14582230265218601
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.0117284	0.1451639629647525
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.011690820000000001	0.1446988303185079
ALAZAMI-YUAN SYNDROME	0.011656654	0.14427595320324463
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.011656654	0.14427595320324463
MACDERMOT-WINTER SYNDROME	0.011656654	0.14427595320324463
TREACHER-COLLINS SYNDROME	0.011656654	0.14427595320324463
CRANIOSYNOSTOSIS 6; CRS6	0.011656654	0.14427595320324463
LIG4 SYNDROME	0.011656654	0.14427595320324463
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.011656654	0.14427595320324463
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.011656654	0.14427595320324463
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.011656654	0.14427595320324463
HYPERTELORISM, TEEBI TYPE; TBHS	0.01163752	0.1440391291464792
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.011603744	0.14362107911296249
BARDET-BIEDL SYNDROME 1; BBS1	0.011603744	0.14362107911296249
SIALIDOSIS TYPE 1	0.01153357	0.142752526204033
ASPARTYLGLUCOSAMINURIA; AGU	0.01153357	0.142752526204033
ZIMMERMANN-LABAND SYNDROME 1	0.01153357	0.142752526204033
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01153357	0.142752526204033
MOSAIC TRISOMY 1	0.01153357	0.142752526204033
FOUNTAIN SYNDROME	0.01153357	0.142752526204033
MUCOPOLYSACCHARIDOSIS TYPE 6	0.01153357	0.142752526204033
DUANE RETRACTION SYNDROME	0.011523304	0.14262546255990455
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.011486684	0.14217221196103605
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.011486534	0.14217035539113354
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.011481974	0.14211391566609693
WIEDEMANN-STEINER SYNDROME; WDSTS	0.011457734	0.14181389396984975
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.01145599	0.14179230825044975
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.01145599	0.14179230825044975
BOWEN-CONRADI SYNDROME	0.01145599	0.14179230825044975
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.011450749999999999	0.1417274520751884
20Q11.2 MICRODELETION SYNDROME	0.011366664	0.14068670849636658
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.011305544	0.1399302181467532
AICARDI-GOUTIERES SYNDROME 5	0.011305544	0.1399302181467532
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.011305544	0.1399302181467532
FOLATE MALABSORPTION, HEREDITARY	0.011305544	0.1399302181467532
ARGININOSUCCINIC ACIDURIA	0.011305544	0.1399302181467532
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.011305544	0.1399302181467532
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.011263844	0.1394140917138527
ALSTROM SYNDROME; ALMS	0.011263844	0.1394140917138527
BEHET DISEASE	0.01125686	0.13932764981919138
JUVENILE HUNTINGTON DISEASE	0.01115585	0.13807743564683456
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.01113831	0.13786034073956657
EAR-PATELLA-SHORT STATURE SYNDROME	0.011118114	0.13761037216789132
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.0111111	0.13752355895924948
TRISOMY 4P	0.0111111	0.13752355895924948
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0111111	0.13752355895924948
CHROMOSOME 18Q DELETION SYNDROME	0.0111111	0.13752355895924948
TEEBI-SHALTOUT SYNDROME; TBSH	0.0111111	0.13752355895924948
WARBURG MICRO SYNDROME 3; WARBM3	0.0111111	0.13752355895924948
UNILATERAL POLYMICROGYRIA	0.01109745	0.1373546110981202
ADENYLOSUCCINATE LYASE DEFICIENCY	0.01109745	0.1373546110981202
GOLDENHAR SYNDROME	0.01109083	0.13727267447975564
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.011058189999999999	0.13686868486896733
LOWRY-WOOD SYNDROME	0.011058189999999999	0.13686868486896733
LAMB-SHAFFER SYNDROME	0.011027224	0.13648541457829116
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.010998094	0.13612486870322182
PELVISCAPULAR DYSPLASIA	0.01097775	0.1358730683159094
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.01097775	0.1358730683159094
EMERY-NELSON SYNDROME	0.01097775	0.1358730683159094
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.01097775	0.1358730683159094
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.010947004	0.1354925209944236
LOCKED-IN SYNDROME	0.01094113	0.13541981771704092
FRYNS SYNDROME	0.01094098	0.1354179611471384
MUCOLIPIDOSIS TYPE II	0.01094098	0.1354179611471384
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010854853999999999	0.13435196821764225
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.010854853999999999	0.13435196821764225
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.010854853999999999	0.13435196821764225
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.010854853999999999	0.13435196821764225
VICI SYNDROME; VICIS	0.010854853999999999	0.13435196821764225
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.010854853999999999	0.13435196821764225
CREE MENTAL RETARDATION SYNDROME	0.010854853999999999	0.13435196821764225
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.010854853999999999	0.13435196821764225
HYDROXYKYNURENINURIA	0.010854853999999999	0.13435196821764225
WARSAW BREAKAGE SYNDROME; WABS	0.010854853999999999	0.13435196821764225
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.010854853999999999	0.13435196821764225
GABA-TRANSAMINASE DEFICIENCY	0.010854853999999999	0.13435196821764225
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.010854853999999999	0.13435196821764225
MARINESCO-SJOGREN SYNDROME; MSS	0.010854853999999999	0.13435196821764225
ARIMA SYNDROME	0.010854853999999999	0.13435196821764225
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.010854853999999999	0.13435196821764225
HYDROCEPHALUS, NORMAL-PRESSURE	0.010854853999999999	0.13435196821764225
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.010854853999999999	0.13435196821764225
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.010854853999999999	0.13435196821764225
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.010854853999999999	0.13435196821764225
ROSSELLI-GULIENETTI SYNDROME	0.010854853999999999	0.13435196821764225
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.010854853999999999	0.13435196821764225
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.010854853999999999	0.13435196821764225
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.010854853999999999	0.13435196821764225
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.010854853999999999	0.13435196821764225
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.010854853999999999	0.13435196821764225
C SYNDROME	0.010854853999999999	0.13435196821764225
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.010854853999999999	0.13435196821764225
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.010854853999999999	0.13435196821764225
ADAMS-OLIVER SYNDROME 3; AOS3	0.010854853999999999	0.13435196821764225
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.010854853999999999	0.13435196821764225
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.010854853999999999	0.13435196821764225
CHROMOSOME 4Q21 DELETION SYNDROME	0.010854853999999999	0.13435196821764225
SEPTOOPTIC DYSPLASIA	0.010854853999999999	0.13435196821764225
PYRUVATE CARBOXYLASE DEFICIENCY	0.010854853999999999	0.13435196821764225
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.010854853999999999	0.13435196821764225
HARTSFIELD SYNDROME; HRTFDS	0.010854853999999999	0.13435196821764225
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.010854853999999999	0.13435196821764225
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.010854853999999999	0.13435196821764225
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.010854853999999999	0.13435196821764225
MEVALONIC ACIDURIA; MEVA	0.010854853999999999	0.13435196821764225
REVESZ SYNDROME	0.010854853999999999	0.13435196821764225
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.010854853999999999	0.13435196821764225
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.010854853999999999	0.13435196821764225
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.010854853999999999	0.13435196821764225
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.010840454	0.13417373750700037
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01077995	0.13342487147112
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.01077995	0.13342487147112
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01077995	0.13342487147112
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.01077995	0.13342487147112
KABUKI SYNDROME 1	0.010766974	0.13326426579741935
XERODERMA PIGMENTOSUM	0.01071829	0.13266169746985754
ELSAHY-WATERS SYNDROME; ESWS	0.010594734	0.13113242846401932
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.010594734	0.13113242846401932
LEUKOCYTE ADHESION DEFICIENCY	0.01057582	0.13089832737644427
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.01057256	0.13085797792389617
MEIER-GORLIN SYNDROME 6; MGORS6	0.01057256	0.13085797792389617
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.01057256	0.13085797792389617
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.01045254	0.12937247445922667
CHITAYAT SYNDROME	0.01045254	0.12937247445922667
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.010408434	0.12882656864508976
JABERI-ELAHI SYNDROME; JABELS	0.010408434	0.12882656864508976
HOLOPROSENCEPHALY	0.010333354	0.1278972935232152
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.010319494	0.12772574646422238
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.010309299999999999	0.1275995739736471
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.010309299999999999	0.1275995739736471
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.010309299999999999	0.1275995739736471
PIERSON SYNDROME	0.010309299999999999	0.1275995739736471
FUCOSIDOSIS	0.010251964	0.12688991869410798
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.010228413999999998	0.12659843721941236
STVE-WIEDEMANN SYNDROME	0.01022142	0.12651187155342422
FREEMAN-SHELDON SYNDROME	0.01022142	0.12651187155342422
MEIER-GORLIN SYNDROME 3; MGORS3	0.0101692	0.12586553768469366
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.010122164	0.1252833668717942
PIERPONT SYNDROME	0.010122164	0.1252833668717942
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.010058614	0.12449680008976001
DOWN SYNDROME	0.01004918	0.1243800342200242
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.009961134	0.1232902771957758
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009961134	0.1232902771957758
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009961134	0.1232902771957758
SPINOCEREBELLAR ATAXIA 14	0.00990892	0.12264401758984135
IRIDOGONIODYSGENESIS, TYPE 2	0.00986288	0.12207417440109462
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00986288	0.12207417440109462
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.009791154	0.12118641218224041
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.0097878	0.12114489927922006
17Q12 MICRODELETION SYNDROME	0.009757004	0.12076373310110006
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00970641	0.12013752445011285
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.009636984	0.11927822963643057
COWDEN SYNDROME	0.009636984	0.11927822963643057
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.009636984	0.11927822963643057
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.009634684000000001	0.11924976223125863
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.009634684000000001	0.11924976223125863
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00957661	0.11853097262779905
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00957661	0.11853097262779905
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00957661	0.11853097262779905
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00957661	0.11853097262779905
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.009554564	0.11825810636065939
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.009554564	0.11825810636065939
FANCONI ANEMIA	0.009554564	0.11825810636065939
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.009554564	0.11825810636065939
OKAMOTO SYNDROME	0.009554564	0.11825810636065939
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.009554564	0.11825810636065939
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.009554564	0.11825810636065939
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.009554564	0.11825810636065939
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.009554564	0.11825810636065939
RAHMAN SYNDROME	0.009554564	0.11825810636065939
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.009554564	0.11825810636065939
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.009554564	0.11825810636065939
OCULOECTODERMAL SYNDROME; OES	0.009554564	0.11825810636065939
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.009543604	0.11812245298644863
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.009474124	0.11726248980760146
FETAL HYDANTOIN SYNDROME	0.009474124	0.11726248980760146
LATERAL MENINGOCELE SYNDROME	0.009474124	0.11726248980760146
WOLF-HIRSCHHORN SYNDROME	0.009474124	0.11726248980760146
RITSCHER-SCHINZEL SYNDROME 1	0.009474124	0.11726248980760146
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.009474124	0.11726248980760146
DISTAL TRISOMY 17Q	0.009474124	0.11726248980760146
BARAITSER-WINTER SYNDROME 1; BRWS1	0.009474124	0.11726248980760146
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009456589999999999	0.11704546916312956
AICARDI-GOUTIERES SYNDROME 7	0.009426164	0.11666888252410247
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.009426164	0.11666888252410247
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.009426164	0.11666888252410247
KRABBE DISEASE	0.009426164	0.11666888252410247
COG4-CDG	0.009426164	0.11666888252410247
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.009426164	0.11666888252410247
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.009426164	0.11666888252410247
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.009426164	0.11666888252410247
INFANTILE DYSTONIA-PARKINSONISM	0.009426164	0.11666888252410247
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009426164	0.11666888252410247
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.009426164	0.11666888252410247
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.009426164	0.11666888252410247
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.009426164	0.11666888252410247
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00941558	0.11653788295178068
LARYNGOTRACHEAL ANGIOMA	0.00941558	0.11653788295178068
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00937055	0.11598054066704425
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00937055	0.11598054066704425
PLAGUE	0.00937055	0.11598054066704425
ACTH-INDEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704425
ACTH-DEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704425
AUTOIMMUNE HEPATITIS	0.00937055	0.11598054066704425
CUTANEOUS MASTOCYTOSIS	0.00937055	0.11598054066704425
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00937055	0.11598054066704425
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00937055	0.11598054066704425
DYSTONIA 26, MYOCLONIC; DYT26	0.00937055	0.11598054066704425
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00937055	0.11598054066704425
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00937055	0.11598054066704425
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00937055	0.11598054066704425
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009317484000000001	0.11532373574406349
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009317484000000001	0.11532373574406349
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.11532373574406349
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.009317484000000001	0.11532373574406349
FETAL ALCOHOL SYNDROME	0.009317484000000001	0.11532373574406349
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009317484000000001	0.11532373574406349
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009317484000000001	0.11532373574406349
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.11532373574406349
INFANTILE REFSUM DISEASE	0.009317484000000001	0.11532373574406349
WEAVER SYNDROME	0.009317484000000001	0.11532373574406349
HEREDITARY FOLATE MALABSORPTION	0.009317484000000001	0.11532373574406349
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.009317484000000001	0.11532373574406349
MENTAL RETARDATION, X-LINKED 90	0.009317484000000001	0.11532373574406349
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.11532373574406349
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009317484000000001	0.11532373574406349
ARGININEMIA	0.009317484000000001	0.11532373574406349
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0092456	0.11443401793824527
SPINOCEREBELLAR ATAXIA TYPE 27	0.009183779999999999	0.11366886359575343
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.009183779999999999	0.11366886359575343
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00908913	0.11249736798726348
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.00908913	0.11249736798726348
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00908913	0.11249736798726348
SVEINSSON CHORIORETINAL ATROPHY	0.00900901	0.11150571211666425
BRANCHIOGENIC DEAFNESS SYNDROME	0.00900901	0.11150571211666425
HYPEREKPLEXIA 2; HKPX2	0.00900901	0.11150571211666425
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00900901	0.11150571211666425
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00900901	0.11150571211666425
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00900901	0.11150571211666425
EDICT SYNDROME	0.00900901	0.11150571211666425
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00900901	0.11150571211666425
NEUROTROPHIC KERATOPATHY	0.00900901	0.11150571211666425
ALAND ISLAND EYE DISEASE	0.00900901	0.11150571211666425
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00900901	0.11150571211666425
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00900901	0.11150571211666425
MEGALOCORNEA	0.00900901	0.11150571211666425
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00900901	0.11150571211666425
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00900901	0.11150571211666425
SANJAD-SAKATI SYNDROME	0.00900901	0.11150571211666425
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.00900901	0.11150571211666425
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00900901	0.11150571211666425
LAND ISLANDS EYE DISEASE	0.00900901	0.11150571211666425
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.00900901	0.11150571211666425
BABESIOSIS	0.00898989	0.1112690613397564
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.008974934	0.1110839489433425
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.008974934	0.1110839489433425
11P15.4 MICRODUPLICATION SYNDROME	0.008974934	0.1110839489433425
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.008974934	0.1110839489433425
THAUVIN-ROBINET-FAIVRE SYNDROME	0.008948914	0.11076189595091875
8P23.1 DUPLICATION SYNDROME	0.008948914	0.11076189595091875
TEMPLE-BARAITSER SYNDROME; TMBTS	0.008948914	0.11076189595091875
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.008948914	0.11076189595091875
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.008948914	0.11076189595091875
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.008948914	0.11076189595091875
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.008948914	0.11076189595091875
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.008948914	0.11076189595091875
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.008948914	0.11076189595091875
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00892857	0.11051009556360633
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00892857	0.11051009556360633
MAYER-ROKITANSKY-KSTER-HAUSER SYNDROME TYPE 2	0.00892857	0.11051009556360633
SPONDYLO-OCULAR SYNDROME	0.00892857	0.11051009556360633
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.11051009556360633
PTERYGIUM COLLI, ISOLATED	0.00892857	0.11051009556360633
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00892857	0.11051009556360633
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.11051009556360633
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.11051009556360633
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00892857	0.11051009556360633
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00892857	0.11051009556360633
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00892857	0.11051009556360633
THORACOMELIC DYSPLASIA	0.00892857	0.11051009556360633
JUNG SYNDROME	0.00892857	0.11051009556360633
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00892857	0.11051009556360633
ISOLATED KLIPPEL-FEIL SYNDROME	0.00892857	0.11051009556360633
FLOATING-HARBOR SYNDROME	0.00892857	0.11051009556360633
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00892857	0.11051009556360633
WILDERVANCK SYNDROME	0.00892857	0.11051009556360633
CEREBROFACIOTHORACIC DYSPLASIA	0.00892857	0.11051009556360633
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00892857	0.11051009556360633
RING CHROMOSOME 6 SYNDROME	0.00892857	0.11051009556360633
RING CHROMOSOME 8 SYNDROME	0.00892857	0.11051009556360633
SPONDYLOOCULAR SYNDROME; SOS	0.00892857	0.11051009556360633
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00892857	0.11051009556360633
EDINBURGH MALFORMATION SYNDROME	0.00892857	0.11051009556360633
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00892857	0.11051009556360633
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00892857	0.11051009556360633
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.008887593999999999	0.11000293017476863
ZTTK SYNDROME; ZTTKS	0.008887593999999999	0.11000293017476863
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00888061	0.10991648828010733
5Q14.3 MICRODELETION SYNDROME	0.00888061	0.10991648828010733
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00888061	0.10991648828010733
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00888061	0.10991648828010733
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.10857134150006834
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.10857134150006834
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.10857134150006834
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.10857134150006834
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.10857134150006834
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.10857134150006834
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.10857134150006834
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.10857134150006834
CRYPTOCOCCOSIS	0.00877193	0.10857134150006834
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.10857134150006834
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.10857134150006834
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.10857134150006834
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.10857134150006834
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.10857134150006834
PELIZAEUS-MERZBACHER DISEASE	0.00877193	0.10857134150006834
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.10857134150006834
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.10857134150006834
HISTIDINEMIA	0.00877193	0.10857134150006834
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.10857134150006834
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.10857134150006834
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.10857134150006834
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.10857134150006834
CORTICOBASAL SYNDROME	0.00877193	0.10857134150006834
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.10857134150006834
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.10857134150006834
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.10857134150006834
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.10857134150006834
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.10857134150006834
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.10857134150006834
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.10857134150006834
NEUROFERRITINOPATHY	0.00877193	0.10857134150006834
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.10857134150006834
HUNTINGTON DISEASE	0.00877193	0.10857134150006834
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.10857134150006834
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.10857134150006834
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.10857134150006834
BREATH-HOLDING SPELLS	0.00877193	0.10857134150006834
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.10857134150006834
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.10857134150006834
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.10857134150006834
DIENCEPHALIC SYNDROME	0.00877193	0.10857134150006834
PINEOBLASTOMA	0.00877193	0.10857134150006834
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.10857134150006834
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.10857134150006834
LESCH-NYHAN SYNDROME	0.00877193	0.10857134150006834
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.10857134150006834
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.10857134150006834
ANGELMAN SYNDROME	0.00877193	0.10857134150006834
NANCE-HORAN SYNDROME	0.00877193	0.10857134150006834
KEIPERT SYNDROME	0.00877193	0.10857134150006834
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00877193	0.10857134150006834
RHEUMATIC FEVER	0.00877193	0.10857134150006834
ISOLATED CEREBELLAR AGENESIS	0.00877193	0.10857134150006834
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.10857134150006834
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.10857134150006834
SNEDDON SYNDROME	0.00877193	0.10857134150006834
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.10857134150006834
TETRASOMY X	0.008767574	0.10851742671009916
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.008767574	0.10851742671009916
DISTAL MONOSOMY 9P	0.008767574	0.10851742671009916
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.008767574	0.10851742671009916
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.008545554	0.10576945571171624
GAUCHER DISEASE	0.00849302	0.10511923542332309
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.008453974	0.10463595790056449
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.008453974	0.10463595790056449
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00842938	0.10433155469934735
MENTAL RETARDATION, X-LINKED 102	0.00842938	0.10433155469934735
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00842938	0.10433155469934735
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00842938	0.10433155469934735
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00840336	0.1040095017069236
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00840336	0.1040095017069236
XYLT1-CDG	0.00840336	0.1040095017069236
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00840336	0.1040095017069236
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00840336	0.1040095017069236
ATYPICAL RETT SYNDROME	0.00840336	0.1040095017069236
THREE M SYNDROME 2; 3M2	0.00840336	0.1040095017069236
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.00840336	0.1040095017069236
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00840336	0.1040095017069236
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00840336	0.1040095017069236
NEU-LAXOVA SYNDROME	0.00840336	0.1040095017069236
FEINGOLD SYNDROME 1; FGLDS1	0.00840336	0.1040095017069236
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00840336	0.1040095017069236
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.00840336	0.1040095017069236
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00840336	0.1040095017069236
SPONASTRIME DYSPLASIA	0.00840336	0.1040095017069236
MEIER-GORLIN SYNDROME 8; MGORS8	0.00840336	0.1040095017069236
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.008284174	0.10253432077091211
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.008270314	0.10236277371191929
BARDET-BIEDL SYNDROME 4; BBS4	0.00822202	0.10176503246610402
AYME-GRIPP SYNDROME; AYGRP	0.00822202	0.10176503246610402
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00822202	0.10176503246610402
19P13.13 MICRODELETION SYNDROME	0.008179234	0.1012354644671093
MARDEN-WALKER SYNDROME	0.008179234	0.1012354644671093
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.008150294	0.10087727024724981
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.008127704	0.10059767081993032
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.008127704	0.10059767081993032
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.008059213999999999	0.09974996100243977
AARSKOG-SCOTT SYNDROME	0.008059213999999999	0.09974996100243977
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.008	0.09901706146772109
LIPOID PROTEINOSIS	0.008	0.09901706146772109
PROGNATHISM, MANDIBULAR	0.008	0.09901706146772109
BLACKFAN-DIAMOND ANEMIA	0.008	0.09901706146772109
CHEILITIS GLANDULARIS	0.008	0.09901706146772109
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.008	0.09901706146772109
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.008	0.09901706146772109
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.008	0.09901706146772109
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.008	0.09901706146772109
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.008	0.09901706146772109
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.008	0.09901706146772109
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.008	0.09901706146772109
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.008	0.09901706146772109
NOONAN SYNDROME 4; NS4	0.008	0.09901706146772109
NAKAJO-NISHIMURA SYNDROME	0.008	0.09901706146772109
FRYNS-SMEETS-THIRY SYNDROME	0.008	0.09901706146772109
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.008	0.09901706146772109
MENTAL RETARDATION, X-LINKED 19	0.008	0.09901706146772109
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.09843489065482161
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.09843489065482161
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.007952964	0.09843489065482161
300270 ADRENOMYODYSTROPHY	0.007952964	0.09843489065482161
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.09843489065482161
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.09843489065482161
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00790842	0.09788356365656936
SEVERE CANAVAN DISEASE	0.007791934	0.09644180097880324
NIEMANN-PICK DISEASE TYPE C	0.007791934	0.09644180097880324
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.007791934	0.09644180097880324
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.007791934	0.09644180097880324
INFANTILE SYSTEMIC HYALINOSIS	0.007751949999999999	0.09594691370558756
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00773862	0.09578192652691697
CAMURATI-ENGELMANN DISEASE	0.00773862	0.09578192652691697
14Q12 MICRODELETION SYNDROME	0.00772476	0.09561037946792415
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007640864	0.09457198754431216
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0076047400000000005	0.09412487600325467
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0076047400000000005	0.09412487600325467
15Q26 OVERGROWTH SYNDROME	0.0076047400000000005	0.09412487600325467
MESOMELIA-SYNOSTOSES SYNDROME	0.0076047400000000005	0.09412487600325467
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.007587804	0.09391525688412751
MACROCEPHALY/AUTISM SYNDROME	0.007587804	0.09391525688412751
TIMOTHY SYNDROME; TS	0.007587804	0.09391525688412751
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.007587804	0.09391525688412751
AUSTRALIA ANTIGEN	0.007587804	0.09391525688412751
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.007587804	0.09391525688412751
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.007587804	0.09391525688412751
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.007587804	0.09391525688412751
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.007587804	0.09391525688412751
MENTAL RETARDATION, X-LINKED 88	0.007587804	0.09391525688412751
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.007582150000000001	0.0938452765759352
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.007454094	0.09226031047302137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.007454094	0.09226031047302137
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.007454094	0.09226031047302137
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.09168249641082649
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00740741	0.09168249641082649
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00740741	0.09168249641082649
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00740741	0.09168249641082649
CRANIOFACIAL DYSSYNOSTOSIS	0.00740741	0.09168249641082649
DISTAL MONOSOMY 10P	0.00740741	0.09168249641082649
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00740741	0.09168249641082649
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.09168249641082649
TRISOMY XQ28	0.00740741	0.09168249641082649
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00740741	0.09168249641082649
COG8-CDG	0.00740741	0.09168249641082649
NEONATAL ADRENOLEUKODYSTROPHY	0.00740741	0.09168249641082649
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.09168249641082649
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.09168249641082649
DPM1-CDG	0.00740741	0.09168249641082649
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.09168249641082649
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00740741	0.09168249641082649
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.09168249641082649
CROME SYNDROME	0.00740741	0.09168249641082649
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00740741	0.09168249641082649
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.09168249641082649
ADRENOMYODYSTROPHY	0.00740741	0.09168249641082649
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.09168249641082649
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00740741	0.09168249641082649
HEREDITARY METHEMOGLOBINEMIA	0.00740741	0.09168249641082649
MONOSOMY 5P	0.00740741	0.09168249641082649
LOWRY-MACLEAN SYNDROME	0.00740741	0.09168249641082649
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.09168249641082649
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.09168249641082649
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.09168249641082649
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00740741	0.09168249641082649
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.09168249641082649
SECKEL SYNDROME 7; SCKL7	0.00740741	0.09168249641082649
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00740741	0.09168249641082649
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00740741	0.09168249641082649
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.007260204	0.08986050821702432
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.007256964	0.0898204063071299
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.007256964	0.0898204063071299
WYBURN-MASON SYNDROME	0.007256964	0.0898204063071299
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.007256964	0.0898204063071299
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.007256964	0.0898204063071299
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.007256964	0.0898204063071299
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.007256964	0.0898204063071299
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.007256964	0.0898204063071299
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.007256964	0.0898204063071299
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.007256964	0.0898204063071299
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.007256964	0.0898204063071299
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.007256964	0.0898204063071299
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.007256964	0.0898204063071299
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.007256964	0.0898204063071299
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.007256964	0.0898204063071299
MEDULLOBLASTOMA	0.007256964	0.0898204063071299
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.007256964	0.0898204063071299
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.007256964	0.0898204063071299
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.007256964	0.0898204063071299
AICARDI-GOUTIRES SYNDROME	0.007256964	0.0898204063071299
CITRULLINEMIA, CLASSIC	0.007256964	0.0898204063071299
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007256964	0.0898204063071299
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.007256964	0.0898204063071299
NARP SYNDROME	0.007256964	0.0898204063071299
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.007256964	0.0898204063071299
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007256964	0.0898204063071299
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.007256964	0.0898204063071299
JOUBERT SYNDROME 14	0.007256964	0.0898204063071299
MACHADO-JOSEPH DISEASE TYPE 2	0.00724638	0.0896894067348081
PREECLAMPSIA	0.00724638	0.0896894067348081
BRONCHOPULMONARY DYSPLASIA	0.00724638	0.0896894067348081
MACHADO-JOSEPH DISEASE TYPE 3	0.00724638	0.0896894067348081
MACHADO-JOSEPH DISEASE TYPE 1	0.00724638	0.0896894067348081
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00724638	0.0896894067348081
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00724638	0.0896894067348081
NEURALGIC AMYOTROPHY	0.00724638	0.0896894067348081
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00724638	0.0896894067348081
HEREDITARY HYPEREKPLEXIA	0.00724638	0.0896894067348081
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00724638	0.0896894067348081
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00704225	0.08716286264013236
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00704225	0.08716286264013236
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00704225	0.08716286264013236
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00704225	0.08716286264013236
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00704225	0.08716286264013236
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00704225	0.08716286264013236
HYPERLEXIA	0.00704225	0.08716286264013236
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0069085399999999995	0.08550791622902623
OROFACIODIGITAL SYNDROME IX; OFD9	0.006718394	0.08315445395779607
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.006718394	0.08315445395779607
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.006718394	0.08315445395779607
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.006718394	0.08315445395779607
GALLOWAY-MOWAT SYNDROME	0.006718394	0.08315445395779607
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.006718394	0.08315445395779607
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.006718394	0.08315445395779607
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.006718394	0.08315445395779607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.006718394	0.08315445395779607
CEDNIK SYNDROME	0.006718394	0.08315445395779607
PELGER-HUET ANOMALY; PHA	0.006718394	0.08315445395779607
3Q29 MICRODUPLICATION SYNDROME	0.006718394	0.08315445395779607
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.006718394	0.08315445395779607
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.006718394	0.08315445395779607
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.006718394	0.08315445395779607
POLYMYOCLONUS, INFANTILE	0.00671141	0.08306801206313476
RHABDOID TUMOR	0.00671141	0.08306801206313476
MENTAL RETARDATION, X-LINKED 82	0.00671141	0.08306801206313476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.00671141	0.08306801206313476
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00671141	0.08306801206313476
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00671141	0.08306801206313476
GRAFT VERSUS HOST DISEASE	0.00671141	0.08306801206313476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00671141	0.08306801206313476
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00671141	0.08306801206313476
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	0.08306801206313476
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	0.08306801206313476
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00671141	0.08306801206313476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00671141	0.08306801206313476
BEHCET SYNDROME	0.00671141	0.08306801206313476
9Q21.13 MICRODELETION SYNDROME	0.00671141	0.08306801206313476
KAWASAKI DISEASE	0.00671141	0.08306801206313476
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00671141	0.08306801206313476
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00671141	0.08306801206313476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00671141	0.08306801206313476
BETA-THALASSEMIA	0.00671141	0.08306801206313476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00671141	0.08306801206313476
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00671141	0.08306801206313476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00671141	0.08306801206313476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00671141	0.08306801206313476
46,XY SEX REVERSAL 9; SRXY9	0.00671141	0.08306801206313476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00671141	0.08306801206313476
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	0.08306801206313476
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00671141	0.08306801206313476
PETERS-PLUS SYNDROME; PTRPLS	0.006643314000000001	0.08222517883592152
3C SYNDROME	0.006643314	0.08222517883592151
OROFACIODIGITAL SYNDROME TYPE 6	0.006643314	0.08222517883592151
PETERS PLUS SYNDROME	0.006643314	0.08222517883592151
CORNEODERMATOOSSEOUS SYNDROME	0.006594630000000001	0.08162261050835971
SSR4-CDG	0.006404794	0.07927298514826141
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.006404794	0.07927298514826141
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.006404794	0.07927298514826141
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.006404794	0.07927298514826141
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.006404794	0.07927298514826141
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.006404794	0.07927298514826141
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.006404794	0.07927298514826141
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.006404794	0.07927298514826141
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.006404794	0.07927298514826141
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.006404794	0.07927298514826141
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006284774	0.07778748168359192
MATERNAL PHENYLKETONURIA	0.006284774	0.07778748168359192
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0062483239999999995	0.0773363351972796
COFFIN-SIRIS SYNDROME 3; CSS3	0.0062483239999999995	0.0773363351972796
COFFIN-SIRIS SYNDROME 4; CSS4	0.0062483239999999995	0.0773363351972796
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0062483239999999995	0.0773363351972796
GENITOPATELLAR SYNDROME	0.0062483239999999995	0.0773363351972796
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00617284	0.07640205971380093
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00617284	0.07640205971380093
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00617284	0.07640205971380093
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00617284	0.07640205971380093
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00617284	0.07640205971380093
BRITTLE CORNEA SYNDROME	0.00617284	0.07640205971380093
ERYTHEMA OF ACRAL REGIONS	0.00617284	0.07640205971380093
TEETH, FUSED	0.00617284	0.07640205971380093
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00617284	0.07640205971380093
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00617284	0.07640205971380093
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00617284	0.07640205971380093
JUVENILE PAGET DISEASE	0.00617284	0.07640205971380093
SEVERE COMBINED IMMUNODEFICIENCY	0.00617284	0.07640205971380093
ISOLATED HEMIHYPERPLASIA	0.00617284	0.07640205971380093
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00617284	0.07640205971380093
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.00617284	0.07640205971380093
8Q21.11 MICRODELETION SYNDROME	0.00617284	0.07640205971380093
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00617284	0.07640205971380093
TOOTH SIZE	0.00617284	0.07640205971380093
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.00617284	0.07640205971380093
EPILEPSY-TELANGIECTASIA SYNDROME	0.00617284	0.07640205971380093
LEGG-CALV-PERTHES DISEASE	0.00617284	0.07640205971380093
PREMATURE OVARIAN FAILURE 2B	0.00617284	0.07640205971380093
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00617284	0.07640205971380093
PARAMOLAR TUBERCLE OF BOLK	0.00617284	0.07640205971380093
MULTIPLE OSTEOCHONDROMAS	0.00617284	0.07640205971380093
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00617284	0.07640205971380093
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00617284	0.07640205971380093
ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	0.00617284	0.07640205971380093
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.00617284	0.07640205971380093
DEAFNESS-CRANIOFACIAL SYNDROME	0.00617284	0.07640205971380093
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00617284	0.07640205971380093
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00617284	0.07640205971380093
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00617284	0.07640205971380093
BUSCHKE-OLLENDORFF SYNDROME	0.00617284	0.07640205971380093
MOLAR I REINCLUSION	0.00617284	0.07640205971380093
DENS EVAGINATUS	0.00617284	0.07640205971380093
125300 DENS IN DENTE AND PALATAL INVAGINATIONS	0.00617284	0.07640205971380093
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00617284	0.07640205971380093
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00617284	0.07640205971380093
SPLIT LOWER LIP	0.00617284	0.07640205971380093
INCISORS, FUSED MANDIBULAR	0.00617284	0.07640205971380093
TEETH, ODD SHAPES OFLOBODONTIA, INCLUDED	0.00617284	0.07640205971380093
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.00617284	0.07640205971380093
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.00617284	0.07640205971380093
FAMILIAL TUMORAL CALCINOSIS	0.00617284	0.07640205971380093
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00617284	0.07640205971380093
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.00617284	0.07640205971380093
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00617284	0.07640205971380093
LAMELLAR ICHTHYOSIS	0.00617284	0.07640205971380093
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00617284	0.07640205971380093
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00617284	0.07640205971380093
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00617284	0.07640205971380093
BANGSTAD SYNDROME	0.00617284	0.07640205971380093
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00617284	0.07640205971380093
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00617284	0.07640205971380093
VELO-FACIAL-SKELETAL SYNDROME	0.00617284	0.07640205971380093
NON-DISTAL TRISOMY 13Q	0.00617284	0.07640205971380093
CANINE TEETH, ABSENCE OF UPPER PERMANENT	0.00617284	0.07640205971380093
CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH	0.00617284	0.07640205971380093
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00617284	0.07640205971380093
CHOPS SYNDROME; CHOPS	0.006128303999999999	0.07585083173261012
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.006101114	0.07551429749494672
HERNNDEZ-AGUIRRE NEGRETE SYNDROME	0.006101114	0.07551429749494672
LATHOSTEROLOSIS	0.006101114	0.07551429749494672
MOSAIC TRISOMY 9	0.006101114	0.07551429749494672
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.006101114	0.07551429749494672
XQ27.3Q28 DUPLICATION SYNDROME	0.006101114	0.07551429749494672
NOONAN SYNDROME 11; NS11	0.006101114	0.07551429749494672
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.006101114	0.07551429749494672
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.006101114	0.07551429749494672
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.006101114	0.07551429749494672
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.006101114	0.07551429749494672
JEUNE SYNDROME	0.006097760000000001	0.07547278459192638
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.006097760000000001	0.07547278459192638
INCONTINENTIA PIGMENTI	0.006010034	0.0743869882501367
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.006010034	0.0743869882501367
8Q12 MICRODUPLICATION SYNDROME	0.006010034	0.0743869882501367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.006010034	0.0743869882501367
CHROMOSOME 15Q25 DELETION SYNDROME	0.006010034	0.0743869882501367
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006010034	0.0743869882501367
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.006010034	0.0743869882501367
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.006010034	0.0743869882501367
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.006010034	0.0743869882501367
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.006010034	0.0743869882501367
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.006010034	0.0743869882501367
8P23.1 MICRODELETION SYNDROME	0.006010034	0.0743869882501367
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.006010034	0.0743869882501367
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00585924	0.07252059090426627
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00585924	0.07252059090426627
CRISS-CROSS HEART	0.00585924	0.07252059090426627
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00573922	0.07103508743959677
LARON SYNDROME	0.00573922	0.07103508743959677
ATELOSTEOGENESIS TYPE II	0.00573922	0.07103508743959677
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00573922	0.07103508743959677
PALLISTER-KILLIAN SYNDROME	0.005702769999999999	0.07058394095328446
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00558275	0.069098437488615
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00558275	0.069098437488615
RIN2 SYNDROME	0.00558275	0.069098437488615
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00558275	0.069098437488615
CAMPOMELIA, CUMMING TYPE	0.00558275	0.069098437488615
BASAL CELL NEVUS SYNDROME	0.00558275	0.069098437488615
NOSE, ANOMALOUS SHAPE OF	0.00555556	0.06876190325095158
ZIMMERMANN-LABAND SYNDROME	0.00555556	0.06876190325095158
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00555556	0.06876190325095158
JOHNSON NEUROECTODERMAL SYNDROME	0.00555556	0.06876190325095158
KAPUR-TORIELLO SYNDROME	0.00555556	0.06876190325095158
260150 PALANT CLEFT PALATE SYNDROME	0.00555556	0.06876190325095158
CONGENITAL HYDROCEPHALUS	0.00555556	0.06876190325095158
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00555556	0.06876190325095158
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00555556	0.06876190325095158
3M SYNDROME	0.00555556	0.06876190325095158
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00555556	0.06876190325095158
OROFACIAL CLEFT 15	0.00555556	0.06876190325095158
RUIJS-AALFS SYNDROME; RJALS	0.00555556	0.06876190325095158
OROFACIODIGITAL SYNDROME III	0.00555556	0.06876190325095158
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.00555556	0.06876190325095158
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00555556	0.06876190325095158
OROFACIODIGITAL SYNDROME TYPE 3	0.00555556	0.06876190325095158
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00555556	0.06876190325095158
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00555556	0.06876190325095158
DISTAL MONOSOMY 7Q36	0.00555556	0.06876190325095158
THAKKER-DONNAI SYNDROME	0.00555556	0.06876190325095158
BARBER-SAY SYNDROME; BBRSAY	0.00555556	0.06876190325095158
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00555556	0.06876190325095158
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00555556	0.06876190325095158
BEEMER-ERTBRUGGEN SYNDROME	0.00555556	0.06876190325095158
CHROMOSOME 13Q14 DELETION SYNDROME	0.00555556	0.06876190325095158
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00555556	0.06876190325095158
BARBER-SAY SYNDROME	0.00555556	0.06876190325095158
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00555556	0.06876190325095158
CERNUNNOS-XLF DEFICIENCY	0.00555556	0.06876190325095158
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.005471664	0.06772351132733959
DYSTONIA-APHONIA SYNDROME	0.005471664	0.06772351132733959
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00546448	0.06763459400614157
MICROTIA	0.00546448	0.06763459400614157
SPASTIC PARAPLEGIA TYPE 7	0.00546448	0.06763459400614157
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00546448	0.06763459400614157
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.00546448	0.06763459400614157
NEUROFIBROMATOSIS TYPE 1	0.00546448	0.06763459400614157
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00546448	0.06763459400614157
SPINOCEREBELLAR ATAXIA TYPE 36	0.00546448	0.06763459400614157
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00546448	0.06763459400614157
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00546448	0.06763459400614157
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.06763459400614157
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00546448	0.06763459400614157
IMMUNODEFICIENCY 61; IMD61	0.00546448	0.06763459400614157
MENTAL RETARDATION, X-LINKED 99	0.005284894	0.0654118342560488
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.005284894	0.0654118342560488
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.005284894	0.0654118342560488
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.005284894	0.0654118342560488
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.005284894	0.0654118342560488
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.005284894	0.0654118342560488
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.005284894	0.0654118342560488
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.005284894	0.0654118342560488
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.005284894	0.0654118342560488
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.005284894	0.0654118342560488
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.005284894	0.0654118342560488
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0050910040000000005	0.06301203200005175
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0050910040000000005	0.06301203200005175
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.0050910040000000005	0.06301203200005175
CHDIAK-HIGASHI SYNDROME	0.0050910040000000005	0.06301203200005175
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.0050910040000000005	0.06301203200005175
MUCOLIPIDOSIS IV; ML4	0.0050910040000000005	0.06301203200005175
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0050910040000000005	0.06301203200005175
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.0050910040000000005	0.06301203200005175
L1 SYNDROME	0.004989994	0.06176181782769493
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.004989994	0.06176181782769493
ACQUIRED METHEMOGLOBINEMIA	0.00492611	0.06097111708334445
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00492611	0.06097111708334445
GENIOSPASM 1; GSM1	0.00492611	0.06097111708334445
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	0.00492611	0.06097111708334445
PANIC DISORDER 1	0.00492611	0.06097111708334445
MENTAL RETARDATION, X-LINKED 63	0.00492611	0.06097111708334445
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00492611	0.06097111708334445
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00492611	0.06097111708334445
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004763933999999999	0.05896384321327079
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.05865944001205366
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.05865944001205366
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00473934	0.05865944001205366
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00473934	0.05865944001205366
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00473934	0.05865944001205366
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.05865944001205366
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.05865944001205366
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00473934	0.05865944001205366
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.05865944001205366
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.004594134000000001	0.05686220608361842
GALACTOSEMIA	0.004594134000000001	0.05686220608361842
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004594134000000001	0.05686220608361842
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004594134000000001	0.05686220608361842
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.004594134000000001	0.05686220608361842
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.004594134000000001	0.05686220608361842
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.004594134000000001	0.05686220608361842
WEAVER SYNDROME	0.004594134000000001	0.05686220608361842
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.004594134000000001	0.05686220608361842
SHASHI-PENA SYNDROME; SHAPNS	0.004594134000000001	0.05686220608361842
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004594134000000001	0.05686220608361842
CANAVAN DISEASE	0.004594134000000001	0.05686220608361842
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.004594134000000001	0.05686220608361842
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004594134000000001	0.05686220608361842
JOUBERT SYNDROME	0.004594134000000001	0.05686220608361842
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004594134000000001	0.05686220608361842
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004594134000000001	0.05686220608361842
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.004594134000000001	0.05686220608361842
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.004594134000000001	0.05686220608361842
PEHO SYNDROME; PEHO	0.004594134000000001	0.05686220608361842
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004594134000000001	0.05686220608361842
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.004594134000000001	0.05686220608361842
METHYLMALONIC ACIDURIA, CBLB TYPE	0.004594134000000001	0.05686220608361842
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00454545	0.05625963775605661
ALACRIMA, CONGENITAL	0.00454545	0.05625963775605661
CORNEAL DYSTROPHY, MEESMANN	0.00454545	0.05625963775605661
CHRONIC GRAFT VERSUS HOST DISEASE	0.00454545	0.05625963775605661
NEOVASCULAR GLAUCOMA	0.00454545	0.05625963775605661
RETINAL CONE DYSTROPHY 1; RCD1	0.00454545	0.05625963775605661
ISOLATED CONGENITAL ALACRIMA	0.00454545	0.05625963775605661
MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	0.00454545	0.05625963775605661
MACULAR DYSTROPHY, CORNEAL, 1	0.00454545	0.05625963775605661
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00454545	0.05625963775605661
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00454545	0.05625963775605661
LEUKONYCHIA TOTALIS	0.00454545	0.05625963775605661
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00454545	0.05625963775605661
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00454545	0.05625963775605661
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00454545	0.05625963775605661
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00454545	0.05625963775605661
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00454545	0.05625963775605661
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00454545	0.05625963775605661
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00454545	0.05625963775605661
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00454545	0.05625963775605661
CORNEAL FLECK DYSTROPHY	0.00454545	0.05625963775605661
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00454545	0.05625963775605661
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	0.00454545	0.05625963775605661
XERODERMA PIGMENTOSUM VARIANT	0.00454545	0.05625963775605661
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00454545	0.05625963775605661
BOUCHER-NEUHAUSER SYNDROME	0.00454545	0.05625963775605661
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.00454545	0.05625963775605661
BLAU SYNDROME	0.00454545	0.05625963775605661
REACTIVE ARTHRITIS	0.00454545	0.05625963775605661
COGAN SYNDROME	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA 51; RP51	0.00454545	0.05625963775605661
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	0.00454545	0.05625963775605661
CONE DYSTROPHY 4	0.00454545	0.05625963775605661
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00454545	0.05625963775605661
BLUE CONE MONOCHROMATISM	0.00454545	0.05625963775605661
AMOEBIC KERATITIS	0.00454545	0.05625963775605661
MICROPHTHALMIA, ISOLATED 5	0.00454545	0.05625963775605661
BILATERAL ACUTE DEPIGMENTATION OF THE IRIS	0.00454545	0.05625963775605661
VERNAL KERATOCONJUNCTIVITIS	0.00454545	0.05625963775605661
RETINAL CONE DYSTROPHY 4	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 11; CORD11	0.00454545	0.05625963775605661
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 10	0.00454545	0.05625963775605661
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00454545	0.05625963775605661
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00454545	0.05625963775605661
BRADYOPSIA	0.00454545	0.05625963775605661
OLIGOCONE TRICHROMACY	0.00454545	0.05625963775605661
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA	0.00454545	0.05625963775605661
BIRDSHOT CHORIORETINOPATHY	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 8; CORD8	0.00454545	0.05625963775605661
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00454545	0.05625963775605661
LEBER CONGENITAL AMAUROSIS 16	0.00454545	0.05625963775605661
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00454545	0.05625963775605661
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00454545	0.05625963775605661
ACHROMATOPSIA 7; ACHM7	0.00454545	0.05625963775605661
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.00454545	0.05625963775605661
STEVENS-JOHNSON SYNDROME	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA 79	0.00454545	0.05625963775605661
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00454545	0.05625963775605661
OCULOCUTANEOUS ALBINISM TYPE 5	0.00454545	0.05625963775605661
OCULOCUTANEOUS ALBINISM TYPE 6	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00454545	0.05625963775605661
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00454545	0.05625963775605661
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 21; CORD21	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 16	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA 72; RP72	0.00454545	0.05625963775605661
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00454545	0.05625963775605661
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00454545	0.05625963775605661
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.05625963775605661
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.00454545	0.05625963775605661
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00454545	0.05625963775605661
ACHROMATOPSIA	0.00454545	0.05625963775605661
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 17; CORD17	0.00454545	0.05625963775605661
RETINITIS PUNCTATA ALBESCENS	0.00454545	0.05625963775605661
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00454545	0.05625963775605661
ALPORT SYNDROME	0.00454545	0.05625963775605661
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00454545	0.05625963775605661
IDIOPATHIC ANTERIOR UVEITIS	0.00454545	0.05625963775605661
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00454545	0.05625963775605661
OCULOCUTANEOUS ALBINISM TYPE 4	0.00454545	0.05625963775605661
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.00454545	0.05625963775605661
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II	0.00454545	0.05625963775605661
IDIOPATHIC PANUVEITIS	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 6; CORD6	0.00454545	0.05625963775605661
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.05625963775605661
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00454545	0.05625963775605661
IRVAN SYNDROME	0.00454545	0.05625963775605661
TYROSINEMIA TYPE 2	0.00454545	0.05625963775605661
ALACRIMA	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY 5; CORD5	0.00454545	0.05625963775605661
SJGREN-LARSSON SYNDROME	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA 17	0.00454545	0.05625963775605661
BLUE CONE MONOCHROMACY; BCM	0.00454545	0.05625963775605661
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00454545	0.05625963775605661
FLOTCH SYNDROME	0.00454545	0.05625963775605661
PROGRESSIVE CONE DYSTROPHY	0.00454545	0.05625963775605661
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00454545	0.05625963775605661
OCULOCUTANEOUS ALBINISM TYPE 2	0.00454545	0.05625963775605661
CONE DYSTROPHY 3	0.00454545	0.05625963775605661
ALBINISM, OCULAR, TYPE I	0.00454545	0.05625963775605661
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00454545	0.05625963775605661
CONE ROD DYSTROPHY	0.00454545	0.05625963775605661
JALILI SYNDROME	0.00454545	0.05625963775605661
HIDROTIC ECTODERMAL DYSPLASIA	0.00454545	0.05625963775605661
SJOGREN-LARSSON SYNDROME; SLS	0.00454545	0.05625963775605661
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00454545	0.05625963775605661
EEC SYNDROME	0.00454545	0.05625963775605661
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00454545	0.05625963775605661
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.00454545	0.05625963775605661
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.00454545	0.05625963775605661
ECTODERMAL DYSPLASIA SYNDROME	0.00454545	0.05625963775605661
RETINITIS PIGMENTOSA 25; RP25	0.00454545	0.05625963775605661
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00454545	0.05625963775605661
SCRUB TYPHUS	0.00454545	0.05625963775605661
DE SANCTIS-CACCHIONE SYNDROME	0.00454545	0.05625963775605661
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00444444	0.05500942358369979
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00444444	0.05500942358369979
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00444444	0.05500942358369979
SPINOCEREBELLAR ATAXIA TYPE 28	0.00444444	0.05500942358369979
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00444444	0.05500942358369979
ACERULOPLASMINEMIA	0.00444444	0.05500942358369979
GIANT CELL ARTERITIS	0.00444444	0.05500942358369979
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00444444	0.05500942358369979
SPINOCEREBELLAR ATAXIA 42	0.00444444	0.05500942358369979
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00444444	0.05500942358369979
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00444444	0.05500942358369979
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.05500942358369979
CADASIL	0.00444444	0.05500942358369979
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00444444	0.05500942358369979
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.00444444	0.05500942358369979
WOLFRAM SYNDROME 2; WFS2	0.00444444	0.05500942358369979
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00444444	0.05500942358369979
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00444444	0.05500942358369979
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00444444	0.05500942358369979
TRIMETHYLAMINURIA	0.00444444	0.05500942358369979
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.05500942358369979
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00444444	0.05500942358369979
PRIMARY SCLEROSING CHOLANGITIS	0.00444444	0.05500942358369979
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00444444	0.05500942358369979
SPINOCEREBELLAR ATAXIA TYPE 8	0.00444444	0.05500942358369979
CENTRAL NEUROCYTOMA	0.00444444	0.05500942358369979
GLUCAGONOMA	0.00444444	0.05500942358369979
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00444444	0.05500942358369979
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00444444	0.05500942358369979
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004235594	0.052424508931288825
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.004235594	0.052424508931288825
JOUBERT SYNDROME 35; JBTS35	0.004235594	0.052424508931288825
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004235594	0.052424508931288825
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.004235594	0.052424508931288825
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.052424508931288825
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.004235594	0.052424508931288825
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004235594	0.052424508931288825
SLC35A2-CDG	0.004235594	0.052424508931288825
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004235594	0.052424508931288825
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004235594	0.052424508931288825
SRD5A3-CDG	0.004235594	0.052424508931288825
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.004235594	0.052424508931288825
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.004235594	0.052424508931288825
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.004235594	0.052424508931288825
MONOSOMY 13Q34	0.004235594	0.052424508931288825
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004235594	0.052424508931288825
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004235594	0.052424508931288825
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.004235594	0.052424508931288825
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.004235594	0.052424508931288825
HOLOPROSENCEPHALY 5; HPE5	0.004235594	0.052424508931288825
SPINOCEREBELLAR ATAXIA TYPE 13	0.004235594	0.052424508931288825
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.004235594	0.052424508931288825
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.004235594	0.052424508931288825
FREE SIALIC ACID STORAGE DISEASE	0.004235594	0.052424508931288825
SYNDROMIC DIARRHEA	0.004235594	0.052424508931288825
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004235594	0.052424508931288825
RING CHROMOSOME 12 SYNDROME	0.004235594	0.052424508931288825
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.004235594	0.052424508931288825
7P22.1 MICRODUPLICATION SYNDROME	0.004235594	0.052424508931288825
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004235594	0.052424508931288825
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.004235594	0.052424508931288825
ROIFMAN-CHITAYAT SYNDROME	0.004235594	0.052424508931288825
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004235594	0.052424508931288825
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.004235594	0.052424508931288825
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004235594	0.052424508931288825
TRANSALDOLASE DEFICIENCY	0.004235594	0.052424508931288825
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.004235594	0.052424508931288825
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.004235594	0.052424508931288825
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.004235594	0.052424508931288825
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004235594	0.052424508931288825
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.004079124	0.05048785898030704
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.004079124	0.05048785898030704
THYROID HYPOPLASIA	0.004079124	0.05048785898030704
INFANTILE SIALIC ACID STORAGE DISEASE	0.004079124	0.05048785898030704
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004079124	0.05048785898030704
SIALIDOSIS TYPE 2	0.004079124	0.05048785898030704
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004079124	0.05048785898030704
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.004079124	0.05048785898030704
TETRASOMY 5P	0.004079124	0.05048785898030704
SIMPSON-GOLABI-BEHMEL SYNDROME	0.004079124	0.05048785898030704
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.004079124	0.05048785898030704
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.004079124	0.05048785898030704
MULTIPLE SULFATASE DEFICIENCY	0.004079124	0.05048785898030704
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.004079124	0.05048785898030704
MENTAL RETARDATION, X-LINKED 103	0.004079124	0.05048785898030704
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.050109811839623285
POTASSIUM-AGGRAVATED MYOTONIA	0.00404858	0.050109811839623285
CONGENITAL ADRENAL HYPERPLASIA	0.00404858	0.050109811839623285
INCLUSION BODY MYOSITIS	0.00404858	0.050109811839623285
SYSTEMIC SCLEROSIS	0.00404858	0.050109811839623285
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.050109811839623285
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.00404858	0.050109811839623285
ISOLATED POLYCYSTIC LIVER DISEASE	0.00404858	0.050109811839623285
APERT SYNDROME	0.00404858	0.050109811839623285
PRADER-WILLI SYNDROME (TYPE 1)	0.00404858	0.050109811839623285
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.050109811839623285
AORTIC ARCH DEFECTS	0.00404858	0.050109811839623285
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.050109811839623285
LIVER FAILURE, INFANTILE, TRANSIENT	0.00404858	0.050109811839623285
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.050109811839623285
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00404858	0.050109811839623285
OHDO SYNDROME	0.00404858	0.050109811839623285
DERMATOMYOSITIS	0.00404858	0.050109811839623285
HYPOADRENOCORTICISM, FAMILIAL	0.00404858	0.050109811839623285
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.050109811839623285
NEMALINE MYOPATHY 4	0.00404858	0.050109811839623285
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00404858	0.050109811839623285
GMS SYNDROME	0.00404858	0.050109811839623285
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00404858	0.050109811839623285
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00404858	0.050109811839623285
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00404858	0.050109811839623285
COHEN SYNDROME	0.00404858	0.050109811839623285
%608572 BURN-MCKEOWN SYNDROME	0.00404858	0.050109811839623285
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.050109811839623285
ACROCARDIOFACIAL SYNDROME	0.00404858	0.050109811839623285
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00404858	0.050109811839623285
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.00404858	0.050109811839623285
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.050109811839623285
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00404858	0.050109811839623285
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00404858	0.050109811839623285
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00404858	0.050109811839623285
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00404858	0.050109811839623285
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00404858	0.050109811839623285
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00404858	0.050109811839623285
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00404858	0.050109811839623285
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00404858	0.050109811839623285
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00404858	0.050109811839623285
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.050109811839623285
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00404858	0.050109811839623285
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.050109811839623285
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.050109811839623285
PIERRE ROBIN SYNDROME	0.00404858	0.050109811839623285
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00404858	0.050109811839623285
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.00404858	0.050109811839623285
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00404858	0.050109811839623285
PRADER-WILLI SYNDROME (TYPE 2)	0.00404858	0.050109811839623285
601095 HARROD SYNDROME	0.00369004	0.045672114687293694
CROUZON DISEASE	0.00369004	0.045672114687293694
SZARY SYNDROME	0.00369004	0.045672114687293694
KENNERKNECHT SYNDROME	0.00369004	0.045672114687293694
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00369004	0.045672114687293694
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.045672114687293694
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00369004	0.045672114687293694
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00369004	0.045672114687293694
BETA-MANNOSIDOSIS	0.00369004	0.045672114687293694
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.045672114687293694
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.045672114687293694
EPILEPSY-TELANGIECTASIA	0.00369004	0.045672114687293694
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.00369004	0.045672114687293694
DIAMOND-BLACKFAN ANEMIA 4	0.00369004	0.045672114687293694
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.045672114687293694
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00369004	0.045672114687293694
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00369004	0.045672114687293694
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.045672114687293694
JUVENILE POLYPOSIS OF INFANCY	0.00369004	0.045672114687293694
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00369004	0.045672114687293694
JUVENILE POLYPOSIS SYNDROME	0.00369004	0.045672114687293694
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00369004	0.045672114687293694
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00369004	0.045672114687293694
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.045672114687293694
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00369004	0.045672114687293694
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00369004	0.045672114687293694
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00369004	0.045672114687293694
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00369004	0.045672114687293694
ISOLATED BILIARY ATRESIA	0.00369004	0.045672114687293694
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.045672114687293694
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00369004	0.045672114687293694
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.045672114687293694
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00369004	0.045672114687293694
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00369004	0.045672114687293694
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.045672114687293694
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00369004	0.045672114687293694
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00369004	0.045672114687293694
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00369004	0.045672114687293694
HAIRY ELBOWS	0.00369004	0.045672114687293694
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00369004	0.045672114687293694
MCDONOUGH SYNDROME	0.00369004	0.045672114687293694
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00369004	0.045672114687293694
VERVERI-BRADY SYNDROME; VERBRAS	0.00369004	0.045672114687293694
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.045672114687293694
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.045672114687293694
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.045672114687293694
ISOLATED AGAMMAGLOBULINEMIA	0.00369004	0.045672114687293694
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00369004	0.045672114687293694
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00369004	0.045672114687293694
ZECHI-CEIDE SYNDROME	0.00369004	0.045672114687293694
IMMUNODEFICIENCY 55; IMD55	0.00369004	0.045672114687293694
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.045672114687293694
LICHTENSTEIN SYNDROME	0.00369004	0.045672114687293694
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.045672114687293694
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.045672114687293694
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.045672114687293694
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00369004	0.045672114687293694
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00369004	0.045672114687293694
UROFACIAL SYNDROME	0.00369004	0.045672114687293694
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.045672114687293694
MUCOLIPIDOSIS III GAMMA	0.00353357	0.0437354647363119
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00353357	0.0437354647363119
X-LINKED ACROGIGANTISM	0.00353357	0.0437354647363119
HURLER-SCHEIE SYNDROME	0.00353357	0.0437354647363119
FRYNS SYNDROME; FRNS	0.00353357	0.0437354647363119
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00353357	0.0437354647363119
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00353357	0.0437354647363119
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.00353357	0.0437354647363119
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00353357	0.0437354647363119
GALACTOSIALIDOSIS	0.00353357	0.0437354647363119
MORQUIO SYNDROME A	0.00353357	0.0437354647363119
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00353357	0.0437354647363119
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00353357	0.0437354647363119
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00353357	0.0437354647363119
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00353357	0.0437354647363119
NEURAMINIDASE DEFICIENCY	0.00353357	0.0437354647363119
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00353357	0.0437354647363119
SANDHOFF DISEASE	0.00353357	0.0437354647363119
GM1 GANGLIOSIDOSIS	0.00353357	0.0437354647363119
GRFOMA	0.00353357	0.0437354647363119
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00353357	0.0437354647363119
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.0437354647363119
NF1-MICRODELETION SYNDROME	0.00353357	0.0437354647363119
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00353357	0.0437354647363119
FRANK-TER HAAR SYNDROME; FTHS	0.00353357	0.0437354647363119
ALAGILLE SYNDROME	0.00353357	0.0437354647363119
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00353357	0.0437354647363119
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00353357	0.0437354647363119
FRONTOMETAPHYSEAL DYSPLASIA	0.00353357	0.0437354647363119
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00353357	0.0437354647363119
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00353357	0.0437354647363119
CRANIODIAPHYSEAL DYSPLASIA	0.00353357	0.0437354647363119
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00353357	0.0437354647363119
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00353357	0.0437354647363119
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00353357	0.0437354647363119
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00353357	0.0437354647363119
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00353357	0.0437354647363119
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00353357	0.0437354647363119
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00353357	0.0437354647363119
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00353357	0.0437354647363119
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00353357	0.0437354647363119
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.0437354647363119
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00353357	0.0437354647363119
PITUITARY GIGANTISM	0.00353357	0.0437354647363119
BECKWITH-WIEDEMANN SYNDROME	0.00353357	0.0437354647363119
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00353357	0.0437354647363119
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00353357	0.0437354647363119
MUCOLIPIDOSIS TYPE III	0.00353357	0.0437354647363119
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0027147539999999998	0.03360087046096771
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0027147539999999998	0.03360087046096771
EMANUEL SYNDROME	0.0027147539999999998	0.03360087046096771
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0027147539999999998	0.03360087046096771
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0027147539999999998	0.03360087046096771
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027147539999999998	0.03360087046096771
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0027147539999999998	0.03360087046096771
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0027147539999999998	0.03360087046096771
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0027147539999999998	0.03360087046096771
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0027147539999999998	0.03360087046096771
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0027147539999999998	0.03360087046096771
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0027147539999999998	0.03360087046096771
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0027147539999999998	0.03360087046096771
OROFACIODIGITAL SYNDROME TYPE 4	0.0027147539999999998	0.03360087046096771
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0027147539999999998	0.03360087046096771
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0027147539999999998	0.03360087046096771
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0027147539999999998	0.03360087046096771
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.0027147539999999998	0.03360087046096771
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0027147539999999998	0.03360087046096771
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0027147539999999998	0.03360087046096771
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0027147539999999998	0.03360087046096771
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0027147539999999998	0.03360087046096771
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0027147539999999998	0.03360087046096771
PEHO SYNDROME	0.0027147539999999998	0.03360087046096771
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0027147539999999998	0.03360087046096771
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0027147539999999998	0.03360087046096771
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0027147539999999998	0.03360087046096771
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0027147539999999998	0.03360087046096771
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027147539999999998	0.03360087046096771
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0027147539999999998	0.03360087046096771
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.0027147539999999998	0.03360087046096771
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0027147539999999998	0.03360087046096771
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0027147539999999998	0.03360087046096771
AU-KLINE SYNDROME; AUKS	0.0027147539999999998	0.03360087046096771
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0027147539999999998	0.03360087046096771
JOUBERT SYNDROME WITH RENAL DEFECT	0.0027147539999999998	0.03360087046096771
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.0027147539999999998	0.03360087046096771
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0027147539999999998	0.03360087046096771
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0027147539999999998	0.03360087046096771
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0027147539999999998	0.03360087046096771
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0027147539999999998	0.03360087046096771
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0027147539999999998	0.03360087046096771
RFT1-CDG	0.0027147539999999998	0.03360087046096771
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0027147539999999998	0.03360087046096771
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0027147539999999998	0.03360087046096771
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0027147539999999998	0.03360087046096771
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0027147539999999998	0.03360087046096771
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0027147539999999998	0.03360087046096771
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0027147539999999998	0.03360087046096771
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0027147539999999998	0.03360087046096771
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0027147539999999998	0.03360087046096771
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0027147539999999998	0.03360087046096771
8P11.2 DELETION SYNDROME	0.0027147539999999998	0.03360087046096771
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0027147539999999998	0.03360087046096771
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.0027147539999999998	0.03360087046096771
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.0027147539999999998	0.03360087046096771
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0027147539999999998	0.03360087046096771
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0027147539999999998	0.03360087046096771
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0027147539999999998	0.03360087046096771
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0027147539999999998	0.03360087046096771
STT3B-CDG	0.0027147539999999998	0.03360087046096771
STT3A-CDG	0.0027147539999999998	0.03360087046096771
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0027147539999999998	0.03360087046096771
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0027147539999999998	0.03360087046096771
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0027147539999999998	0.03360087046096771
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0027147539999999998	0.03360087046096771
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0027147539999999998	0.03360087046096771
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0027147539999999998	0.03360087046096771
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0027147539999999998	0.03360087046096771
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0027147539999999998	0.03360087046096771
PMM2-CDG	0.0027147539999999998	0.03360087046096771
GALACTOSE EPIMERASE DEFICIENCY	0.0027147539999999998	0.03360087046096771
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.0027147539999999998	0.03360087046096771
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.0027147539999999998	0.03360087046096771
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0027147539999999998	0.03360087046096771
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0027147539999999998	0.03360087046096771
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0027147539999999998	0.03360087046096771
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0027147539999999998	0.03360087046096771
HAREL-YOON SYNDROME; HAYOS	0.0027147539999999998	0.03360087046096771
PONTINE TEGMENTAL CAP DYSPLASIA	0.0027147539999999998	0.03360087046096771
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.0027147539999999998	0.03360087046096771
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.0027147539999999998	0.03360087046096771
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0027147539999999998	0.03360087046096771
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0027147539999999998	0.03360087046096771
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0027147539999999998	0.03360087046096771
MONOSOMY 9Q22.3	0.0027147539999999998	0.03360087046096771
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0027147539999999998	0.03360087046096771
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0027147539999999998	0.03360087046096771
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0027147539999999998	0.03360087046096771
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0027147539999999998	0.03360087046096771
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0027147539999999998	0.03360087046096771
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0027147539999999998	0.03360087046096771
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0027147539999999998	0.03360087046096771
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0027147539999999998	0.03360087046096771
PEHO-LIKE SYNDROME; PEHOL	0.0027147539999999998	0.03360087046096771
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0027147539999999998	0.03360087046096771
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0025947339999999996	0.032115366996298224
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.032115366996298224
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0025947339999999996	0.032115366996298224
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0025947339999999996	0.032115366996298224
TEMTAMY SYNDROME; TEMTYS	0.0025947339999999996	0.032115366996298224
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0025947339999999996	0.032115366996298224
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.032115366996298224
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0025947339999999996	0.032115366996298224
TRISOMY 8Q	0.0025947339999999996	0.032115366996298224
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0025947339999999996	0.032115366996298224
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.0025947339999999996	0.032115366996298224
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0025947339999999996	0.032115366996298224
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0025947339999999996	0.032115366996298224
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.032115366996298224
ROBERTS SYNDROME	0.0025947339999999996	0.032115366996298224
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0025947339999999996	0.032115366996298224
GRACILE BONE DYSPLASIA; GCLEB	0.0025947339999999996	0.032115366996298224
ADAMS-OLIVER SYNDROME 1; AOS1	0.0025947339999999996	0.032115366996298224
AL-RAQAD SYNDROME; ARS	0.0025947339999999996	0.032115366996298224
RAINE SYNDROME	0.0025947339999999996	0.032115366996298224
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0025947339999999996	0.032115366996298224
RUVALCABA SYNDROME	0.0025947339999999996	0.032115366996298224
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0025947339999999996	0.032115366996298224
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.032115366996298224
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0025947339999999996	0.032115366996298224
CODAS SYNDROME	0.0025947339999999996	0.032115366996298224
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.032115366996298224
CINCA SYNDROME	0.0025947339999999996	0.032115366996298224
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.032115366996298224
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0025947339999999996	0.032115366996298224
MARINESCO-SJGREN SYNDROME	0.0025947339999999996	0.032115366996298224
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0025947339999999996	0.032115366996298224
OROFACIODIGITAL SYNDROME VI	0.0025947339999999996	0.032115366996298224
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.032115366996298224
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.032115366996298224
PHENOBARBITAL EMBRYOPATHY	0.0025947339999999996	0.032115366996298224
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0021691999999999996	0.02684847621697257
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.02684847621697257
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0021691999999999996	0.02684847621697257
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.02684847621697257
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.02684847621697257
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0021691999999999996	0.02684847621697257
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0021691999999999996	0.02684847621697257
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0021691999999999996	0.02684847621697257
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.02684847621697257
KABUKI SYNDROME	0.0021691999999999996	0.02684847621697257
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.02684847621697257
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.02684847621697257
SMITH-KINGSMORE SYNDROME; SKS	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.02684847621697257
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.02684847621697257
SANDIFER SYNDROME	0.0021691999999999996	0.02684847621697257
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0021691999999999996	0.02684847621697257
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0021691999999999996	0.02684847621697257
DESMOSTEROLOSIS	0.0021691999999999996	0.02684847621697257
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.02684847621697257
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0021691999999999996	0.02684847621697257
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.02684847621697257
CITRULLINEMIA TYPE I	0.0021691999999999996	0.02684847621697257
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0021691999999999996	0.02684847621697257
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.02684847621697257
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.02684847621697257
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0021691999999999996	0.02684847621697257
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.02684847621697257
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.02684847621697257
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0021691999999999996	0.02684847621697257
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0021691999999999996	0.02684847621697257
COMBINED SAPOSIN DEFICIENCY	0.0021691999999999996	0.02684847621697257
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0021691999999999996	0.02684847621697257
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.02684847621697257
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0021691999999999996	0.02684847621697257
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.02684847621697257
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0021691999999999996	0.02684847621697257
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.02684847621697257
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.02684847621697257
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.02684847621697257
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.02684847621697257
TEMPLE SYNDROME	0.0021691999999999996	0.02684847621697257
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0021691999999999996	0.02684847621697257
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.02684847621697257
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.02684847621697257
RETINITIS PIGMENTOSA 59; RP59	0.0021691999999999996	0.02684847621697257
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0021691999999999996	0.02684847621697257
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0021691999999999996	0.02684847621697257
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0021691999999999996	0.02684847621697257
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0021691999999999996	0.02684847621697257
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.02684847621697257
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.02684847621697257
NEONATAL MARFAN SYNDROME	0.0021691999999999996	0.02684847621697257
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.02684847621697257
CRISPONI SYNDROME	0.0021691999999999996	0.02684847621697257
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.02684847621697257
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0021691999999999996	0.02684847621697257
CHIARI MALFORMATION TYPE II	0.0021691999999999996	0.02684847621697257
CHARGE SYNDROME	0.0021691999999999996	0.02684847621697257
COCKAYNE SYNDROME	0.0021691999999999996	0.02684847621697257
CLASSIC GALACTOSEMIA	0.0021691999999999996	0.02684847621697257
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0021691999999999996	0.02684847621697257
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0021691999999999996	0.02684847621697257
MEIER-GORLIN SYNDROME 2; MGORS2	0.0021691999999999996	0.02684847621697257
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.02684847621697257
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0021691999999999996	0.02684847621697257
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.0021691999999999996	0.02684847621697257
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0021691999999999996	0.02684847621697257
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0021691999999999996	0.02684847621697257
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0021691999999999996	0.02684847621697257
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.02684847621697257
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.02684847621697257
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.02684847621697257
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.02684847621697257
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.02684847621697257
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0021691999999999996	0.02684847621697257
STUVE-WIEDEMANN SYNDROME	0.0021691999999999996	0.02684847621697257
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0021691999999999996	0.02684847621697257
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0021691999999999996	0.02684847621697257
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.02684847621697257
NATIVE AMERICAN MYOPATHY	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.02684847621697257
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.02684847621697257
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.02684847621697257
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.02684847621697257
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.025362972752303085
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.025362972752303085
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.025362972752303085
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00204918	0.025362972752303085
CRANIOSYNOSTOSIS 2	0.00204918	0.025362972752303085
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.025362972752303085
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00204918	0.025362972752303085
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.025362972752303085
LARSEN SYNDROME	0.00204918	0.025362972752303085
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.025362972752303085
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00204918	0.025362972752303085
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00204918	0.025362972752303085
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00204918	0.025362972752303085
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00204918	0.025362972752303085
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00204918	0.025362972752303085
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.025362972752303085
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00204918	0.025362972752303085
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.025362972752303085
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.025362972752303085
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00204918	0.025362972752303085
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.025362972752303085
MULTIPLE SYNOSTOSES SYNDROME 2	0.00204918	0.025362972752303085
PYCNODYSOSTOSIS	0.00204918	0.025362972752303085
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00204918	0.025362972752303085
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.025362972752303085
SATOYOSHI SYNDROME	0.00204918	0.025362972752303085
EIKEN SYNDROME	0.00204918	0.025362972752303085
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.025362972752303085
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.025362972752303085
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.025362972752303085
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.025362972752303085
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00204918	0.025362972752303085
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.025362972752303085
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.025362972752303085
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00204918	0.025362972752303085
OROFACIODIGITAL SYNDROME I; OFD1	0.00204918	0.025362972752303085
FOCAL DERMAL HYPOPLASIA; FDH	0.00204918	0.025362972752303085
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00204918	0.025362972752303085
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.025362972752303085
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.025362972752303085
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.025362972752303085
ADAMS-OLIVER SYNDROME 5; AOS5	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.025362972752303085
POTOCKI-SHAFFER SYNDROME	0.00204918	0.025362972752303085
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00204918	0.025362972752303085
GRANGE SYNDROME; GRNG	0.00204918	0.025362972752303085
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.025362972752303085
RHYNS SYNDROME; RHYNS	0.00204918	0.025362972752303085
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.025362972752303085
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00204918	0.025362972752303085
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00204918	0.025362972752303085
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00204918	0.025362972752303085
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00204918	0.025362972752303085
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00204918	0.025362972752303085
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.025362972752303085
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00204918	0.025362972752303085
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.025362972752303085
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00204918	0.025362972752303085
PFEIFFER SYNDROME	0.00204918	0.025362972752303085
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.025362972752303085
608028 THAI SYMPHALANGISM SYNDROME	0.00204918	0.025362972752303085
THANATOPHORIC DYSPLASIA	0.00204918	0.025362972752303085
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.025362972752303085
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00204918	0.025362972752303085
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00204918	0.025362972752303085
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00204918	0.025362972752303085
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00204918	0.025362972752303085
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.025362972752303085
SILLENCE SYNDROME	0.00204918	0.025362972752303085
CRANIOECTODERMAL DYSPLASIA 1	0.00204918	0.025362972752303085
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00204918	0.025362972752303085
SHORT SYNDROME	0.00204918	0.025362972752303085
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.025362972752303085
PSEUDOACHONDROPLASIA	0.00204918	0.025362972752303085
ODONTOCHONDRODYSPLASIA; ODCD	0.00204918	0.025362972752303085
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.025362972752303085
ATELOSTEOGENESIS TYPE I	0.00204918	0.025362972752303085
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.025362972752303085
BANKI SYNDROME	0.00204918	0.025362972752303085
SYMPHALANGISM, DISTAL	0.00204918	0.025362972752303085
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00204918	0.025362972752303085
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.025362972752303085
THANATOPHORIC DYSPLASIA TYPE 1	0.00204918	0.025362972752303085
LERI PLEONOSTEOSIS	0.00204918	0.025362972752303085
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.025362972752303085
20P13 MICRODELETION SYNDROME	0.00204918	0.025362972752303085
SUMMITT SYNDROME	0.00204918	0.025362972752303085
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.025362972752303085
ACRODYSOSTOSIS	0.00204918	0.025362972752303085
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00204918	0.025362972752303085
METATROPIC DYSPLASIA	0.00204918	0.025362972752303085
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.025362972752303085
GENITOPALATOCARDIAC SYNDROME	0.00204918	0.025362972752303085
MONOSOMY 13Q14	0.00204918	0.025362972752303085
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00204918	0.025362972752303085
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.025362972752303085
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.025362972752303085
DISTAL TRISOMY 5Q	0.00204918	0.025362972752303085
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00204918	0.025362972752303085
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.025362972752303085
FIBROCHONDROGENESIS	0.00204918	0.025362972752303085
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.025362972752303085
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00204918	0.025362972752303085
ENG-STROM SYNDROME	0.00204918	0.025362972752303085
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.025362972752303085
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00204918	0.025362972752303085
FGFR2-RELATED BENT BONE DYSPLASIA	0.00204918	0.025362972752303085
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.00204918	0.025362972752303085
JACOBSEN SYNDROME	0.00204918	0.025362972752303085
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00204918	0.025362972752303085
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.025362972752303085
COOKS SYNDROME	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.025362972752303085
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.025362972752303085
SHORT RIB-POLYDACTYLY SYNDROME	0.00204918	0.025362972752303085
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.025362972752303085
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.025362972752303085
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00204918	0.025362972752303085
WEYERS ACROFACIAL DYSOSTOSIS	0.00204918	0.025362972752303085
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00204918	0.025362972752303085
CRANIOECTODERMAL DYSPLASIA	0.00204918	0.025362972752303085
ACROCALLOSAL SYNDROME; ACLS	0.00204918	0.025362972752303085
WOLCOTT-RALLISON SYNDROME	0.00204918	0.025362972752303085
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.025362972752303085
HYPERTELORISM, TEEBI TYPE	0.00204918	0.025362972752303085
RADIO-RENAL SYNDROME	0.00204918	0.025362972752303085
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00204918	0.025362972752303085
ADAMS-OLIVER SYNDROME	0.00204918	0.025362972752303085
NON-DISTAL MONOSOMY 10Q	0.00204918	0.025362972752303085
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00204918	0.025362972752303085
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.025362972752303085
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.00204918	0.025362972752303085
GREENBERG DYSPLASIA	0.00204918	0.025362972752303085
SYNDACTYLY, TYPE V	0.00204918	0.025362972752303085
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.025362972752303085
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.025362972752303085
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00204918	0.025362972752303085
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.025362972752303085
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00204918	0.025362972752303085
FEINGOLD SYNDROME	0.00204918	0.025362972752303085
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.025362972752303085
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.025362972752303085
CAMPTOBRACHYDACTYLY	0.00204918	0.025362972752303085
HEART-HAND SYNDROME TYPE 3	0.00204918	0.025362972752303085
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00204918	0.025362972752303085
CAREY-FINEMAN-ZITER SYNDROME	0.00204918	0.025362972752303085
PERIPHERAL DYSOSTOSIS	0.00204918	0.025362972752303085
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00204918	0.025362972752303085
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00204918	0.025362972752303085
CHARLIE M SYNDROME	0.00204918	0.025362972752303085
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.025362972752303085
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.025362972752303085
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.025362972752303085
PROXIMAL SYMPHALANGISM	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.025362972752303085
HAND-FOOT-GENITAL SYNDROME; HFG	0.00204918	0.025362972752303085
ROIFMAN SYNDROME	0.00204918	0.025362972752303085
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00204918	0.025362972752303085
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.025362972752303085
OPSISMODYSPLASIA	0.00204918	0.025362972752303085
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00204918	0.025362972752303085
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.025362972752303085
ISOLATED BRACHYCEPHALY	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00204918	0.025362972752303085
MULTIPLE METAPHYSEAL DYSPLASIA	0.00204918	0.025362972752303085
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00204918	0.025362972752303085
DESBUQUOIS DYSPLASIA 1	0.00204918	0.025362972752303085
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.025362972752303085
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.025362972752303085
THANATOPHORIC DYSPLASIA TYPE 2	0.00204918	0.025362972752303085
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.025362972752303085
OROFACIODIGITAL SYNDROME TYPE 1	0.00204918	0.025362972752303085
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.025362972752303085
ATELOSTEOGENESIS, TYPE I; AO1	0.00204918	0.025362972752303085
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.025362972752303085
LAURENCE-MOON SYNDROME	0.00204918	0.025362972752303085
CAMPTOBRACHYDACTYLY	0.00204918	0.025362972752303085
LRI-WEILL DYSCHONDROSTEOSIS	0.00204918	0.025362972752303085
OROFACIODIGITAL SYNDROME IV; OFD4	0.00204918	0.025362972752303085
MLLERIAN APLASIA AND HYPERANDROGENISM	0.00204918	0.025362972752303085
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.025362972752303085
ABRUZZO-ERICKSON SYNDROME	0.00204918	0.025362972752303085
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.025362972752303085
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.025362972752303085
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.025362972752303085
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00204918	0.025362972752303085
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.025362972752303085
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.025362972752303085
CHST3-RELATED SKELETAL DYSPLASIA	0.00204918	0.025362972752303085
PYCNODYSOSTOSIS	0.00204918	0.025362972752303085
ROBERTS SYNDROME; RBS	0.00204918	0.025362972752303085
FRONTORHINY	0.00204918	0.025362972752303085
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.025362972752303085
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.025362972752303085
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.025362972752303085
HYPOCHONDROPLASIA	0.00204918	0.025362972752303085
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00204918	0.025362972752303085
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00204918	0.025362972752303085
URBAN-ROGERS-MEYER SYNDROME	0.00204918	0.025362972752303085
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00204918	0.025362972752303085
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.025362972752303085
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.025362972752303085
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.025362972752303085
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00204918	0.025362972752303085
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00204918	0.025362972752303085
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00204918	0.025362972752303085
2Q37 MONOSOMY	0.00204918	0.025362972752303085
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.025362972752303085
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00204918	0.025362972752303085
WEILL-MARCHESANI SYNDROME	0.00204918	0.025362972752303085
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.006752394243995139
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995139
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.006752394243995139
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.006752394243995139
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.006752394243995139
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.006752394243995139
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.006752394243995139
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.006752394243995139
LISSENCEPHALY 1; LIS1	0.000545554	0.006752394243995139
POTOCKI-SHAFFER SYNDROME	0.000545554	0.006752394243995139
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.006752394243995139
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.006752394243995139
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.006752394243995139
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995139
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.006752394243995139
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.006752394243995139
JOUBERT SYNDROME 6	0.000545554	0.006752394243995139
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.006752394243995139
12Q14 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.006752394243995139
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.006752394243995139
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.006752394243995139
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.006752394243995139
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.006752394243995139
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.006752394243995139
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.006752394243995139
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.006752394243995139
SCHINDLER DISEASE, TYPE I	0.000545554	0.006752394243995139
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.006752394243995139
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.006752394243995139
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.006752394243995139
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.006752394243995139
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.006752394243995139
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.006752394243995139
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.006752394243995139
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.006752394243995139
WOLMAN DISEASE	0.000545554	0.006752394243995139
PALLISTER-HALL SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.006752394243995139
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.006752394243995139
CURRARINO SYNDROME	0.000545554	0.006752394243995139
LARSEN-LIKE SYNDROME	0.000545554	0.006752394243995139
NOONAN SYNDROME 3; NS3	0.000545554	0.006752394243995139
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.006752394243995139
JOUBERT SYNDROME 2	0.000545554	0.006752394243995139
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.006752394243995139
FRIAS SYNDROME	0.000545554	0.006752394243995139
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.006752394243995139
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.006752394243995139
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.006752394243995139
KAGAMI-OGATA SYNDROME	0.000545554	0.006752394243995139
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.006752394243995139
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.006752394243995139
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.006752394243995139
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.006752394243995139
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995139
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.006752394243995139
ROTHMUND-THOMSON SYNDROME	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.006752394243995139
HYDROXYKYNURENINURIA	0.000545554	0.006752394243995139
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000545554	0.006752394243995139
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.006752394243995139
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.006752394243995139
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.006752394243995139
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.006752394243995139
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.006752394243995139
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.006752394243995139
PFEIFFER SYNDROME TYPE 2	0.000545554	0.006752394243995139
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.006752394243995139
MEND SYNDROME; MEND	0.000545554	0.006752394243995139
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.006752394243995139
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.006752394243995139
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.006752394243995139
BRESEK SYNDROME	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.006752394243995139
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.006752394243995139
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.006752394243995139
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.006752394243995139
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.006752394243995139
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000545554	0.006752394243995139
KEUTEL SYNDROME	0.000545554	0.006752394243995139
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.006752394243995139
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.006752394243995139
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.006752394243995139
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.006752394243995139
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.006752394243995139
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.006752394243995139
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.006752394243995139
NETHERTON SYNDROME; NETH	0.000545554	0.006752394243995139
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.006752394243995139
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.006752394243995139
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.006752394243995139
WALKER-WARBURG SYNDROME	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.006752394243995139
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.006752394243995139
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000545554	0.006752394243995139
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.006752394243995139
3MC SYNDROME 2	0.000545554	0.006752394243995139
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995139
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.006752394243995139
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995139
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.006752394243995139
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.006752394243995139
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.006752394243995139
WAARDENBURG-SHAH SYNDROME	0.000545554	0.006752394243995139
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.006752394243995139
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.006752394243995139
PELLAGRA-LIKE SYNDROME	0.000545554	0.006752394243995139
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 7	0.000545554	0.006752394243995139
OROTIC ACIDURIA	0.000545554	0.006752394243995139
DPAGT1-CDG	0.000545554	0.006752394243995139
LISSENCEPHALY 2; LIS2	0.000545554	0.006752394243995139
NAVAJO NEUROHEPATOPATHY	0.000545554	0.006752394243995139
CONGENITAL TOXOPLASMOSIS	0.000545554	0.006752394243995139
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.006752394243995139
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.006752394243995139
ELEJALDE DISEASE	0.000545554	0.006752394243995139
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000545554	0.006752394243995139
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.006752394243995139
WAISMAN SYNDROME; WSMN	0.000545554	0.006752394243995139
TAY-SACHS DISEASE	0.000545554	0.006752394243995139
ALG3-CDG	0.000545554	0.006752394243995139
CURRY-JONES SYNDROME	0.000545554	0.006752394243995139
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.006752394243995139
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.006752394243995139
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.006752394243995139
CDAGS SYNDROME	0.000545554	0.006752394243995139
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.006752394243995139
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.006752394243995139
ZEBRA BODY MYOPATHY	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.006752394243995139
ALG1-CDG	0.000545554	0.006752394243995139
RIGID SPINE SYNDROME	0.000545554	0.006752394243995139
SALLA DISEASE	0.000545554	0.006752394243995139
ALG6-CDG	0.000545554	0.006752394243995139
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.006752394243995139
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.006752394243995139
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.006752394243995139
NOONAN SYNDROME 2; NS2	0.000545554	0.006752394243995139
FRONTOOCULAR SYNDROME	0.000545554	0.006752394243995139
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000545554	0.006752394243995139
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.006752394243995139
PHACE ASSOCIATION	0.000545554	0.006752394243995139
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.006752394243995139
LIG4 SYNDROME	0.000545554	0.006752394243995139
FUMARASE DEFICIENCY; FMRD	0.000545554	0.006752394243995139
BIOTINIDASE DEFICIENCY	0.000545554	0.006752394243995139
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.006752394243995139
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.006752394243995139
GRISCELLI SYNDROME TYPE 1	0.000545554	0.006752394243995139
SCHIZENCEPHALY	0.000545554	0.006752394243995139
TARP SYNDROME; TARPS	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.006752394243995139
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995139
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.006752394243995139
KETOADIPICACIDURIA	0.000545554	0.006752394243995139
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.006752394243995139
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.006752394243995139
PELIZAEUS-MERZBACHER DISEASE	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.006752394243995139
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995139
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.006752394243995139
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.006752394243995139
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.006752394243995139
DISTAL MONOSOMY 19P13.3	0.000545554	0.006752394243995139
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.006752394243995139
LOWRY-MACLEAN SYNDROME	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.006752394243995139
CODAS SYNDROME	0.000545554	0.006752394243995139
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.006752394243995139
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.006752394243995139
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.006752394243995139
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.006752394243995139
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.006752394243995139
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.006752394243995139
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995139
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.006752394243995139
COACH SYNDROME	0.000545554	0.006752394243995139
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.006752394243995139
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.006752394243995139
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995139
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.006752394243995139
ISOLATED PLAGIOCEPHALY	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.006752394243995139
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.006752394243995139
FARBER DISEASE	0.000545554	0.006752394243995139
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.006752394243995139
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.006752394243995139
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.006752394243995139
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995139
TRISOMY 18	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.006752394243995139
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.006752394243995139
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.006752394243995139
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.006752394243995139
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.006752394243995139
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000545554	0.006752394243995139
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.006752394243995139
YUNIS-VARON SYNDROME	0.000545554	0.006752394243995139
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.006752394243995139
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.006752394243995139
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.006752394243995139
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000545554	0.006752394243995139
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000545554	0.006752394243995139
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.006752394243995139
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.006752394243995139
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.006752394243995139
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000545554	0.006752394243995139
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.006752394243995139
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.006752394243995139
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.006752394243995139
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.006752394243995139
ISOVALERIC ACIDEMIA	0.000545554	0.006752394243995139
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.006752394243995139
PROPIONIC ACIDEMIA	0.000545554	0.006752394243995139
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000545554	0.006752394243995139
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.006752394243995139
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.006752394243995139
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.006752394243995139
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.006752394243995139
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.006752394243995139
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.006752394243995139
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.006752394243995139
OPTIC ATROPHY 11; OPA11	0.000545554	0.006752394243995139
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.006752394243995139
LISSENCEPHALY 8; LIS8	0.000545554	0.006752394243995139
GRISCELLI SYNDROME	0.000545554	0.006752394243995139
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.006752394243995139
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.006752394243995139
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.006752394243995139
JOUBERT SYNDROME 28	0.000545554	0.006752394243995139
JOUBERT SYNDROME 27	0.000545554	0.006752394243995139
MECKEL SYNDROME 13; MKS13	0.000545554	0.006752394243995139
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.006752394243995139
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000545554	0.006752394243995139
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000545554	0.006752394243995139
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.006752394243995139
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.006752394243995139
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.006752394243995139
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.006752394243995139
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.006752394243995139
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.006752394243995139
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.006752394243995139
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.006752394243995139
AL KAISSI SYNDROME; ALKAS	0.000545554	0.006752394243995139
DISTAL MONOSOMY 1Q	0.000545554	0.006752394243995139
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.006752394243995139
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.006752394243995139
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.006752394243995139
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.006752394243995139
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.006752394243995139
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.006752394243995139
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.006752394243995139
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.006752394243995139
OTOFACIOCERVICAL SYNDROME	0.000545554	0.006752394243995139
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.006752394243995139
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.006752394243995139
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995139
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.006752394243995139
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.006752394243995139
HYDRANENCEPHALY	0.000545554	0.006752394243995139
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.006752394243995139
ZECHI-CEIDE SYNDROME	0.000545554	0.006752394243995139
DONNAI-BARROW SYNDROME	0.000545554	0.006752394243995139
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.006752394243995139
CUTIS LAXA	0.000545554	0.006752394243995139
OPTIC PATHWAY GLIOMA	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.006752394243995139
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.006752394243995139
GERODERMA OSTEODYSPLASTICA	0.000545554	0.006752394243995139
GERMAN SYNDROME	0.000545554	0.006752394243995139
PERLMAN SYNDROME	0.000545554	0.006752394243995139
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.006752394243995139
COLE-CARPENTER SYNDROME	0.000545554	0.006752394243995139
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.006752394243995139
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.006752394243995139
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.006752394243995139
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.006752394243995139
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.006752394243995139
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.006752394243995139
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995139
XP21 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
20P12.3 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.006752394243995139
N SYNDROME	0.000545554	0.006752394243995139
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.006752394243995139
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.006752394243995139
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.006752394243995139
OPITZ G/BBB SYNDROME	0.000545554	0.006752394243995139
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995139
ICF SYNDROME	0.000545554	0.006752394243995139
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.006752394243995139
6Q25 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
MICRO SYNDROME	0.000545554	0.006752394243995139
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.006752394243995139
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.006752394243995139
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.006752394243995139
1Q44 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
MICROVILLUS INCLUSION DISEASE	0.000545554	0.006752394243995139
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.006752394243995139
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.006752394243995139
EAST SYNDROME	0.000545554	0.006752394243995139
PENTASOMY X	0.000545554	0.006752394243995139
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.006752394243995139
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.006752394243995139
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.006752394243995139
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.006752394243995139
OXOGLUTARIC ACIDURIA	0.000545554	0.006752394243995139
AYM-GRIPP SYNDROME	0.000545554	0.006752394243995139
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.006752394243995139
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.006752394243995139
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.006752394243995139
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995139
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000545554	0.006752394243995139
SENIOR-LOKEN SYNDROME	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000545554	0.006752394243995139
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.006752394243995139
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.006752394243995139
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.006752394243995139
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.006752394243995139
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.006752394243995139
XQ21 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.006752394243995139
TOLUENE EMBRYOPATHY	0.000545554	0.006752394243995139
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.006752394243995139
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.006752394243995139
MEVALONIC ACIDURIA	0.000545554	0.006752394243995139
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.006752394243995139
CONGENITAL VARICELLA SYNDROME	0.000545554	0.006752394243995139
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995139
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.006752394243995139
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.006752394243995139
DYSKERATOSIS CONGENITA	0.000545554	0.006752394243995139
DISTAL TRISOMY 6P	0.000545554	0.006752394243995139
MOSAIC TRISOMY 14	0.000545554	0.006752394243995139
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.006752394243995139
TRISOMY 12P	0.000545554	0.006752394243995139
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.000545554	0.006752394243995139
DEXTROCARDIA	0.000545554	0.006752394243995139
HEREDITARY OROTIC ACIDURIA	0.000545554	0.006752394243995139
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.006752394243995139
2P21 MICRODELETION SYNDROME	0.000545554	0.006752394243995139
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.006752394243995139
PYRIDOXINE-DEPENDENT EPILEPSY	0.000545554	0.006752394243995139
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995139
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.006752394243995139
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.006752394243995139
STEEL SYNDROME; STLS	0.000545554	0.006752394243995139
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.006752394243995139
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.006752394243995139
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.006752394243995139
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.006752394243995139
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.006752394243995139
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.006752394243995139
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.006752394243995139
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.006752394243995139
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.006752394243995139
MAPLE SYRUP URINE DISEASE	0.000545554	0.006752394243995139
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.006752394243995139
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.006752394243995139
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.006752394243995139
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.006752394243995139
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.006752394243995139
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.006752394243995139
CHROMOSOME 5Q12 DELETION SYNDROME	0.000545554	0.006752394243995139
JOUBERT SYNDROME 21	0.000545554	0.006752394243995139
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.006752394243995139
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.006752394243995139
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.006752394243995139
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.006752394243995139
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.006752394243995139
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.006752394243995139
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.006752394243995139
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.006752394243995139
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.006752394243995139
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.006752394243995139
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.006752394243995139
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.006752394243995139
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.006752394243995139
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.006752394243995139
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.006752394243995139
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.006752394243995139
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.006752394243995139
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.006752394243995139
NOONAN SYNDROME 6; NS6	0.000545554	0.006752394243995139
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.006752394243995139
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.006752394243995139
NETHERTON SYNDROME	0.000545554	0.006752394243995139
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.006752394243995139
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000545554	0.006752394243995139
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.006752394243995139
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.006752394243995139
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000545554	0.006752394243995139
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.006752394243995139
JOUBERT SYNDROME 8	0.000545554	0.006752394243995139
LEBER CONGENITAL AMAUROSIS	0.000545554	0.006752394243995139
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.006752394243995139
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.006752394243995139
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.006752394243995139
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.006752394243995139
JOUBERT SYNDROME 7	0.000545554	0.006752394243995139
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.006752394243995139
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.006752394243995139
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.006752394243995139
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.006752394243995139
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.006752394243995139
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.006752394243995139
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.006752394243995139
JOUBERT SYNDROME 15	0.000545554	0.006752394243995139
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.006752394243995139
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.006752394243995139
HOLOPROSENCEPHALY 11	0.000545554	0.006752394243995139
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000545554	0.006752394243995139
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.006752394243995139
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.006752394243995139
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.006752394243995139
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.006752394243995139
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.006752394243995139
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.006752394243995139
LISSENCEPHALY 4	0.000545554	0.006752394243995139
ATELOSTEOGENESIS TYPE III	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.006752394243995139
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.006752394243995139
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.006752394243995139
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.006752394243995139
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.006752394243995139
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.006752394243995139
SECKEL SYNDROME 8; SCKL8	0.000545554	0.006752394243995139
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.006752394243995139
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.006752394243995139
EVEN-PLUS SYNDROME	0.000545554	0.006752394243995139
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.006752394243995139
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.006752394243995139
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.006752394243995139
JOUBERT SYNDROME 26	0.000545554	0.006752394243995139
JOUBERT SYNDROME 25	0.000545554	0.006752394243995139
SECKEL SYNDROME 9; SCKL9	0.000545554	0.006752394243995139
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.006752394243995139
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.006752394243995139
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.006752394243995139
PHACE SYNDROME	0.000545554	0.006752394243995139
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995139
JOUBERT SYNDROME 24	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.006752394243995139
SENIOR-LOKEN SYNDROME 9	0.000545554	0.006752394243995139
RING CHROMOSOME 14 SYNDROME	0.000545554	0.006752394243995139
COG2-CDG	0.000545554	0.006752394243995139
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.006752394243995139
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.006752394243995139
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.006752394243995139
MIRAGE SYNDROME; MIRAGE	0.000545554	0.006752394243995139
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995139
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.006752394243995139
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.006752394243995139
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.006752394243995139
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.006752394243995139
MEIER-GORLIN SYNDROME 7	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.006752394243995139
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.006752394243995139
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.006752394243995139
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.006752394243995139
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.006752394243995139
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.006752394243995139
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.006752394243995139
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.006752394243995139
NOONAN SYNDROME 9; NS9	0.000545554	0.006752394243995139
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.006752394243995139
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.006752394243995139
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.006752394243995139
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000545554	0.006752394243995139
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.006752394243995139
BARDET-BIEDL SYNDROME 2	0.000545554	0.006752394243995139
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.006752394243995139
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.006752394243995139
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.006752394243995139
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.006752394243995139
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.006752394243995139
CULLER-JONES SYNDROME; CJS	0.000545554	0.006752394243995139
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.006752394243995139
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.006752394243995139
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.006752394243995139
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.006752394243995139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.006752394243995139
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.006752394243995139
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.006752394243995139
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.006752394243995139
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000545554	0.006752394243995139
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.006752394243995139
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.006752394243995139
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.006752394243995139
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.006752394243995139
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.006752394243995139
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.006752394243995139
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.006752394243995139
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995139
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.006752394243995139
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.006752394243995139
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.006752394243995139
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.006752394243995139
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.006752394243995139
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.006752394243995139
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.006752394243995139
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.006752394243995139
